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Statement of the Research Question and 
Aims of the Project 
 
The research in this thesis compared apoptosis in Langerhans Cell Histiocytosis 
(LCH) and non-LCH inflammatory diseases (inflammatory controls: inflammatory bowel 
disorder (IBD); sarcoidosis; tonsillitis and foreign body granuloma (controls)). A better 
understanding of the apoptosis in LCH could be important in developing new treatments 
in cancer, neurological and autoimmune diseases.  
The potential role of apoptosis in LCH was determined by: 
 Identifying cells undergoing apoptosis in LCH and control  tissues 
 Quantitatively assessing and comparing apoptotic cells in LCH and 
controls 
 Investigating apoptotic pathways in LCH cells  
 Investigating cytokine profile in conditioned media produced by LCH 
cells 
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Contribution 
 
 Cell composition in LCH and inflammatory control lesions was identified 
by immunofluorescent  and flow cytometry techniques 
 Rates of apoptotic cell death and apoptotic cell composition were 
compared in LCH and non-LCH inflammatory lesions. This work 
indicated that levels of both early and late apoptosis were elevated in LCH. 
CD68+ cells were found to be the major lineage to undergo apoptosis in all 
diseases, but in LCH those cells were dying at the highest rates.    
 Apoptosis-related proteins were examined in LCH and controls. This work 
indicated to a novel, caspase 3-independent apoptotic pathway activated in 
LCH. Apoptotic proteins and apoptosis-related cytokine profiles were 
determined for LCH and control tissues.  
 Human Apoptosis Antibody Assay results were confirmed by microarray 
analysis.   
 This contribution could add to a better understanding of programmed cell 
death in LCH, cancer, autoimmune, neurological and other diseases and 
potentially improve medical treatments.  
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Summary 
 
The single-site form of LCH has a high incidence of spontaneous remission, and 
previous research by Professor Kannourakis and colleagues, provided the initial 
observation of high levels of apoptosis within LCH tissues. The underlying mechanism(s) 
involved in this process is currently unknown.  
Apoptotic cell composition in LCH and non-LCH inflammatory controls 
investigated in this thesis, demonstrated that the majority of cells dying by apoptosis 
belonged to the CD68-positive lineage. In LCH, CD68-positive cells were undergoing 
apoptosis at the highest rates, suggesting that malfunction of the clearance mechanism 
may play a role in the persistence of LCH lesions. The high number of non-engulfed 
apoptotic bodies found in LCH lesions compared to inflammatory controls supported this 
suggestion.  
Numbers of cells undergoing both early and late apoptosis were elevated in LCH 
lesions. In non-LCH lesions, the majority of apoptotic cells were cleared at the early onset 
of apoptosis. This implied the possible presence of factors involved in the regulation of 
“persistent” apoptosis in LCH. Interestingly, apoptosis in LCH was proven to follow 
caspase 3-independent apoptotic pathway while in all inflammatory controls it was 
predominantly caspase 3-dependent.  
Apoptotic protein profiles from LCH and tonsillar tissues were compared using 
the Human Apoptosis Antibody Array. All tested apoptotic proteins were paradoxically 
down-regulated in LCH. Microarray analysis confirmed this observation. Individual 
protein profiles indicated that the apoptotic pathway in LCH was of extrinsic origin.  
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Conditioned medium (CM) obtained from LCH lesional cells, induced apoptosis 
in a target cultured cell-line, suggesting the secretion of potent apoptotic factors by LCH 
cells.  Cytokine profiling of the LCH CM showed increased concentration of macrophage 
migration inhibitory factor (MIF), which may cause higher death rates in CD68-positive 
macrophages as they were unable to migrate from the lesion.  
Further research in apoptosis in LCH and non-LCH lesions may answer many 
remaining questions and could lead to novel therapeutical outcomes. 
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Chapter 1. Introduction 
LANGERHANS CELL HISTIOCYTOSIS 
The history of Langerhans Cell Histiocytosis (LCH) dates back to about 450-
400BC, when non-fatal, painful bone lesions were described by Hippocrates (Bernstrand, 
2003; Donadieu & Pritchard, 1999). It has also been speculated that Edward V in the 15th 
century may have suffered from LCH of the mandible, since osteolytic lesions were found 
during the archaeological examination of his skeleton (Hargreaves & MacLeod, 1994).  
Case reports have been documented rarely but regularly since 1865 (T. Smith, 
1865) and the disease was named after physicians who published their observations: 
Hand-Schuller-Christian disease (Christian, 1920; Hand, 1893; Schuller, 1915) and 
Letterer-Siwe’s disease (Letterer, 1924; Siwe, 1933). Since 1940, LCH has been variously 
named “solitary granuloma of bone” and “eosinophilic granuloma (EoG) of bone” 
(Lichtenstein, 1953; Otani & Ehrlich, 1940) and later, “Histiocytosis X” (Lichtenstein, 
1953). 
A significant improvement in the understanding of Histiocytosis X occurred when 
Nezelof and colleagues (1973) reported it was the result of the proliferation and 
dissemination of histiocytic cells, identified as Langerhans Cells (LCs).  Recently, 
Senechal and colleagues (Senechal et al., 2007), suggested that the accumulation of LCs 
in granulomas is mainly the consequence of increased survival rather than proliferation.  
In 1983, investigators at the University of Minnesota suggested a name change 
from Histiocytosis X to LCH, since LCs were thought to be the key cellular component in 
all forms of the disease spectrum (Risdall et al., 1983).  
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Langerhans cell discovery 
Paul Wilhelm Heinrich Langerhans (Figure 1-1.A) made his first contribution to 
medicine, when still an undergraduate, he used Cohnheim’s gold chloride staining 
technique to describe novel non-pigmentary dendritic cells in the epidermis (Egeler, 
1993). He initially regarded these cells as intra-epidermal nervous system receptors 
(Langerhans, 1868), but later corrected himself (Langerhans & Hans, 1882). Today the 
name “Langerhans Cell” belongs to the dendritic cell (DC) of the epidermis (Figure 1-1 
B, C) (Nezelof, Basset, & Rousseau, 1973; Risdall et al., 1983; Silberberg, 1973).  
Clinical overview 
LCH is a rare disease of unknown aetiology. The incidence in children is 3-4 cases 
a year per one million population and in adults it is rarer: 1 case per 560,000 a year 
(although this is likely to be an underestimate) (Glotzbecker et al., 2002). LCH varies 
widely in its clinical manifestations. The presence of LCs in high numbers and their 
infiltration into normal tissues is common to all LCH lesions. Lesions may develop in any 
tissue, but bone, skin and lymph nodes are the most commonly affected. More than 75% 
of patients have skeletal lesions. Bone lesions (Figure 1-2) caused by LCH vary from 
focal, sharply defined areas to diffuse osteopenia and can resemble lesions caused by a 
wide variety of metabolic, infectious and neoplastic diseases. The clinical picture varies 
from a disorder that resolves spontaneously to a progressively fatal disease. In general, 
the younger the individual at the time of onset of the disease, the more extensive it is and
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Figure 1-1. Paul Langerhans and Langerhans Cell. 
 
Paul Langerhans first described Langerhans cells in 1868. 
A. Paul Langerhans and his wife. B. A Langerhans cell (black) stained using Cohnheim’s 
gold chloride technique. C. Langerhans cells in the epidermis. 
 
 From: Jolles, S. 2002. 
 Fair dealing rules apply. 
 B C 
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Figure 1-2. X-Ray of LCH Bone Lesion. 
 
LCH lesions may develop in any tissue, but bone, skin and lymph nodes are the 
most commonly affected. More than 75% of patients have skeletal lesions. A. Left 
femur of the young child (red arrow). B. Skull of an adult showing multiple lytic 
lesions of the bone (arrowed). 
 
From: “Radiology Cases, Histiocytosis X” website.  
Copyright: fair dealing rules for the purpose of research or study apply. 
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the poorer the prognosis. Treatment may include surgery, chemotherapy and radiation 
therapy, depending on the extent and severity of the case (Buckwalter et al., 1999). 
The Histiocyte Society was founded in 1985, and in 1987 a standardised 
nomenclature, and clinical and pathological criteria were established for LCH (T. Chu et 
al., 1987). These criteria have since been partly revised, refer Table 1-1 (Bernstrand, 
2003; Favara & members of the WHO committee on histiocytic/reticulum cell 
proliferations, 1997). For the definitive diagnosis of LCH (refer Table 1-2) the 
microscopic examination is critical (Al-Abbadi et al., 1997; Chu et al., 1987; Egeler & 
D'Angio, 1995; Favara & members of the WHO committee on histiocytic/reticulum cell 
proliferations, 1997; Ghadially, 1997; Glotzbecker et al., 2002; Howarth et al., 1999; 
Huang & Arceci, 1999; Kilpatrick et al., 1995; Schmitz & Favara, 1998; Weiss et al., 
2001). The tissues from LCH lesions contain an abnormal proliferation of histiocytic-like 
cells. The lesions are locally proliferative and have been shown to demonstrate elevated 
proliferation rates ranging from 3% to 48%, with the larges indices found in the lymph 
nodes (Favara & members of the WHO committee on histiocytic/reticulum cell 
proliferations, 1997; Glotzbecker et al., 2002; Schmitz & Favara, 1998). Characteristic 
pathologic morphology of tissue from children with LCH includes large cells with 
elongated, irregular nuclei, prominent nuclear grooves, folding, and indentation, moderate 
to abundant cytoplasm, and frequent mitotic figures (Al-Abbadi et al., 1997; Glotzbecker 
et al., 2002; Kilpatrick et al., 1995). Variable numbers of eosinophils are often present. 
The lesions are also characterised by osteoclast-like multinucleated giant histiocytes with 
bone destruction, necrosis, haemorrhage, and eosinophilic abscesses (Glotzbecker et al., 
2002; Kilpatrick et al., 1995). Indeterminate cells, interdigitating dendritic cells, 
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TABLE 1-1 
Contemporary Classification of Histiocytic Disorders 
(From: Favara, B. E. 1997) 
 
From: Favara, B.; 1997 
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TABLE 1-2. Identifying Features of Histiocytes 
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macrophages, and T-lymphocytes are often found in increased numbers in the lesions 
(Glotzbecker et al., 2002; Howarth et al., 1999; Huang & Arceci, 1999). Granulomas may 
or not be seen, and fibrosis may be seen in later lesions (Weiss et al., 2001). On electron 
microscopy, LCs are characterised by intracytoplasmic inclusions, rod-shaped or tennis 
racket-shaped profiles in sectioned material with a stippled line representing a transverse 
section through a paracrystalline net or lattice, called Birbeck granules (Birbeck et al., 
1961; Ghadially, 1997). Birbeck granules distinguish Langerhans cells from 
indeterminate cells at the ultrastructural level (Huang & Arceci, 1999). Therefore, the 
Birbeck granule is the only specific property of this phenotype, and demonstration of the 
Birbeck granule remains the gold standard of phenotype determination as well as 
diagnosis of LCH (Favara & members of the WHO committee on histiocytic/reticulum 
cell proliferations, 1997; Schmitz & Favara, 1998). The CD1a immunohistochemical stain 
is a very helpful adjunct to the diagnosis, although a less specific marker of the 
pathogenic Langerhans cells (Favara & members of the WHO committee on 
histiocytic/reticulum cell proliferations, 1997; Schmitz & Favara, 1998). A positive CD1a 
with the described histology in the right clinical setting is often considered adequate for 
diagnosis. The Histiocyte Society’s Treatment Protocol (Favara & members of the WHO 
committee on histiocytic/reticulum cell proliferations, 1997; Ladisch & Gadner, 1994) for 
LCH categorizes patients as those with single-system disease involving a single site, those 
with single-system disease affecting multiple sites, and those with multisystem disease. 
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Current theories on the causation of LCH  
Hereditary factors. LCH is usually considered to be a sporadic disorder, but at 
least 1% of patients with LCH have another affected family member in their own or 
another generation (Arico et al., 1999; Bernstrand, 2003; Egeler, 1993) refers to the two-
mutation model. According to this model, LCH develops as a consequence of two 
mutational events. The first mutation occurs either pre-zygotically or post-zygotically, 
while the second mutation always occurs post-zygotically. When the first mutation is pre-
zygotic, and thus present in all the person’s cells including their germ cells, the disease 
will be heritable. Individuals with constitutional mutations will be at risk to develop 
disseminated LCH, since the second event needs to occur in only one of all predisposed 
LCs. However, LCH would still be dependent on the occurrence of this second event. 
Accordingly, there is an early average age at onset and distribution suggesting a single 
post-zygotic event phenomenon in disseminated and (rare) familial cases. When the first 
mutation is postzygotic, and thus present in only some somatic cells, the disorder will not 
be heritable and the individual will not be likely to develop more than one lesion, as it is 
much less likely for both mutations to occur independently in more than one cell.  
Chromosome studies. LCH appears to be characterised by karyotypic instability, 
but it is still unclear what stimulus promotes the chromosomal instability, and whether it 
is genetic, viral, or due to other environmental factors (Bernstrand, 2003; Betts et al., 
1998; Scappaticci et al., 2000).  
Viral studies. Viral infection has been suggested as a cause of LCH disease. 
Studies of individual viruses, however, have been negative to date. Epidemiological 
studies have not identified any clustering of cases by time or place, nor any consistent 
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association with symptoms of a preceding viral infection (Jenson et al., 2000; Kawakubo 
et al., 1999; Leahy et al., 1993; McClain et al., 1994; Slacmeulder et al., 2002).  
Immune response dysfunction. Persistent, long-term or chronic presence of lytic 
lesions in LCH patients suggests that there may be a dysfunction of the normal immune 
response. High mortality among children under 2 years of age (the time of immune 
system maturation) indirectly supports this hypothesis.  
Recent research (Senechal et al., 2007) demonstrated that the pathogenesis of 
LCH may be connected with the expansion of regulatory T cells (TR). The authors 
suggest that in vivo expansion could result in the failure of the host immune system to 
eliminate LCH cells, causing their local accumulation in the tissues. This would attract 
inflammatory cells to the site and cause a subsequent increase in local cytokine 
expression.   
A gene under investigation for its role in LCH pathogenesis is interleukin 17A 
(IL-17A). This T-cell-specific cytokine, produced by TH-17 T cells (Yao et al., 1995) is 
involved in chronic inflammation and also has a positive effect on granuloma formation, 
(Umemura et al., 2007), neurodegeneration (Komiyama et al., 2006) and bone resorption 
(Kotake et al., 1999; Sato et al., 2006). Coury and colleagues (Coury et al., 2008) 
investigated the correlation of IL-17A in lesion formation and found high serum levels of 
IL-17A during active LCH. The researchers discovered an IL-17A-dependent pathway for 
DC fusion, which is involved in the expression of three major tissue-destructive enzymes 
by giant cells. Serum IL-17A fusion activity correlated with LCH activity (24th annual 
meeting of the histiocyte society, berlin, germany.2009). This finding proposed a central 
role for IL-17A in LCH severity (Coury et al., 2008). IL-17A however is not elevated in 
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all LCH lesions and implies that other mechanisms may be important in the aetiology of 
LCH. 
Dendritic origin of the Langerhans cell 
As DCs, LCs have a bone-marrow origin, express major histocompatibility 
complex (MHC) class II molecules and bear Fc and C3 receptors . The LC precursor has 
not been characterised. However, in vitro studies indicate that it could be a CD34+ cell 
bearing a skin-homing cutaneous–associated antigen, and that it is already committed to 
LC development under the influence of granulocyte-macrophage colony-stimulating 
factor (GM-CSF) in conjunction with tumour necrosis factor  (TNF), interleukin-4 (IL-
4) or the CD40 ligand (Kaplan et al., 1992; Nezelof & Basset, 1998; Strunk et al., 1997) 
(Figure 1-3). 
Langerhans cell morphology and distribution 
LCs represent a peripheral outpost of the immune system. LCs are present in all 
the organs that come in contact with antigens. They have been described within the 
epidermis of skin, regional lymph nodes, thymic epithelium and bronchial mucosa 
(Wright-Browne, McClain, Talpaz, Ordonez, & Estrov, 1997). They are also found in 
stratified epithelia such as the mouth, oesophagus and lung (de Fraissinette et al., 1989; 
Holt et al., 1990; McWilliam et al., 1995; Schon-Hegrad et al., 1991).   
Within the skin, LCs represent 1-2% of the entire epidermal cell population and 
can be seen within the supra-basal area, with an even distribution throughout the skin 
(Chu & Jaffe, 1994).  LCs within the skin have been identified in different phases of the 
cell cycle with a total cell cycle time of 16.3 days, indicating a slowly cycling cell 
population (Czernielewski & Demarchez, 1987). Chu and colleagues (Chu & Jaffe, 1994) 
showed that LCs have a flattened disc shape, and are aligned in a horizontal plane parallel 
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density of about 1.6 x 105 cells per mm2 of epidermis. They usually possess between five 
to nine dendrites which extend out in the same horizontal plane, and although dendrites 
from individual cells may overlap, there does not seem to be any direct cell-to-cell contact 
(Chu & Jaffe, 1994). With their dendrites, LCs cover 25% of the surface area of the skin 
(Yu et al., 1992).  
During migration from the periphery to the draining lymph nodes (Figure 1-3), 
LCs undergo maturation followed by modifications in their phenotype and functions  
(Romani et al., 1989a; Romani et al., 1989b; Sallusto et al., 1995). Mature LCs display 
higher levels of MHC class I and II molecules on their surfaces (Abstracts of the 15th 
european immunology congress (EFIS 2003).2003) and contain higher amounts of 
adhesion and co-stimulatory molecules . Markers for mononuclear phagocytes are lacking 
or reduced to very low levels. Mature LCs are not adherent or phagocytic in culture. They 
possess thin cytoplasmic sheets (“veils”) that constantly extend and retract (in all 
directions) in culture (“veiled LCs” in Figure 1-3), as can be easily watched under phase 
contrast microscopy (Romani et al., 1996).  
indented nuclei. The cytoplasm has few vacuoles and low organelle content (Chu et al., 
1982). Specific cytoplasmic organelles called “Birbeck granules” are present, first 
described by Birbeck (Birbeck et al., 1961) (Figure 1-4).  
How LCs initiate an immune response  
After stimulation of LCs by an environmental event in the periphery, their 
behaviour can be divided into three distinct stages: antigen capture, processing and 
presentation (Figures 1-3, 1-5). Following the capture of antigen, LCs migrate via the 
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afferent lymph and the lymphatics into the T cell-rich areas of secondary lymphoid organs 
such as the thymus-dependent zones of the lymph nodes (LN) (Figure 1-6) (Austyn et al., 
1988; de Smedt et al., 1996; Fossum, 1988; Kudo et al., 1997; Larsen et al., 1990; 
Macatonia et al., 1987). LCs present processed antigen to naive T cells which generate an 
antigen-specific primary T cell response (Inaba et al., 1990; Liu & MacPherson, 1993; 
Sornasse et al., 1992). This T cell priming is then followed by the extra-follicular primary 
B cell response (Inaba & Steinman, 1985; Sornasse et al., 1992). After fulfilling their role 
of initiating the immune response, LCs die in the lymph node. New LC precursors are 
produced continually in the bone marrow to replenish lost LCs (Figure 1-3). 
The biological apparatus of LCs is specialised to fulfil their professional antigen- 
presenting role. It can be described from three different perspectives: antigen handling; 
production of accessories molecules necessary for T cell stimulation; properties necessary 
for positioning of LCs in the body.  
Antigen handling  
Romani and colleagues (Romani et al., 1996) demonstrated that in contrast to 
phagocytes, LCs lack or have very low levels of receptors and organelles required to 
engulf and digest particulates. Instead:  
1. LCs express very high levels of MHC products, especially MHC class II 
(the highest that is observed among leukocytes) 
2. the LCs’ vacuolar system is replete with acidic endosomes rather than 
lysosomes, and input and recycling through this endocytic system can be 
very rapid (Lanzavecchia, 1995; Stossel et al., 1990); 
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Figure 1-3. Origin of Normal Langerhans Cells. 
 
The progenitor of a LC is formed in the bone marrow and is delivered to the 
employment sites via the blood stream. It undergoes partial maturation on the 
way.  Whilst still immature, LCs occupy areas of the body that come into direct 
contact with the environment (skin epidermis, gastro-intestinal tract mucosal 
layers, etc.). The dendritic shape of LCs allows them to sense the surrounding 
area for the presence of foreign agents. The capture of an antigen triggers LCs 
activation and movement towards local lymph nodes, while antigen is 
undergoing processing. This process causes further maturation of LCs and 
change of their morphology from “dendritic” to “veiled”.  In the thymus-
dependent zone of the lymph node, LCs present antigens to naive T cells, 
triggering an immune response.  After their role is  fulfilled, the LCs die in the 
lymph node. 
 
Diagram by Ioulia Sims 
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Figure 1-4. Birbeck Granules. 
 
An electron micrograph of the cytoplasm of a LC, showing Birbeck granules. 
Birbeck granules consist of a rod-shaped structure which are sometimes 
associated with a bulbous structure at one end, giving a “tennis racket” shape. 
The origin of the Birbeck granules is still uncertain. 
 
Fair dealing rules apply. 
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Figure 1-5. Antigen Presentation by LCs. 
 
LCs capture and process foreign antigens and display them on MHC class II 
molecules. The antigen-MHC class II complex is presented to naive T cells in the 
draining lymph node, causing T cell activation which triggers the immune 
response.  
 
Reprinted with permission from “Serotech”. 
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Figure 1-6. Diagram of a Lymph Node.  
 
Thymus-dependent zone extends for a variable distance to each side of the dotted 
line. Antigen presentation by LCs to naive T cells takes place in the thymus-
dependent zone. 
 
From:  the 8
th
 Edition of Histology by A. W. Ham and D. H. Cormack, J. B. Lippincott, 
Philadelphia (Fig. 13-11, p. 345)  with the permission. 
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3. LCs can retain antigens in an immunogenic form for long periods, at least 
days in tissue culture and in vivo (Pure et al., 1990; Romani et al., 1989a); 
4. only very small amounts of MHC-associated ligands need to be presented 
on LCs to stimulate T cells, even naive T cells  (Bhardwaj et al., 1993).  
Accessory molecules  
LCs can express most of the known adhesive molecules (for example, E-cadherin, 
6 integrins, epidermal protein kinase C (PKC) PKC-, PKC-2, metalloproteinases etc. 
(Bechan et al., 2006; de Graaf et al., 1995; Ratzinger et al., 2002) and co-stimulatory 
molecules (CD40, CD80 and CD86; IL-12p70 etc. (Bechan et al., 2006; Caux et al., 1994; 
Peiser et al., Wanner & Kolde, 2004; Ratzinger et al., 2004)  to interact with T cells and:  
the levels of these molecules can be very high (Caux et al., 1994; Inaba et al., 1994); 
(ii)  the levels of accessory molecules seem to be controlled differently on LCs than on 
other leukocytes; 
LCs may produce very high amounts of cytokines that influence T cell activation.  
Localisation  
LCs are distributed at external surfaces (skin, airway epithelium) and from these 
areas LCs migrate to draining lymphoid tissues. LCs localize to the T cell areas of 
lymphoid organs where the access to antigen-responsive T cells is optimised. LCs also 
have ready access to memory T cells. 
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The normal and LCH Langerhans cell 
LCH is characterised by proliferation (Chu & Jaffe, 1994) or, according to a more 
recent point of view, accumulation (Senechal et al., 2007) in various organs of the body, 
of cells bearing the LC phenotype. 
The LCH LCs found in many organs are immature (Broadbent et al., 1994). The 
fact that LCH LCs are hardly ever found in lymph nodes that drain the lesion sites, 
strongly suggests that LCs do not migrate through normal lymphoid drainage pathways 
(Laman et al., 2003).  
At the ultra-structural level, LCH LCs are large rounded cells 15-25m in 
diameter, lacking dendritic extensions, with irregular deeply grooved nuclei (Laman et al., 
2003; Schmitz & Favara, 1998). Antigen is not presented properly on the MHC 
complexes (Geissmann et al., 2001; K. L. McClain et al., 2005). Chu and colleagues (Chu 
& Jaffe, 1994) and Nezelof and colleagues (Nezelof & Basset, 1998) published a detailed 
list of morphological features of LCH LCs suggesting, that they are “arrested” at a very 
early stage of maturation. High levels of cytokines in LCH lesions may be responsible for 
the tissue damage seen in LCH lesions (de Graaf et al., 1996; Egeler et al., 1999; Foss et 
al., 1996; Geissmann et al., 2001; Kannourakis & Abbas, 1994).  
A typical LCH lesion consists of LCs and macrophages accompanied by T cells 
and variable numbers of multinucleated giant histiocytes
1
 and eosinophils. B cells, plasma 
cells, granulocytes and mast cells are also present (Bernstrand, 2003) (Figure 1-7). Most 
of the cells in the lesions can be characterised immunohistochemically by the presence of 
                                                 
1
 Favara and co-authors (Favara, 1997) view histiocytes as “…a group of immune cells that are 
phenotypically and functionally diverse. Macrophages with predominately antigen processing 
functions and dendritic cells with antigen presenting functins are considered as polar 
representatives of one common regulatory system. The term “histiocyte” is analogous to 
“lymphocyte”…” as the title for the group of cells.  
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specific lineage markers, refer Table 1-3. The histopathological appearance of LCH is the 
same across all types of LCH. 
CELL DEATH 
“Programmed Cell Death” (PCD), as a definition, was introduced by C. M. 
Williams in the 1960s to describe the fate of cells, undergoing “a sequence of controlled 
(and thereby implicitly genetic) steps towards their own destruction” (Lockshin & Zakeri, 
2001). PCD as a phenomenon, however, has been known for at least 150 years. Soon after 
Schleiden and Schwann established the cell theory between 1839 and 1842, Vogt 
described naturally-occurring cell death in notochordal and cartilaginous cells (Vogt, 
1842). The subject was actively followed by others, and generated many publications at 
the end of nineteenth century (1864-1890). (Collin, 1906) was the first to understand the 
numerical importance of natural cell death. Collin put forward the theory that cell over-
production and subsequent self-destruction were common to all tissues.  
The existence of different types of cell death was common knowledge within 
pathology and embryology disciplines. In 1885, Flemming published the first distinct 
morphological description of apoptosis (Flemming, 1885) and called it “chromatolysis”. 
This term was used for the next 30 years (Clarke & Clarke, 1995). 
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Figure 1-7. H&E Staining of Paraffin Embedded LCH Tissue. 
 
Similar cells are observed within lesions in most LCH cases. The lesions are 
characterised by the presence of large numbers of Langerhans cells (Histiocytes).  
Macrophages, T cells and various numbers of multinucleated giant cells are also 
present as well as B cells, plasma cells and granulocytes. 
 
Photo by: George Kannorakis and Ioulia Sims 
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TABLE 1-3. Specific Markers of Cell Types 
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Technological developments in the first half of the twentieth century opened new 
horizons for scientists. New methods, like ultra-centrifugation, allowed better cell 
separation and fractionation. The implementation of electron microscopy made high-
resolution cell morphology studies possible.  
The term “apoptosis” first appeared in literature in 1972. John Kerr (Kerr et al., 
1972) observed a pattern of cell death which displayed a similar morphological pattern in 
different tissues. He initially called this process “shrinkage necrosis” (1965) and later, 
“apoptosis” (Greek “apo”– ‘from’ “ptosis” – ‘falling’ (describing the process similar to 
the leaves falling from the tree without harm). The novel assumption in this publication 
was that apoptosis was not an incidental part of life, but a general developmental 
mechanism under strict genetic control, that may operate in most cells.  
General interest in apoptosis began to grow during the 1990s triggered by the 
publication of four influential papers:  
B cell lymphoma (Bcl-2) gene was identified as an anti-apoptotic gene in the 
immune system (Vaux et al., 1988); 
p53 was proved to be a pro-apoptosis regulator in cancer (Lowe et al., 1993; 
Yonish-Rouach et al., 1991);  
Fas/Apo-1 was described as a death-transducing cell-surface receptor (Trauth et 
al., 1989; Yonehara et al., 1989); 
Raff summarised an idea of “social control of apoptosis” (Raff, 1992). 
An electronic search of the literature for “Apoptosis” shows that in 1975 only 
three papers, containing this key word were published. The number of publications grew 
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to 31 in 1985; 3047 in 1995; 17,041 in 2005 and 18,520 in 2009. This places apoptosis 
amongst the most studied processes in fundamental biological science.  
Types of cell death 
There are many types of cell death reported: necrosis, oncosis, autophagy, 
atrophy, stepwise or other alternate means of self-disassembly, and programmed cell 
death (Walker, 1988; Johannisson, 1968; Parsons, 1983; Sperandio, 2000; Bursch, 2000; 
Lockshin, 2007; Kitagawa, 2008). Since apoptosis was described in 1972 as a process of 
cell death which displayed a similar morphological pattern in different tissues (Kerr,  
1972), terms “apoptosis” and “programmed cell death” (PCD) became almost synonyms. 
Death receptors, mitochondria and caspases were considered major participants in the 
apoptotic signal transduction within the cell. Apoptosis executed by caspases is referred 
to as caspase-dependent PCD (CD-PCD).  
Recent reviews (Broker, 2005; Kroemer, 2005; Constantinou, 2009) synthesise the 
accumulating evidence for the existence of caspase-independent PCD (CI-PCD) and 
propose different models for cell death classification. Broker (Broker, 2005) and co-
authors do not limit cell death to apoptosis and necrosis and consider mitotic catastrophe, 
slow cell death, paraptosis and autophagy as distinct types of CI-PCD. Kroemer and 
Martin (Kroemer, 2005) and Leist and Jaattela (Leist, 2001) divide cell death types into 
four broad categories:  (I) apoptosis, (II) apoptosis-like, (III) necrosis-like and (IV) 
necrosis. Lorenzo and Susin (Lorenzo, 2007) suggest type I (classical apoptosis), type II 
(autophagic cell death) and type III (programmed necrosis) classification in PCD. Most 
authors agree, however, that different pathways of cell death are interrelated, cooperate 
and crosstalk.  
Chapter 1. Introduction 25 
 
Necrosis 
Necrosis refers to the progressive degradation of cell structure that occurs in 
response to severe, injurious changes in environmental conditions (Walker et al., 1988). 
Necrosis generally affects large groups of cells, causing an inflammatory response in the 
tissue (Allen, et al., 1997).  
The cellular response to necrosis is accompanied by an elevation in cytosolic 
calcium (Bursch et al., 1990; Trump & Berezesky, 1987; Walker et al., 1988). Calcium-
dependent phospholipases (digest membranes) and proteases (digest proteins) are 
activated, causing the destruction of cell membranes and loss of ion homeostasis. An 
important consequence of phospholipase activation is the generation of arachidonic acid 
metabolites and release of the lysosome contents into the surroundings, which explains 
the association of acute inflammatory reactions with foci of necrosis (Thompson et al., 
1992; Walker et al., 1988). High proteolytic activity during necrosis permits the 
degradation of histones, allowing extensive access of endogenous nucleases to DNA 
(Arends et al., 1990; Bursch et al., 1990; Kizaki et al., 1989; McConkey et al., 1989; 
Searle et al., 1982). This results in the random breaking of DNA and is evidenced by a 
continuous spectrum of DNA fragments as visualised after size fractionation of DNA by 
neutral agarose gel electrophoresis (so called “DNA smear”) (Afanas'ev et al., 1986; 
Duvall & Wyllie, 1986; Trump et al., 1982). Regular oligonucleosome fragments, 
characteristic of apoptosis, are not found (Duke et al., 1983). The necrotic DNA 
fragments are also larger, and therefore significantly less in number, than apoptotic DNA 
(Allen et al., 1997). The necrotic cells are ultimately removed by mononuclear 
phagocytes (Lockshin & Zakeri, 2001; Walker et al., 1988). 
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Apoptosis 
Apoptosis is a fundamental process of biological development and is responsible 
for cell turnover in multicellular organisms. It occurs constantly and, under normal 
circumstances, causes no harm. Apoptosis is a highly regulated process under strict 
genetic control.  
Cytokines, chemicals, environmental insults, viruses, cells, withdrawal of trophic 
factors can all be apoptotic signals (Figure 1-8).  
In normal animal development, cell death is involved not only in sculpturing 
shapes, but also in optimizing functions (Golstein, 1998). Some examples of apoptotic 
cell death are: 
 removal of over-produced cells and cells in abnormal locations; 
 elimination of cells not required in one sex; 
 sculpturing of the body (removal of webbing between fingers in the foetus); 
 removal of lymphocytes that fail to produce functional antigen-specific antibodies; 
 removal of lymphocytes that produce high-affinity self-reactive receptors and 
which are therefore potentially harmful to the body. 
Cells can follow different pathways to die by apoptosis. However, it is not known 
what influences the crucial decision undertaken by the cell to choose pro-survival or pro-
apoptotic pathways or, in some circumstances, to switch from a pro-survival to pro-
apoptotic pathway. 
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Figure 1-8. Apoptosis Signals Received by the Cell. 
 
A cell receives a variety of signals from the outside: ionizing radiation directly 
affects genetic material in organelles such as the nucleus. Other factors, including 
stress or viral infection, induce apoptosis through cell surface death receptors or 
through intracellular organelle activation. 
 
Fair dealing rules apply. 
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Apoptosis: morphology 
Apoptosis characteristically affects scattered, single cells in an asynchronous 
fashion and, unlike necrosis, is not accompanied by an inflammatory reaction (Kerr et al., 
1987; Searle et al., 1982; Walker et al., 1988; Wyllie et al., 1980).  
Bursch and colleagues (1990) divided the process of apoptosis into stages: 
stimulation, condensation of chromatin followed by DNA fragmentation, simultaneous 
condensation of cytoplasm, phagocytosis and degradation (Figure 1-9). After stimulation 
of apoptosis there is a period during which there is no histological evidence of apoptosis 
in individual cells. This period could range from several minutes to several hours or days 
and varies from tissue to tissue and from stimulus to stimulus (Bursch et al., 1990).  
Chromatin condensation is the earliest stage of apoptosis that can be recognised 
under the electron microscope. The nuclear chromatin becomes condensed into sharply 
circumscribed, uniformly dense masses that gather around the nuclear membrane (Walker 
et al., 1988). Nucleolar chromatin disperses, forming osmophilic aggregates in the centre 
of the nucleus (Allen et al., 1997). The chromatin condensation stage lasts only a few 
minutes (Bursch et al., 1985) and requires the activation of endogenous Ca
2+
 and Mg
2+
-
dependent endonucleases (Wyllie, 1980). DNA fragmentation itself occurs in two steps: 
first, initial cleavage into 50-to 300-kb long genomic fragments, believed to reflect the 
higher-order organisation of the chromatin into chromosomal loop domains (Oberhammer 
et al., 1993; Widlak & Garrard, 2009) and, next, fragmentation down to oligonucleosomal 
sized segments (Widlak & Garrard, 2009; Wyllie, 1980). Both of these cleavage events 
are catalysed by the major apoptotic nuclease, DNA fragmentation factor 
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Figure 1-9. Progression of Cell Apoptosis. 
 
Apoptosis eliminates scattered cells in an asynchronous manner. It occurs quickly and can be divided into three stages: stimulation, 
condensation and the formation of apoptotic bodies.  At the stimulation stage the cell receives an apoptotic signal and internalise it 
triggering cross-talk of pro- and anti-apoptotic molecules. If the cell decides to undergo apoptosis, it enters the condensation stage.  
Cytoplasmic shrinkage, cytoskeleton rearrangements and DNA fragmentation occur during the condensation stage. It is followed 
by the formation of apoptotic bodies which are rapidly engulfed by adjacent cells. 
 
Fair dealing rules apply. 
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 (Liu et al., 1997; Liu et al., 1998; Widlak, 2000), also known as caspase-activated DNase 
(CAD) (Enari et al., 1998). Allera and co-workers (Allera et al., 1997) observed particles 
tightly packed face-to-face in smooth 11-nm filaments that progressively folded to 
generate a closely woven network in apoptotic thymocytes. The network finally collapses 
producing dense apoptotic bodies. Since trypsin digestion relaxed condensed chromatin 
and histone H4 underwent deacetylation in the apoptotic cell, researchers (Benedetti et al., 
1988; Bursch et al., 1990) suggest that changes in the DNA-histone interactions 
represented a major modulation factor of condensation. When DNA is visualised after 
agarose gel electrophoresis, these endonucleolytic products display a ladder-type pattern 
of oligonucleosomal-length fragments, known as a “DNA ladder”, a biochemical criterion 
for apoptosis (Benedetti et al., 1988; Bursch et al., 1990), (Figure 1-10).  
Larger DNA fragments, however, have been shown to occur in the absence of 
oligonucleosome formation (Oberhammer et al., 1993). Cleavage of DNA into larger 
fragments is sufficient to allow chromatin condensation and subsequent apoptosis. 
Cytoplasmic condensation is characterised by the disruption of the desmosomal contacts 
between cells and the disruption of the cytoskeleton of the affected cell, resulting in the 
condensation of the intermediate filaments around the nucleus and the formation of blebs 
on the cell surface (Kinn & Allen, 1981; Martin et al., 1992), (Figure 1-11). 
The cytoplasmic and nuclear condensation changes usually occur simultaneously 
(Allen et al., 1997; Walker et al., 1988) with convolution of the cell and the nuclear 
outline often evident together. Cytoplasm shrinkage occurs due to a net outward fluid 
movement, most likely because of the inhibition of the Na+, K+, Cl- co-transporter 
systems (Allen et al., 1997; Wilcock & Hickman, 1988). The initial changes are followed 
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Figure 1-10. DNA Fragmentation.  
 
Ca2+ and Mg2+-dependent nucleases cleave DNA double-strands at linker regions 
between nucleosomes. A. Endonucleolytic products display a pattern known as a 
“DNA ladder” when visualized after agarose gel electrophoresis. B. The “DNA 
ladder” differs from a “DNA smear” observed after necrosis,  and non-
fragmented DNA extracted from intact cells.   
 
From: “Immuteach” public domain. 
 Fair dealing rules apply 
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Figure 1-11. Apoptotic Cell Blebbing. 
 
Apoptotic activation of tissue transglutaminaze (tTG) plays a key role in the 
formation of surface blebs and keeping of the contents inside the cell. tTG activity 
cross-links cytoplasmic proteins and leads to the formation of high  molecular 
mass protein polymers, providing a rigid framework within  apoptotic bodies 
which functions to maintain their integrity and prevent leakage of the contents 
into the extracellular space.  
Apoptotic bodies contain portions of fragmented nucleus and an array of  intact, well 
preserved organelles such as mitochondria and lysosomes.  
 
From: National Library of Medicine (USA) Public Domain.  
Fair dealing rules apply 
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by further condensation of cytoplasm, breaking-up of the nucleus into discrete fragments 
(Kerr et al., 1994) in which the chromatin segregation is maintained, and the development 
of protuberances on the cell surface. The latter finally separates with plasmalemmal 
sealing to produce membrane-bound apoptotic bodies of varying sizes. The apoptotic 
bodies contain portions of the fragmented nucleus and an array of intact, well preserved 
organelles such as mitochondria and lysosomes (Martin et al., 1992). This process appears 
to be partly dependent on cell size and occurs very rapidly (Russell et al., 1972). At this 
time, new epitopes can be identified on the surface of the apoptotic bodies that seem to be 
required for their recognition by the neighbouring cells and macrophages (Duvall et al., 
1985). 
During the formation of apoptotic bodies, the cytoplasm and organelles of the 
apoptotic cells are essentially repackaged without the leakage of any of the cellular 
components into the extracellular space or blood stream (Clouston & Kerr, 1979; Martin 
et al., 1992; Wyllie, 1980). During the early stages of the process, the lysosomes remain 
intact (Kerr, 1965; Kerr, 1967; Kerr, 1971). This characteristic of apoptosis are different 
from necrosis, since the intracellular enzymes and arachidonic acid are released into the 
circulation during necrotic cell death, refer Table 1-4. 
The shrinkage and budding of a cell are completed within several minutes (Matter, 
1979; Russell et al., 1972; Sanderson, 1976), and discrete apoptotic bodies are the most 
frequently encountered histological manifestations of the process. They are round or oval 
in shape, vary considerably in size and remain visible in tissues for only a few hours 
(Wyllie et al.,1980). 
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TABLE 1-4. Apoptosis and Necrosis 
 
 
Chapter 1. Introduction 35 
 
Phagocytosis of apoptotic bodies by adjacent cells usually occurs rapidly (Walker 
et al., 1988). Interestingly, macrophages do not respond using inflammatory mediators 
when they engulf and degrade apoptotic bodies (Allen et al., 1997; Meagher et al., 1992). 
This contributes to the lack of inflammation seen in apoptotic tissues.  
The cell death program causes plasma membrane (PM) changes in apoptotic cells 
which allow their recognition by phagocytes. These changes have been shown to occur 
very early in the cell undergoing PCD (Andree et al., 1990; Creutz, 1992; Fadok et al., 
1992). A critical role is played by PS, a normal constituent of the PM which is located on 
the inner leaflet of the PM in viable cells. Translocation of PS to the outer leaflet of the 
PM in lymphocytes undergoing apoptosis has been shown to mediate phagocytic 
recognition by macrophages and subsequent removal of these apoptotic cells (Martin et 
al., 1995). It is important to note that other surface molecules (N-acetyl galactosamine; D-
galactose; L-fucose; D-mannose; N-acetyl neuraminic acid; N,N’-diacetyl chitobiose) 
undoubtedly play various roles in phagocytic recognition and uptake of apoptotic cells 
(Allen et al., 1997; Duvall et al., 1985; Haslett et al., 1994; Meagher et al., 1992; Savill et 
al., 1989; Savill et al., 1990). 
Apoptosis: biochemistry 
The majority of the biochemical events associated with apoptosis occurs prior to 
the visible histological changes. The activation of endogenous Ca
2+
 and Mg
2+
-dependent 
endonuclease(s) does not require gene transcription or protein synthesis (Cohen & Duke, 
1984; Kyprianou & Isaacs, 1988). Ca
2+
 is regulated within narrow limits to very low 
levels in 
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the cytosol at ~10-7 –10-8 M (Trump & Berezesky, 1987). This regulation is in the 
presence of high concentrations of extracellular ionised calcium at ~ 10-3 M. Therefore 
extracellular Ca
2+
 leaks down its gradient into the cytosol through a variety of channels 
(Trump & Berezesky, 1987). This generates a considerable electrochemical force which is 
balanced by the active extrusion of Ca
2+
 from the cell and by intracellular 
compartmentation processes (Carafoli, 1987). Although a substantial amount of Ca
2+
 is 
normally bound to cell constituents, such as phospholipids and Ca
2+
-binding proteins, the 
buffering effect that they provide is insignificant. Thus, it is generally accepted that the 
regulation of the cytosolic Ca
2+
 concentration is mainly dependent on membrane-
associated transport systems. Three principal buffer systems regulating Ca
2+
 are known to 
exist in virtually all cells: the PM, the mitochondria and the endoplasmic reticulum (ER) 
(Trump & Berezesky, 1987). All require adenosine triphosphate (ATP) directly or 
indirectly and all may involve Ca
2+
-ATPases (Trump & Berezesky, 1987).  
Deregulation of the PM buffering system could happen following ATP depletion, 
oxidative stress to the membrane from a variety of xenobiotic chemicals and some 
metabolites of the arachidonic acid pathway (Trump & Berezesky, 1987). Several reactive 
species have been shown to inhibit Ca
2+
 efflux from cells by reacting with thiol groups 
required for plasma membrane Ca
2+
-ATPase activity, or by depleting intracellular ATP. 
This results in a sustained increase in cytosolic Ca
2+
 concentration (Orrenius et al., 1991). 
The ER is the major calcium storage compartment of the cell (Artal-Sanz et al., 
2006). Cell injury and death can be induced by disturbances of Ca
2+
 homeostasis in the  
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ER (Artal-Sanz et al., 2006; Mattson et al., 2000; Paschen, 2001). Sequestration of 
calcium into the ER is mediated by sarcoendoplasmic reticulum Ca
2+
-ATPase, and release 
back to the cytoplasm is controlled by ryanodine and 1,4,5-inositol triphosphate receptors 
(Carafoli, 2002). Within the ER, calcium binds to calcium-binding molecular chaperones 
such as calreticulin and calnexin (Llewellyn et al., 2000; Michalak et al., 1999). ER 
calcium stores can rapidly mobilize, boosting intracellular calcium concentration (Ferri & 
Kroemer, 2001a). Release of Ca
2+
 from the ER is facilitated by the messenger inositol 
triphosphate (IP3), one of the main effector molecules of the phosphatidyl inositol (PI) 
pathway (Trump & Berezesky, 1987).  
Release of Ca
2+
 from mitochondria can be accomplished by uncoupling agents, 
such as halogenated phenols, and by some hydroperoxides of the prostanoid pathway 
(Trump & Berezesky, 1987). Increased concentrations of intracellular Ca
2+
 have a number 
of effects on the cell development (Orrenius et al., 1991; Trump & Berezesky, 1987). 
These include activation of Ca
2+
-dependent enzymes (phospholipases, proteases and 
nucleases); depolymerisation of microtubules, decreased cell-cell communication. 
Enzymes resulting in DNA hydrolysis, such as some endonucleases, are Ca
2+
-dependent 
and may cause single-strand breaks and genetic rearrangements (Trump & Berezesky, 
1987) (Figure 1-12). 
Activation of the enzyme tissue trans-glutaminase (tTG), (Fesus et al., 1987) 
which extensively cross-links cytoplasmic proteins, plays a key role in the formation of 
surface blebs and in keeping intracellular constituents within the cell (Allen et al., 1997). 
The highest concentration of tTG is detected in apoptotic bodies (Allen et al., 1997; 
Piacentini et al., 1991b). 
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As surface protuberances begin to form, increased tTG activity leads to the formation of 
high molecular mass protein polymers, providing a rigid framework within apoptotic 
bodies which function to maintain their integrity and prevent leakage of their contents 
into the extracellular space (Allen et al., 1997).  
A number of enzyme activities have been shown to increase during the regression 
of hormone-dependent tissues. These include cathepsin D, tissue-type plasminogen 
activator, and several other proteases that appear to be responsible for the degradation of 
the cytoskeleton and cytoplasm components; enzymes required to release cells both from 
the neighbouring cells and from the basement membrane (e.g. collagenase and possibly 
metallo- proteinases); and RNAse which degrades both messenger and ribosomal 
ribonucleic acid (RNA) (Bursch et al., 1990).  
Other observations have led to the suggestion that at early, pre-condensation stage 
of apoptosis changes in expression of genes responsible for cytoskeleton and cell 
membrane molecules takes place and that the products of these genes play a role in the 
cell’s morphological changes during the condensation stage of apoptosis. This is 
discussed in detail by  (Bursch et al., 1990) and Pittman (Pittman et al., 1993). 
Regardless of whether or not a cell requires RNA and protein synthesis for 
apoptosis to occur, it is without doubt that the cell remains metabolically active during 
this time (Allen et al., 1997).  
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Role of cellular organelles in apoptosis  
Activation of death receptors and nuclear DNA damage have long been 
recognised as initial triggers of apoptosis. Although mitochondria play the predominant 
role in apoptosis, accumulating evidence suggests that other organelles, including the ER, 
lysosomes and the Golgi apparatus, are also major points of integration of pro-apoptotic 
or damage signalling (Ferri & Kroemer, 2001b). Each organelle possesses sensors that 
detect specific alterations, locally activates signal transduction pathways and emits signals 
that ensure cross-talk between organelles (Ferri & Kroemer, 2001b). Chaperons, Ca
2+
-
binding proteins and Ca
2+
 release channels are involved in ER recognition of local stress. 
Ca
2+
 stimulated ER might transmit signals to mitochondria. The ER also contains several 
Bcl-2 binding proteins, and Bcl-2 has been reported to exert part of its cyto-protective 
effect within the ER (Ferri & Kroemer, 2001b). After a signal is received and transduced 
inside the cell, it causes a wide range of responses from different organelles. For example, 
lysosome membranes sensitisation/destabilization is followed by the release of cathespins 
that are endowed with the capacity of triggering mitochondria membrane 
permeabilization (MMP). The Golgi apparatus is an important site for the generation of 
the pro-apoptotic mediator ganglioside (GD3), which facilitates local caspase-2 activation 
and might serve as a storage organelle for latent death receptors  
Interestingly, most organelle-specific death responses finally lead to either MMP 
or caspase activation, both of which might function as central integrators of the death 
pathway, thereby streamlining lysosome-, Golgi- or ER-elicited responses into a common 
pathway (Ferri & Kroemer, 2001b). 
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Apoptosis model  
In 2002, the Nobel Prize in Physiology or Medicine was awarded to Sydney 
Brenner, H. Robert Horvitz and John E. Sulston for their work in the field of PCD. The 
subject of their work was Caenorhabditis elegans (C. elegans), a free-living nematode 
(roundworm). They demonstrated that about 13% of somatic cells in the embryo of C. 
elegans die predictably. Three C.elegans cell death genes (CED-3, CED-4 and CED-9) 
are essential for apoptosis. Unlocking the mechanism of their interaction provided a 
simple model to study the genetic basis of PCD. Vertebrates have evolved entire gene 
families that resemble C. elegans cell death genes. Mammalian caspases are similar to 
CED-3. Apaf-1 is the only mammalian CED-4 homolog known so far. The products of 
the mammalian Bcl-2 gene family are related to CED-9 but include two subgroups of 
proteins that either inhibit or promote apoptosis.  
Apoptosis pathways 
The ability of cells to receive, and to correctly respond to the signals from the 
environment is the basis of normal development. Cell signalling is part of a complex 
system of the cell communicating with the outside world. Currently there are two signal 
transduction pathways leading to the activation of the caspases and apoptotic cell death: 
“extrinsic” and “intrinsic” (Figure 1-13). Also, caspase-independent pathways may exist. 
Also known as the “death receptor pathway”, the extrinsic or caspase-8, -10 
dependent pathway is activated by ligand binding (Berry, 2007). 
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Figure 1-12. Role of Ca
2+
 in Apoptosis. 
 
 
Deregulation of the plasma membrane buffering system during apoptosis may 
cause increased intracellular Ca2+ concentration. This can result in an activation 
of Ca2+ dependent enzymes such as phospholipases, nucleases and proteases, 
followed by rearrangements in cell development.  
 
 
With modifications from: Debatin, K. M. 2006 
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Death receptors are cell surface receptors that transmit apoptotic signals, initiated 
by specific “death ligands”. These receptors can activate caspases – proteins responsible 
for the proteolytic death of the apoptotic cells - within seconds of ligand binding, causing 
an apoptotic death of the cell within hours (Ashkenazi & Dixit, 1998). Death receptors 
belong to the tumour necrosis factor (TNF) receptor gene superfamily, which is 
characterised by the presence of cysteine-rich extracellular domains (Smith et al., 1994), 
and a cytoplasmic sequence referred to as the “death domain” (DD) (Nagata, 1997; 
Tartaglia et al., 1993) (Figure 1-14). Most widely studied death receptors are CD95 (also 
called Fas or Apo1) and TNF receptor-1 (TNFR1), also called p55 or CD120a in 
lymphoid cells (Nagata, 1997; Smith et al., 1994). CD95 receptor contains a DD in the 
cytoplasmic region which interacts with the adaptor protein, Fas-associated death domain 
(FADD) protein, forming a death receptor induced signalling complex (DISC).  
The ligands that activate “death receptors” are structurally related molecules (with 
rare exceptions) that belong to the TNF gene superfamily (Smith et al., 1994). CD95 
ligand (CD95L) binds to CD95; TNF to TNFR1; Apo3 ligand (Apo3L) binds to death 
receptor 3 (DR3) (Chicheportiche et al., 1997) Apo2 ligand (Apo2L) binds to death 
receptor 4 (DR4) and death receptor 5 (DR5) (Ashkenazi & Dixit, 1998). 
Each CD95L binds three CD95 molecules (Nagata, 1997; Smith et al., 1994) 
(Figure 1-14). CD95 ligation causes clustering of the receptor’s cytoplasmic death 
domains. FADD then binds to the clustered receptor death domains, catching the 
zymogen form of caspase-8 with the help of its “death effector domain” (DED). DED has 
an analogue within the caspase’s zymogen structure. Interaction between these analogues 
enables pro-caspase oligomerization, activation and autoproteolytic cleavage followed by
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Figure 1-13.  Apoptosis Signalling Pathways. 
 
The extrinsic apoptotic pathway is triggered by death ligand - death receptor 
interaction. Signals are transduced to large DISC complexes which employ 
procaspase 8 and 10 zymogens and activate them into active initiator caspases. 
These initiator caspases then activate effector caspases 3, 6, 7 causing a caspase 
cascade and committing the cell to die by apoptosis.  
The intrinsic apoptotic pathway is triggered by outside signals that activate internal cell 
components including Bcl-2 protein family members. Such activation causes pore 
formation in the outer mitochondrion membrane, release of cyt C and AIF, activation of 
Apaf-1 and the formation of the apoptosome.  The apoptosome activates caspase 9, 
initiating a cascade leading to death by apoptosis.  
 
Diagram by Ioulia Sims 
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Figure 1-14. Apoptosis Signalling by CD95. 
 
DD: death domain; FADD: Fas-Associated Death Domain; DED: Death Effector 
Domain; DISC: death receptor induced signalling complex 
 
CD95 receptor contains DD in the cytoplasmic region which interacts with FADD 
protein, forming DISC. The DED area of FADD has an analogue in procaspase 8 and 10 
structure. Upon DISC formation these areas interact causing clustering, oligomerisation 
and autoactivation of zymogens into active initiator caspases 8 and 10.  
 
From: “Caspases: Enemies Within” by Thornberry, N. A.; Lazebnik, Y. in “Science”, 28th 
August, 1998, Vol. 281, No. 5381, page1314.  
Reprinted with the permission from AAAS. 
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the activation of downstream effector caspases, ultimately committing the cell to undergo 
apoptosis. DED is a specific example of a more global homophilic interaction domain 
called caspase recruitment domain (CARD), which is found in several caspases (Hofmann 
et al., 1997). 
The initiator caspase is recruited into and activated within a specific adaptor 
protein complex. These adaptor protein complexes are always oligomeric and generally 
referred to as apoptosomes (Bao, 2007). 
Salvesen (Salvesen, 2002) and Renatus (Renatus et al., 2001) analysed “initiator” 
caspase activation. The induced proximity theory (Martin et al., 1998; Muzio et al., 1998; 
Srinivasula et al., 1998) describes one of the possibilities of such activation for caspase 8. 
It postulates that the recruitment to protein complexes causes a local high concentration of 
caspase zymogens. Zymogen oligomers possess a small amount of enzymatic activity 
sufficient for processing in “trans”, and activation of the first caspase in the cascade (Troy 
& Salvesen, 2002). 
Mitochondria are membrane-enclosed organelles found in most eukaryotic cells 
(Henze & Martin, 2003). Mitochondria range from 1–10 f outer 
and inner membranes and an internal part, called the matrix. The area between the outer 
and inner membrane is known as the intermembrane space (Yamada & Harashima, 2008). 
The membranes are primarily composed of phospholipid bilayers with proteins embedded 
in them (Mukhopadhyay & Weiner, 2007). The inner membrane forms numerous folds, 
cristae, that dramatically increases its surface area where most of the oxidative 
phosphorylation enzyme complexes reside (Mukhopadhyay & Weiner, 2007). The outer 
membrane, like a plasma membrane, has a lipid to protein ratio of 1:1 and does not offer a 
barrier to small molecules up to 10,000 Dalton (Da) in size (Mukhopadhyay & Weiner, 
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2007). They can simply diffuse through pores in the membrane formed by a protein called 
porin. Larger molecules, such as proteins, cross the outer membrane by using a unique 
protein import apparatus. The composition of the non-permeable inner membrane is 
different from the outer membrane (Mukhopadhyay & Weiner, 2007). Only those 
molecules that have affinity to special transport complexes on the inner membrane can be 
transported in or out of the mitochondria matrix. Even simple ions like Cl- or Na+ cannot 
diffuse into the matrix space and require specific translocators on the inner membrane to 
allow their entry from the inter-membrane space to the matrix space. Ca
2+
 ions also 
require the action of an energy dependant transporter (Mukhopadhyay & Weiner, 2007). 
Ferri and Kroemer (Ferri & Kroemer, 2001a) suggest that mitochondria 
continually monitor the overall bioenergetic state of the cell, as well as non-specific 
cellular stress responces mediated by small molecules. The authors suggest that pore 
formation in the outer mitochondria membrane followed by MMP is a key stage for both 
early and late apoptosis as it provides the apoptotic machinery with the necessary proteins 
normally confined to mitochondria inter-membrane space, inner membrane or matrix 
(Figure 1-15).  
Participation of mitochondria in apoptosis can be stimulated by DNA damage 
after chemotherapy, irradiation or withdrawal of the survival stimuli (Korsmeyer, 1999). 
A range of other conditions causing MMP is discussed by Ferri and Kroemer (Ferri & 
Kroemer, 2001a). 
The decisive role of mitochondria in both apoptosis and necrosis depends on the 
mitochondria mega-channel (also called “multiple conductance channel”, “permeability 
transition pore” or “mega pore”) (Lizard et al., 2000). The mega-channel is a composite 
channel formed by apposition of several proteins in contact between the inner and the 
Chapter 1. Introduction 47 
 
outer mitochondrial membranes (Lizard et al., 2000). It participates in the regulation of 
matrix Ca 
2+
, pH, and volume (Kroemer, 1998). 
An important role in mitochondria-dependent apoptosis belongs to the Bcl-2 
family of proteins (Figure 1-16). Some proteins from this group have structures 
resembling the membrane insertion domains of bacterial toxins. This prompts the 
hypothesis that Bcl-2 family members with homology (BH) domains BH1 and BH2, form 
pores in organelles such as mitochondria (Muchmore, 1996; Sattler et al., 1997). Bax, 
Bak, Bcl-2 and Bcl-XL all have the ability to form pores in the mitochondrion outer 
membrane. However, the shape and ion selectivity of the pores are different (Antonsson 
et al., 1997; Minn et al., 1997; Schendel et al., 1998; Schendel et al., 1999) and despite 
intensive investigations, it is still not known how the pores are formed.  
It is postulated that upon receiving apoptotic signals, Bax and Bak change their 
conformations, oligomerise and form pores in the outer mitochondrial membrane, 
facilitating the release of cytochrome C (cyt C) and a mitochondrial flavoprotein 
apoptosis inducing factor (AIF)2. The release of AIF activates Apaf-1 (Cai & Jones, 
1998; Green & Reed, 1998; Hampton et al., 1998; Matsuyama et al., 1998; Matsuyama et 
al., 1998; Susin et al., 1998; Susin et al., 1999; Vander Heiden et al., 1999)3. In the 
presence of cyt C and ATP, CARD of Apaf-1 binds CARD of procaspase-9, forming the 
“apoptosome” (Budijardijo et al., 1999) (Figure 1-17). Within the apoptosome, pro-
                                                 
2 Bcl-2 can inhibit Bax and Bak oligomerization by binding the pre-formed oligomer (Rufollo, 
2003; Green, 2004; Galluzzi, 2006; Antignani, 2006; Matsuyama, 2007). 
 
3 Some studies have demonstrated other molecules than cyt C may facilitate caspase activation 
(Claveria, 1998; Haining, 1999; Samali, 1999; Ferri, 2001).  
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caspase-9 auto-activates into caspase-9 (Budijardijo et al., 1999) which in turn activates 
the downstream effector caspases, caspase-3, 6 or 7 (Korsmeyer, 1999) thus committing 
the cell to die by apoptosis. 
Some apoptosis related proteins 
Caspases  
During the early 1990s it was discovered that the protease responsible for the post-
translational maturation of the interleukin-
(named ICE: interleukin- (Cerretti et al., 1992; 
Thornberry et al., 1992), was similar to the death gene CED3 in C. elegans, essential for 
all PCD that occurred during C. elegans development (Yuan et al., 1993). This realisation 
stimulated a search for other family members. At least 14 have been discovered to date.  
They were named “caspases” around 1997 (Salvesen, 2002) (abbreviation “cysteinyl 
aspartate-specific proteinase” or “cysteinyl aspartate-specific proteinase”). 
Caspases: Structural Features  
All caspases are similar in amino-acid sequence, structure and substrate specificity 
(Nicholson & Thornberry, 1997), and are expressed as proenzymes (30 to 50 kDa) 
consisting of three domains (NH2-terminal pro-domain, large subunit (~20 kDa) and 
small subunit (~10 kDa) (Thornberry & Lazebnik, 1998) (Figure 1-18). Under normal 
circumstances, caspases are present in the cell as inactive zymogens. The activation of the 
caspase molecule involves cleavage of the zymogen precursor at the specific region 
(internal aspartic acid residue). Such cleavage separates the large and small subunits of 
the molecule (Bao & Shi, 2007; Shi, 2002). Liberated subunits form a heterodimer, two
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Figure 1-15. Mitochondria in Cell Death 
 
Mitochondria play decisive roles in both apoptosis and necrosis. They can function as integrators of different pro-apoptotic signals 
and, simultaneously, be a target for anti-apoptotic molecules. When caspases are inhibited or when basic energy requirements are 
not met (low intracellular ATP levels), necrosis will occur. 
 
From: Kroemer, G. 1998 (with modifications)
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Figure 1-16. Bcl-2 Family of Proteins.  
 
At least 15 members of Bcl-2 family of proteins have been identified. All family members possess at least one of four Bcl-2 
homology (BH) domains, named BH1, BH2, BH3, BH4 that influence pro-survival or pro-apoptotic function.  A widely accepted 
theory is that upon receiving the apoptotic signal, Bax and Bak change their confirmations, oligomerize and form pores in the outer 
mitochondria membrane. Pore formation is followed by the release of cyt C from mitochondria intermembrane spaces, formation 
of apoptosomes in the cytosol, activation of caspase 9 and subsequent apoptosis of the cell.  
 
From: “The Bcl-2 Protein Family: Arbiters of Cell Survival” by Adams, J. M.; Cory, S. in “Science”,  
28
th
 August, 1998, Vol. 281, No. 5381, page1322. Reprinted with permission from AAAS.
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Figure 1-17. Intrinsic Apoptotic Pathway 
 
Pore formation in the outer mitochondria membrane during apoptosis facilitates 
the release of mitochondrial flavoprotein AIF and cyt C from the intermembrane 
space. The release of AIF activates Apaf-1. In the presence of cyt C and ATP, 
CARD of Apaf-1 binds CARD of procaspase-9, forming the “apoptosome”. 
Within the apoptosome, procaspase-9 auto-activates into caspase-9. Active 
caspase-9 initiates a caspase cascade through downstream caspases-3, 6, 7 
resulting in cell death by apoptosis.  
 
Reproduced with permission from “Sigma-Aldrich” 
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heterodimers associate into a tetramer, with two catalytic sites that appear to function 
independently. Within each catalytic domain, the large and small subunits are intimately 
associated and both contribute residues necessary for substrate binding and catalysis 
(Timmer & Salvesen, 2007).  
The preferred tetrapeptide recognition area differs significantly among caspases 
and explains the diversity of their biological functions (Bae et al., 2000; Thornberry et al., 
1997; Timmer & Salvesen, 2007). Tertiary structural elements may influence substrate 
recognition as well (Bae et al., 2000).  
The strict specificity of caspases is consistent with the observation that apoptosis 
is accompanied by a highly selective and coordinated cleavage of proteins, usually at a 
single site, that leads to the loss or change in their function (Figure 1-19). 
Caspases: Activation 
There are three major mechanisms of caspase activation in mammalian cells: (i) 
recruitment-activation; (ii) trans-activation and (iii) auto-activation. Recruitment- 
activation appears to be common to “death domain” containing receptors. Trans-
activation of one caspase by another is a well established mechanism. In general, 
upstream “initiator” caspases cleave and activate downstream “effector” caspases 
(Nordberg et al., 2010).  
In contrast to effector caspases, activation of an initiator caspase and its regulation 
is quite complex.(Bao, 2007) All initiator caspases are activated through autocatalytic 
intra-chain cleavages (Bao & Shi, 2007; Fuentes-Prior & Salvesen, 2004; Riedl & Shi, 
2004) Caspase 2, caspase 8 and caspase 9 in mammalian cells are activated on 
PIDDosome (Bao & Shi, 2007; Tinel & Tschopp, 2004), the death-inducing signalling 
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Figure 1-18. Structural Features of Caspases. 
 
A. Sequence homology and function of caspases. 
B. B. The crystal structure of caspase-3 in complex with a tetrapeptide 
aldehyde inhibitor (red). 
C.  C. In common with other proteases, caspases are synthetized as 
precursors that undergo proteolytic maturation. 
 
From: “Caspases: Enemies Within” by  Thornberry, N. A.; Lazebnik, Y.  in “Science”, 
28
th
 August, 1998, Vol. 281, No. 5381, page1313. Reprinted with the permission from 
AAAS. 
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Figure 1-19. Functions of Caspases. 
 
There are more than 280 caspase substrates identified.  Examples of effector 
caspases functions are: A. Cleavage and subsequent inactivation of inhibitors of 
apoptosis. B. Disassembly of proteins involved in scaffolding of the cytoplasm 
and nucleus. C. Deregulation of protein activity.  
Signal transduction and transcription-regulatory proteins, cell-cycle controlling 
components and proteins involved in DNA replication and repair are all among 
effector caspase targets.  
 
From: “Caspases: Enemies Within” by Thornberry, N. A.; Lazebnik, Y. in “Science”, 28th 
August, 1998, Vol. 281, No. 5381, page1313. Reprinted with the permission from AAAS.
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complex (DISC) (Kischkel, 1995), and the apoptosome (Bao & Shi, 2007; Cain et al., 
1999; Hu et al., 1999; Rodriguez & Lazebnik, 1999; Saleh et al., 1999; Zou et al., 1999). 
In each case, the initiator caspase is recruited into and activated within a specific adaptor 
protein complex. These adaptor protein complexes are always oligomeric and generally 
referred to as apoptosomes (Bao, 2007). 
Salvesen and Renatus (Renatus et al., 2001; Salvesen, 2002) analysed “initiator” 
caspases activation. Induced proximity theory (Martin et al., 1998; Muzio et al., 1998; 
Srinivasula et al., 1998; Yang et al., 1998) describes one of the possibilities of such 
activation for caspase 8. The theory postulates that the recruitment to protein complexes 
causes a local high concentration of caspase zymogens. Zymogen oligomers possess a 
small amount of enzymatic activity sufficient for processing in “trans”, and activation of 
the first caspase in the cascade (Troy & Salvesen, 2002). 
Bcl-2 family of proteins  
The first mammalian regulator of apoptosis emerged when Bcl-2, activated by 
chromosome translocation in human follicular lymphoma (Bakhshi et al., 1985; Cleary et 
al., 1986; Tsujimoto et al., 1984) was found to permit the survival of cytokine-dependent 
hematopoietic cells in the absence of cytokine (Vaux et al., 1988). 
The role played by Bcl-2 family members in mammals resembled CED-9 function 
in C. elegans. At least 15 Bcl-2 family members have been identified in mammalian cells 
(Chao & Korsmeyer, 1998; Cory, 1995; Strasser et al., 1997; Vaux et al., 1988; Yang et 
al., 1998). All members possess at least one of four conserved motifs known as Bcl-2 
homology domains (BH1 to BH4) (Figure 1-16) which influences homo- and hetero-
dimerization required for pro-survival and/or pro-apoptotic function (Cheng et al., 1996; 
Chittenden et al., 1995; Kelekar & Thompson, 1998; Yin et al., 1994). 
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Bcl-2 family members dock with specific proteins on each organelle and may 
register damage to the compartments and affect their behaviour, perhaps by modifying the 
flux of small molecules or proteins (Adams & Cory, 1998; Green & Reed, 1998; Green & 
Kroemer, 2004; Kroemer, 1997; Zamzami et al., 1998). 
Miller (Miller, 1999) summarised that the major role of Bcl-2 family proteins is to 
prevent mitochondrial malfunction by: 
 stimulation of adenosine diphosphate (ADP)/adenosine triphosphate (ATP) 
exchange;  
 
 stabilization of the mitochondrial inner transmembrane potential, preventing 
mitochondrial hyperpolarization and the resultant reactive oxygen formation, and  
 
 prevention of the opening of a permeability transition pore (“mega pore”).  
The Bcl-2 family members themselves are regulated in part by influences 
subsequent to another cytoplasmic multi-protein complex, the signalsome, which contains 
a complex of kinases, adaptor proteins, and ubiquitin-activation components in addition to 
the NF- transcription factor and its inhibitory protein (Miller, 1999). 
Inhibitors of apoptosis (IAP) 
Another important family of intracellular apoptosis regulators is the inhibitor of 
apoptosis (IAP) family. These proteins are thought to inhibit apoptosis in two ways: they 
bind to pro-caspases to prevent their activation, and they bind to caspases to inhibit their 
activity. When mitochondria release cyt C to activate Apaf-1, they also release a protein 
that blocks IAPs, thereby greatly increasing the efficiency of the death activation process 
(Alberts et al., 2002). 
Granzyme B 
Cytotoxic T cells (CTL) and Natural Killer (NK) cells play an important role in 
the immune response and apoptosis. One way in which CTL and NK induce apoptosis is 
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by exocytosis of specialised secretory granules in the vicinity of target cells. The key 
constituents of these granules are perforin, a pore-forming protein, and the granzymes, a 
family of closely related cytotoxic serine proteases (Vermijlen et al., 2001).  
Granzyme B shares with the caspases a preference for aspartate residues of the 
substrates. Current knowledge suggests that there are two distinct actions of granzyme B: 
(I) Granzyme B directly processes caspases-3, 7, 8, 10 thereby directly activating the cell-
death machinery.  
(II) Granzyme-B can cleaves Bid (Bcl-2 family member). Proteolysis of Bid enhances its 
ability to translocate to mitochondria and trigger the opening of cyt C-releasing channels 
(Adrian et al., 2005). 
p53 
When DNA damage is involved an apoptotic response usually requires the p53 
protein (Isobe et al., 1986; Kern et al., 1991; Matlashewski et al., 1984; McBide et al., 
1986). The name p53 is in reference to this protein’s molecular weight: 53 kDa. In normal 
cells, p53 is usually inactive. A ubiquitin ligase protein called murine double minute-2 
(MDM2) (Uhrinovas et al., 2005) binds to p53 and transports it from the nucleus to the 
cytosol where it becomes degraded by the proteasome (Peters et al., 1994). 
Upon DNA damage or other stress, various pathways will lead to the dissociation 
of the p53-MDM2 complex. Once activated, p53 either induces a cell cycle arrest to allow 
repair/survival or apoptosis to discard the damage cell. How p53 makes this choice is 
currently unknown (Evan & Littlewood, 1998; Garner & Raj, 2008; Halazonetis et al., 
2008). 
Recent studies have revealed that each cellular concentration and distribution of 
p53 has a distinct cellular function and that reactive oxygen species (ROS) act as both an 
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up-stream signal that triggers p53 activation and as a down-stream factor that mediates 
apoptosis (Liu et al., 2008).  
More information on proteins involved in apoptosis progression in the cell can be 
found in Chapter 5 and Appendix 6.  
Cell death cuts across a wide range of organisms and invades many fields of 
biology (Golstein, 1998). Tight coupling of cell death and cell multiplication ensures a 
constant, controlled flux of fresh cells in many tissues. This process is crucial to the 
preservation and optimal functioning of the adult organism. Defects in the balance 
between cell death and proliferation may result in disease.   
In the last few decades apoptosis has attracted the attention of scientists as a 
cornerstone biological mechanism occurring in the majority of multicellular organisms. 
Despite a significant effort to elucidate the mechanisms, cellular pathways and molecules 
involved, some basic questions still remain unanswered.  What triggers apoptosis? What 
regulates the cell’s “genetic knowledge” to activate or to not activate self-destruction? Is 
apoptosis the only mechanism of PCD, or are there others, and how does the cell know 
which way to go? In the light of recent discoveries, we wish to know more about the role 
of the cellular organelles in the process of apoptosis. Another interesting question is 
whether the molecules normally involved in apoptosis (like caspases, Bcl-2 family of 
proteins or p53) play roles other than their apoptosis-related functions in cells. 
This project will attempt to study the apoptotic mechanisms in LCH with 
particular reference to the molecular pathways involved.  
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APOPTOSIS IN DISEASE 
In a simplified manner, the diseases in which apoptosis has been involved can be 
divided into two groups: those in which there is an increase in cell survival (or diseases 
associated to inhibition of apoptosis), and those in which there is an increase in cell death 
(and hence hyperactive apoptosis) (Chamond et al., 1999) 
Diseases associated with inhibited apoptosis 
This group includes diseases in which an excessive accumulation of cells occurs 
(neoplastic diseases, autoimmune diseases). It was classically believed that increased cell 
proliferation was the main cause of such cell accumulation. According to the recent 
studies the cell accumulation could be due to defective apoptosis. A detailed list of 
literature reporting these studies can be found in (Chamond et al., 1999).  
In an extensive group of tumours, both solid and haematologic, malignant cells 
demonstrate an abnormal resistance to the induction of apoptosis. Expression of 
antiapoptotic proteins (Sturzl et al., 1999), soluble decoy death receptors (DR) (Cheng et 
al., 1994) or inhibitors of apoptosis (IAP) molecules (Reed, 2001) are common for 
cancerous cells. Chromosomal translocation leading to enhanced Bcl-2 expression in B 
cell lymphoma and correlation between high levels of Bcl-2 expression and the severity 
of malignancy of human tumours have been reported (Igney & Krammer, 2002). 
Inactivation of pro-apoptotic genes  mutation in BAX gene (Meijerink et al., 1998; 
Rampino et al., 1997); lack of Apaf-1 (Soengas et al., 2001); inactivation of caspase-8 
gene by deletion of methylation (Fulda & Debatin, 2004)  are all mechanisms used by 
cancerous cells to escape apoptosis. Furthermore, functional impairment of CD95 due to 
mutations of the CD95 gene has been reported in many tumours (Debatin & Fulda, 2006). 
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Loss of function in CD95/CD95L system could be of major significance in anti-tumour 
immune response, as CD95L produced by NK and cytotoxic T-lymphocytes is unable to 
kill tumour cells (Debatin & Fulda, 2006).  
Apoptosis is of great importance for the maintenance of a healthy immune system. 
Apoptosis enables the removal of activated and clonally-expanded lymphocytes generated 
during the course of an immune response (Maniati et al., 2008). The breakdown of 
apoptosis contributes to autoimmune phenomena via two routes. One is the failure to 
terminate immune responses and to control auto-reactive lymphocytes (Maniati et al., 
2008). The other is the exposure of self-antigens in an inflammatory context that can 
initiate immune response against them. It has been suggested (Hanayama et al., 2004; 
Maniati et al., 2008; Potter et al., 2003) that a defect in the clearance machinery and a 
subsequent overload of apoptotic cells is a potential mechanism for the breakdown of 
self-tolerance in systemic lupus erythematosus (Maniati et al., 2008). Another example of 
apoptosis-related autoimmune disease is autoimmune lymphoproliferative syndrome 
(ALPS). It is a rare human disorder that, in a clinical context, demonstrates the crucial 
role of apoptosis in the maintenance of lymphocyte homeostasis. It is characterised by the 
accumulation of an unusual subset of CD4-/CD8- double-negative T lymphocytes in the 
periphery, in combination with autoantibody production and chronic enlargement of the 
lymph nodes, liver and spleen (Bidere et al., 2006; Maniati et al., 2008). Defects in 
apoptosis play an important role in rheumatoid arthritis (RA) pathogenesis. The disease is 
characterised by the infiltration of inflammatory cells causing the destruction of the 
synovial membrane and secretion of pro-inflammatory cytokines, such as IL-6 and TNF 
(Maniati et al., 2008; Sakkas et al., 1994; Zhang et al., 2001). CD4-positive T-
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lymphocytes in a murine model of RA appear to hyper-proliferate indicating to impaired 
apoptosis (Zhang et al., 2001).  
Diseases associated with excessive apoptosis 
 Many people experience excessive death of one or more populations of neurons 
as the result of disease or injury (Matson, 2000). For example, death of hippocampal and 
cortical neurons is responsible for the symptoms of Alzheimer’s disease; death of 
midbrain neurons that use the neurotransmitter dopamine underlies Parkinson’s disease; 
Huntington’s disease involves the death of neurons in the striatum, which controls body 
movements; and death of lower motor neurons manifests an amyotrophic lateral sclerosis 
(Matson, 2000). Several stimuli (growth factors deprivation, oxidative stress, calorie 
intake, smoking, environmental factors and head trauma) trigger apoptosis of neurons, 
contributing to their excessive death (Festoff, 1996; Gschwind & Huber, 1995; Maniati et 
al., 2008; Wilkinshaw & Waters, 1995).  
APOPTOSIS IN LCH 
Studies of apoptosis in LCH are often conflicting and at times contradictory. 
Consistent and comprehensive research studies that follow the paradigm of scientific 
methodology are required into many areas of LCH pathogenesis.  
In 1995 Hamada and co-authors (Hamada, 1995) published a study on 
proliferative activity and apoptosis of LCs in EoG. Authors concluded that EoG was 
proliferative disorder of LCs (“LCH consists of proliferative histiocytic cells, and its 
spontaneous regression must thus be due to apoptosis”). Study of p53 expression in LCH 
by Weintraub and colleagues (Weintraub et al., 1998) suggested that p53 was abnormally 
stabilized in LCH via alternative to mdm-2 mechanism. In the report published by 
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Schouten and co-authors (Schouten et al., 2002) the role of key factors controlling 
proliferation and apoptosis (TGF receptors I and II); p21; p16; Rb; mdm-2; p53; Bcl-2) 
was investigated in LCH. The authors came to the conclusion that the cellular 
mechanisms that sense and respond to DNA-damage, namely the p53-p21 pathway and 
the p16-Rb pathway, are activated in LCH. The authors suggested that observed over-
expression of Bcl2 could play a role in the activation of p53 and p16 and the arrest of 
apoptosis. They also concluded that taking into account relatively slow growth rate of 
LCH cells in vivo and the inability to propagate the cells in vitro or in immunodeficient 
mice further supported the view that the cellular environment plays an important role in 
the maintenance and progression of LCH lesion.  
In 2003 Petersen and colleagues (Petersen et al., 2003) published an article on 
apoptosis markers expressed in LCH. The study compared the expression of Fas and Fas-
L in single-system and multisystem LCH. Similarly to Weintraub (Weintraub et al., 1998) 
they observed expression of p53 in LCH LCs but found no relationship between p53, Fas 
and FasL expression in the single and multi-system disease groups. The authors also 
reported low numbers of LCs undergoing apoptosis and suggested that Fas/FasL mediated 
apoptosis could contribute to the spontaneous regression of lesions in single-system 
disease.  
In 2008 Amir and Weintraub (Amir & Weintraub, 2008) compared the expression 
of caspase-3; Bcl-2; p53; Ki-67 and NF-B by LCs in patients with single- and multi-
system LCH. The authors suggested the inhibition of apoptosis played a role in the more 
aggressive manifestations of the disease (multisystem, risk bone involvement). However, 
their apoptosis study relied on IHC staining for caspase-3 and the comparison was within 
different forms of LCH.  
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In 2005 McClain compared the expression of cytokines in normal LCs versus 
LCH LCs and differences in cytokine expression in “low risk” and “high risk” disease. 
The authors reported that LCs in LCH had very low expression of many genes except for: 
TNFR; RANKL; IL-1GF-R; GM-CSF. They concluded that minimal if any 
difference existed in cytokine gene expression between low risk/high risk groups of 
patients. 
It is clear from this literature review that the understanding of the significance of 
apoptosis in both health and disease has deepened over the past decade. It is also clear 
that a number of researchers have started to explore the role of apoptosis in LCH and 
provided some insights into the role of this process in LCH.  
The advent of new technologies and access to tissue both fresh and preserved from 
this comparatively rare disease allowed the following questions to be investigated. Firstly: 
the level of apoptosis and apoptotic cell composition in LCH lesions.  Secondly: the 
apoptotic protein profile and possible pathway of apoptosis within LCH. Thirdly: the 
cytokine milieu within LCH lesions.  The work presented in the following chapters 
addresses these questions. 
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Chapter 2. Materials and Methods 
INTRODUCTION 
This chapter describes the techniques and products used throughout this thesis. All 
products were purchased from Sigma-Aldrich (Australia) unless otherwise specified. 
Sterilised solutions were autoclaved at 121C for 20 minutes at 100kPa.  
STERILISATION  
Instruments, DW and PBS used for cell culture were autoclaved at 121C for 20 
minutes at 150kPa in the “Atherton PHA1030” autoclave (“Atherton”, Australia).  
To filter sterilize medium containing non-sterile additives it was passed through 
0.22m MILLEXGP filters (“Millipore”, Australia) in sterile conditions.  
CELL CULTURE  
General cell culture techniques   
All cells were grown in Iscove’s Modified Dulbecco’s Medium (IMDM) with 
glutamax (Gibco, Australia) supplemented with 10% (v/v) heat inactivated fetal bovine 
serum (FBS) (Gibco, Australia) and 50g/ml kanamycin (Invitrogen, Australia) or 
mixture of penicillin (100units/ml) and streptomycin (100g/ml) (Sigma-Aldrich, 
Australia) (full medium). Cells were cultured in 25cm
2
 and 75cm
2
 tissue culture flasks 
(Sarstedt, Australia) at 37C with 5% carbon dioxide (CO2) in a CO2 incubator (Sanyo 
Electric, Japan).  
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Jurkat human T lymphocytes (acute T cell leukemia) were a gift from Dr. Damian 
Purcell (the University of Melbourne).   
For routine subculture of Jurkat cells (suspension cell line) cell culture was spun at 
1500rpm for 5 minutes. Supernatants were removed and pellets were resuspended in full 
medium at a lower concentration every 2-4 days.  
To freeze cells for long-term storage, cell cultures were removed from culture 
flasks and washed in full medium. Cells were resuspended in a solution containing 10% 
(v/v) dimethyl sulfoxide (DMSO) and 90% full medium at the concentration of 10
6 
cells/ml. Aliquots (1ml) were dispensed into cryotubes (Nunc, USA) and placed into a 
polystyrene rack in a -80C freezer for 12 hours to achieve 1C per 1cm in 1 hour regime 
of cooling.  The vials were then moved to a freezing rack and completely immersed in 
liquid nitrogen (LN) for long-term storage.  
To thaw cells following storage, aliquots were placed in a 37C water bath. The 
cells were then rinsed in fresh medium without FBS and kanamycin, resuspended in fresh 
full medium and reseeded at a moderate density to optimise cell viability.  
Cell number and viability estimation  
Jurkat cells (suspension cell line) in log phase of growth were collected from the 
flasks and pelleted at 1500rpm for 5 minutes. Cells were resuspended at the desirable 
concentration in full medium or PBS for further experiments.  
To determine the concentration cells were counted in Fuchs-Rosenthal 
haemocytometer (Hirschmann EM Technology, Germany) using “Leica DMIL” inverted 
microscope. 
Viability of the cells was assessed by inclusion of trypan blue into the cells. 50% 
(v/v) trypan blue was added to cell suspension and dark stained cells seen in Fuchs-
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Rosenthal haemocytometer were considered dead and were excluded from viable cell 
counts.  
Conditioned medium preparation   
Tissues were collected as described in “Single Cell Suspensions” and single cell 
suspensions were prepared in sterile conditions. Leftovers of the tissue after single-cell 
suspension preparation were teased apart and placed in serum free medium in the wells of 
24 wells plate. Size of the tissue was 3-5mm
3
 per 0.5ml. Tissues were incubated for 7 
days at 37C in 5% CO2. At the end of the incubation the tissues were discarded, medium 
was collected, filtered through 0.7m filters (BD-Falcon, USA) and dispensed into sterile 
1.5ml tubes in 0.5ml aliquots. Conditioned media were stored at minus eighty degrees 
(C).  
Apoptosis induction with anti-Fas antibody and dextran sulphate 
(positive control in flow cytometry experiments) 
Jurkat cells were seeded in the wells of  96 wells plate (Sarstedt, USA) at the 
concentration of 20,000.00 cells per 100l of full IMDM/Glutamax medium (Gibco, 
Australia) containing 100ng/ml anti Fas CH11 antibody (Millipore, USA) and  100g/ml 
Dextran Sulphate (Sigma-Aldrich). Cells were incubated in the atmosphere of 5% CO2 
and within the first 24 hours approximately 70% were registered to express annexing V 
on the cell surface.  
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SINGLE CELL SUSPENSIONS  
Human blood   
Male and female volunteers of varying ages were selected randomly from the 
population. Trained St. John of God Pathology personnel (Ballarat, Australia) collected 
the blood samples into 4.5 ml EDTA (BD Vacutainer) tubes (“Beckton Dickinson”, 
Australia). The volume of blood collected ranged from 3-25ml.  
Total White Blood Cells (WBCs) were purified from the blood within two hours 
after collection using alkaline lysis. Following the purification procedure concentration 
and viability of the cells were assessed as described in “Cell number and viability 
estimation”. Cells were either used in the experiments immediately or frozen in LN for 
long term storage as described in “General cell culture techniques”.  
The lysing solutions used in this method selectively lyse red blood cells, leaving 
the white blood cells (WBCs) viable.  
Whole blood samples were spun at 1000g for 15 minutes. Following 
centrifugation, plasma was carefully removed and buffy coat was placed in a 50ml tube. 
RBC/buffy coat mix was diluted with 5-10x the volume of RBC lysis buffer (155mM 
ammonium chloride, 10mM potassium bicarbonate and 0.1mM EDTA, pH=7.2-7.4) and 
agitated at RT for 5-10 minutes. Cells were further centrifuged at 300g for 10 minuntes, 
supernate was discarded, cells were washed twice with sterile ice-cold PBS and 
resuspended in full medium containing 10% FBS.  
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Human tonsil   
Surgically removed tonsils were collected within 1hour after the resection and 
were kept on ice. 
After the transversal cuts were taken out of the tonsils, the rest of the tissue was 
sliced into 1cm strips, and as much as possible of the central lymphoid tissue was 
discarded. Epithelial strips were placed in 5ml of dispase II (Roche) and incubated for 45 
minutes in a water bath at 37°C. Following the incubation more lymphoid tissue was 
scraped off the epidermal layer and discarded. Epidermal layers were cut in smaller 
sections and incubated in 4ml of 0.3% trypsin for 10 minutes in the water bath at 37°C. 
At the end of the incubation 4ml of Iscove’s Modified Dulbecco Medium (IMDM) 
supplemented with 10% FBS was added. Cell suspension was briefly vortexed and 
filtered through a strainer to remove remaining clumps. 10l of 1mg/ml DNAse-1 was 
added to the whole volume of filtrate and incubated for 10 minutes in the water bath at 
37°C. The solution was spun at 250g for 10 minutes at 4°C and the pellet was 
resuspended in 5mls of Buffer A. Red blood cells were lysed by incubating 1volume 
(5ml) of the cell suspension with 5-10 volumes (45ml) of Lysis Buffer for 5 minutes at 
RT.  Cells were centrifuged at 300g for 10 minutes at RT and washed twice by 
resuspending the pellet in HBSS and spinning at 200g for 10 minutes. The pellet was 
resuspended in 4.5ml of IMDM/10%FBS and cell count was performed. The necessary 
amount of the cells was taken out for cytospins preparation. DMSO was added to the cell 
suspension to the final concentration of 10% (v/v) and cells were dispensed into cryovials 
(“Nunc”) and stored at -80°C for 12 hours. In 12 hours vials were transferred into liquid 
nitrogen (LN) for long term storage.  
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LCH  
Fresh LCH samples were collected within 1hour after the surgery and kept on ice. 
Frozen LCH samples were from the BCRC tissue bank collection. 
Biopsy material was placed in a sterile specimen container and kept on ice. 
Further work was performed in sterile conditions. Tissue was teased apart in a small 
amount of PBS. Fat was removed and tissue was digested in 5mls of dispase II (Roche) in 
the water bath at 37°C for 1hour. At the end of the incubation epidermal layer was peeled 
away, remaining tissue was dissociated by mechanical disruption and filtered through 
70m filter. Filtrate was spun at 300g for 10 minutes. Pellet was frozen in LN as 
described in “Single Cell Suspensions”. SN was frozen at -80C. On the day of the 
experiment cells from LN were thawed, transferred into flow tubes (Falcon) and spun at 
300g for 10 minutes. Most of the SN was removed, 50l of full IMDM was added and 
cells were incubated on ice for 5 minutes. Further 50l, 100l, 200l and 500l of full 
medium were added with 5 minutes intervals. Cells suspension was than filtered through 
70m filter and used for flow cytometry or proteome profiler array.  
CYTOSPINS PREPARATION  
Concentration of the cells in SCS for cytospins did not exceed 0.5x10
6
 cells/ml in 
total volume of 100-250l of full medium. Samples were loaded into the chambers with 
slides of cytospin (“Shandon Elliott”, USA) rotor and centrifuged for 2 minutes at 
1200rpm. After centrifugation, slides were carefully removed, air dried and fixed in 100% 
methanol for 3-5 minutes, air dried again and stored at RT.  
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FORMALIN FIXED PARAFFIN EMBEDDED (FFPE) 
TISSUES  
Tonsillar FFPE tissues   
Surgically removed tonsils were collected within 1hour after surgery, briefly 
rinsed in Hank’s Balanced Salt Solution (HBSS), 70% ethanol and HBSS. Transversal 
cuts from the middle of the tonsil were fixed by immersion in 4% formaldehyde for 24 
hours. In 24 hours tissues were embedded in paraffin using standard procedure at St. John 
of God Healthcare Pathology Department.  Paraffin blocks were stored at RT.  
LCH and inflammatory controls FFPE tissues  
LCH and control tissues, refer Table 2-1, were either obtained from the BCRC 
tissue bank or from the archives of the Pathology department at SJOG HC, Ballarat. All 
samples were prepared as FFPE blocks using standard procedures. FFPE sections were 
prepared at BCRC or by SJOG HC Pathology Department. FFPE sections prepared at 
SJOG HC pathology Department using routine procedure were stored at room 
temperature (RT).  
When prepared at BCRC, FFPE sections (3m) were cut using a “JUNG AG” 
microtome, placed in a 20% ethanol bath at RT for 5 minutes, followed by a distilled 
water bath at 40°C for 5 minutes. Sections were then adhered to polysine coated 
(precleaned/ready to use/ground edges) microscope slides (Menzel GmbH & Co KG, 
Germany), incubated at 60°C for 15 minutes and stored at RT.  
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BUFFERS AND REAGENTS 
The Reagents used are listed in the Table 2-2 and the buffers used and their 
preparation methods are listed in APPENDIX 2: BUFFERS.  
ANTIBODIES  
The primary antibodies used were selected to enable the detection of specific cell 
antigens, refer Table 2-3. Technical information regarding the antibody dilutions and their 
isotypes, is shown in Table 2-4.  Normal rabbit or mouse immunoglobulin fractions and 
normal mouse serum were used to detect non-specific binding. The secondary antibodies 
used were all from “Molecular Probes”, refer Table 2-5. All secondary antibodies were 
diluted 1:500 for use. 
STAINING PROCEDURES 
Deparaffinization   
FFPE sections were deparaffinised in two xylene incubations (2x10 minutes each) 
followed by re-hydration with decreasing concentrations of ethanol: 100% (2x5 minutes 
each), 90% (3 minutes), 80% (3 minutes), 70% (3 minutes). Sections were further 
incubated in deionised water (DW) (2 x 5 minutes each) prior to antigen retrieval. If 
sections were stained with Apostain antibody, deparaffinization was followed by 
permeabilisation with 0.1% (v/v) Triton X-100. 
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TABLE 2-1 
Control Tissues for the Cell Composition Study 
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Table 2-2. 
Reagents 
Reagent Supplier 
Ammonium Chloride (NH4Cl) "Ajax Chemicals", Australia 
di-Sodium Hydrogen Orthophosphate 
Anhydrous (Na2HPO4) 
"APC Finechem", Asia/Pacific 
Paraformaldehyde; Sodium Hydrogen 
Carbonate (NaHCO3) 
"BDH Laboratory Supplies" 
BD FITC Annexin V Apoptosis Detection Kit II 
(BD);                         Dithiotreithol (DTT) 
"Beckton Dickinson", Australia 
Normal Goat Serum (NGS) (whole with 0.1% 
NaN3) 
"Bio-Scientific Pty., Ltd", Australia 
Triton X-100 "Boiehringer Mannheim Corporation", USA 
Proteinase K (200g/ml);                                                                                           
"ApopTag Plus Fluorescein In Sity Apoptosis 
Detection Kit S7111" 
"Cheimcon IHC Select", "Millipore Corporation", 
Australia 
Ethanol (100% denaturated);                                                            
Potassium Hydrogen Carbonate (KHCO3);                           
Glycerol;                                                                                 
Chloroform 
"Chem-Supply", Australia 
"Antibody Diluent with Background Reducing 
Components"; "Antibody Diluent"                                                                                                                                                                                                                 
"Dako Cytomation", Denmark 
Milk (skim powder, low in cholesterol) "Diploma" instant 
RPMI 1640 with GlutaMax;                                                                     
Fetal Bovine Serum Heat Inactivated;                                   
Trypsin;                                                                                  
Iscove's Modified Dulbecco's Medium (IMDM) 
"Gibco" 
"Image-iT FX signal enhancer";                                                        
"Prolong Gold antifade reagent with DAPI" 
"Invitrogen", Australia 
Tween-20 Polyoxyethylene (20) sorbitan 
monolaurate 
"Labchem", Australia 
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Table 2-2. Continued 
Xylene (histological grade);                                                                   
Methanol 
"Lab-Scan Analytical Sciences", Thailand 
Formaldehyde Solution 40% "Merck Pty., LTD" 
Potassium Chloride (KCl) "Progen Industries, Ltd." 
RNAsin "Promega" 
DNAse1;                                                                                        
Rnase Free DNA Digestion (RDD) buffer                          
"Qiagen" 
DNAse-1;                                                                                       
DispaseII 
"Roche" 
Bovine Serum Albumin (BSA);                                                         
Ethylenediaminetetraacetic acid disodium salt 
dihydrate (EDTA) (99.0-101.0%);                                                                              
Formamide (cat.#F-7503);                                                                                        
Phosphate Buffered Saline (PBS) in tablets;                                                        
Potassium Hydrogen Phosphate (K2HPO4);                                                         
Sodium Chloride (NaCl); Trisma Base;                                                                               
Diethylpyrocarbonate (DEPC)                                                  
Dimethyl Sulphoxide (DMSO) Hybri-max. 
Cat.no. D2650.  
"Sigma-Aldrich" 
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Antigen retrieval (for standard IHC procedure) 
Sections were placed in a beaker containing hot antigen retrieval solution, pH=9 
(APPENDIX 2). The beaker was placed in a hot water bath to maintain the temperature at 
95°C for 30 minutes. At the end of the incubation, the beaker with the sections was 
removed from the water bath and allowed to cool at room temperature until 
approximately 42°C (about 20 minutes). Sections were then washed in Tris-buffered 
saline with 0.05% (v/v) Tween-20 (TBST) (APPENDIX 2) (3x5 minutes each).  
Antigen retrieval in formamide (for apostain procedure) 
Sections permeabilised for 15 minutes at RT for 15 minutes in 0.1% (v/v) Triton 
X-100 in PBS were placed in a beaker containing 50% (v/v) formamide solution in DW 
heated to 56°-60°C. The beaker was placed in a hot water bath to maintain the 
temperature at 56°-60°C for 20 minutes. After the incubation slides were transferred in 
the coplin jar with ice-cold Phosphate buffered saline (PBS) and incubated on ice for 5 
minutes. Standard immunohistochemistry procedure was further applied. 
Permeabilization   
Liquid was blotted from the slides around the tissue and 15l of 0.1% (v/v) Triton 
X-100 in DW was added. Slides were incubated in a humid chamber RT for 15 minutes 
and washed in PBST (3x5 minutes each). Slides were left in the last PBST wash prior to 
the next step.  
TUNEL control slides  
“Positive”, “Negative” and “TUNEL” controls were used to monitor the TUNEL 
assay, refer Table 2-6.“Positive” control slide. Following the permeabilisation step, the 
liquid was blotted from the slide around the tissue and 15l* of DNAse-1 (diluted to 
5g/ml with PBS) was added to digest all the DNA present within cells on the slide. The 
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slide was incubated in a humid chamber at 37°C for 45 minutes and was washed in DW 
(5x3 minutes each) and in PBST (2x2 minutes each). Excess PBST was tapped off, 
blotted from around the tissue and 15l* of “Equilibration buffer” from the “ApopTag” 
kit was added. The slide was left in “Equilibration buffer” under the plastic cover slip in a 
humid chamber at RT (or at 4°C overnight for dual staining) until the other slides were 
ready to proceed through the TUNEL assay. 
“Negative” control slide. Following the permeabilisation step, the liquid was 
blotted from the slide around the tissue and 15l* of “Equilibration buffer” from the 
“ApopTag” kit was added. The slide was incubated under the plastic cover slip in a humid 
chamber at RT (or at 4°C overnight) until the other slides were ready to proceed through 
the TUNEL assay. 
“TUNEL only” control slide. Following the permeabilisation step, the liquid was 
blotted from the slide around the tissue and 15l* “Equilibration buffer” from “ApopTag” 
kit was added. The slide was incubated under the plastic cover slip in a humid chamber at 
RT (or at 4°C overnight) until the other slides were ready to proceed through the TUNEL 
assay. 
Counterstain and mount   
All slides were counterstained and mounted with the “Prolong gold antifade 
reagent with diamidino-2 phenylindole (DAPI)” mounting medium. Tissues were covered 
by glass cover slips and left to dry in the dark for 12 hours. After 12 hours, the edges were 
sealed with nail polish. The slides were examined using fluorescence microscopy within 
first week. 
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Singular IHC staining   
Following the permeabilization step, the slides were incubated in TBST (PBST for 
apostain procedure) (3x5 minutes each).  Excess buffer was blotted from around the tissue 
on each slide and a sufficient amount of Image-IT Fx signal enhancer was added to cover 
the tissue. The slides were then incubated in a humid chamber at RT for 30 minutes.  
Standard rinsing procedure: the slides were gently rinsed with Tris-buffered saline 
(TBS) (or PBS for apostain procedure) using a plastic bulb-pipette (flow was not focused 
directly on the tissue) and were then immersed in TBST (or PBST for apostain procedure) 
(3x5 minutes each) prior to the next step.  
The excess TBST (or PBST for apostain procedure) was blotted from around the 
tissue and sections were covered with 50l of blocking buffer to block non-specific 
antibody binding. The slides were incubated in a humid chamber at RT for 1hour and 
were rinsed according to the standard rinsing procedure. 
The primary antibodies (1° Ab), refer Table 2-4, were diluted in blocking buffer. 
Excess buffer was be tapped off and blotted from around the tissue. 20l* of 
appropriately diluted primary antibody was added.   
Normal rabbit or mouse immunoglobulin fraction (normal mouse serum for 
apostain procedure) were used as a negative controls for the primary antibodies. Slides 
were incubated in a humid chamber at RT for 1hour and rinsed according to the standard 
rinsing procedure. 
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Table 2-3. 
Primary Antibodies Cell Markers (IHC) 
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Table 2-5. 
Secondary Antibodies for IHC 
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The secondary antibodies, refer Table 2-5, were diluted 1:500 in blocking buffer. 
Excess TBST (or PBST for apostain procedure) was tapped off and blotted from around 
the tissue. 50l of the appropriately diluted secondary antibody was added to cover the 
specimen. Slides were incubated in a humid chamber at RT for 1hour in the dark and 
rinsed according to the standard rinsing procedure, counterstained and mounted.  
Singular TUNEL assay   
The TUNEL assay followed immediately after the antibody incubations. The 
“ApopTag Apoptosis Detection Kit” was used according to the manufacturer’s 
instructions. 
The TUNEL Control slides were already in the “Equilibration buffer” and were 
not included in this step.  
Excess TBST was tapped off each test slide, blotted from around the tissue and 
15l* of “Equilibration buffer” from the “ApopTag” kit was added. The slides were 
incubated under the plastic cover slips in a humid chamber at RT for 10 minutes in the 
dark. The concentrated TdT Enzyme in the “ApopTag” kit is supplied in a stabilization 
buffer. It must be diluted with “Reaction Buffer” prior to use. The reagents were 
combined in a ratio of 30% “TdT-enzyme” to 70% “Reaction buffer”, vortexed and kept 
on ice until use.  
The “Positive control” and “TUNEL only control” slides were included in the 
assay at this step. The “Negative control” slide was not included and remained in the 
“Equilibration buffer”.  
Excess “Equilibration buffer” was tapped off each slide and blotted from around 
the tissue. 11l/cm2 of the TdT-enzyme mixture was added onto the tissue and covered 
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with a plastic cover slip. The slides were incubated in a humid chamber at 37°C for 
exactly 1 hour in the dark.  
The stop/wash solution was prepared by thorough mixing of 1ml of “Stop/wash 
buffer” from the “ApopTag” kit in 34 ml DW. The TdT-enzyme mixture was tapped off 
each slide and blotted from around the tissue. The slides were immersed in the stop/wash 
buffer solution and incubated at RT for 10 minutes. All slides (including all TUNEL 
controls) were washed in PBS (3x1 minutes each).  
All TUNEL controls and test slides were included in this step. 
The working strength anti-digoxigenin antibody conjugated with fluorescein 
solution (“Anti-DIG Conjugate”) was prepared by vortexing the 47% “Anti-Digoxigenin 
Conjugate” and 53% “Blocking Solution”. 13 l/cm2 of the mixture was added onto each 
tissue and covered by a plastic cover slip. The slides were incubated in a humid chamber 
at RT for 30 minutes in the dark. All slides were rinsed in PBST (4x2 minutes each) prior 
to mounting.  
Dual IHC and TUNEL staining  
Dual staining was performed as a two day procedure, refer Table 2-6. On the first 
day TUNEL control slides were initiated and IHC was performed, leaving slides under 
secondary antibodies in the humid chamber at 4ºC overnight. On the second day IHC 
slides were rinsed and the TUNEL assay followed immediately, starting from the 
equilibration step. 
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MICROSCOPY 
Areas of similar tissue morphology were analysed at high power magnification 
(1000x) in control and test slides. Cell counts were conducted on areas which 
demonstrated fluorescent staining in more than 95% of cell nuclei following DNase-1 
treatment (positive control). Five fields were examined with the minimum of 100 cells in 
each field (minimum of 500 cells in total). The results presented as a percentage of 
stained cells compared to the total number of the cells in the microscopic field.   
Slides were examined within 1 week after staining on the “Leica DMLB” 
fluorescent microscope. Images were acquired using “Leica DG 300F” camera (“Leica”, 
Germany). Fluorescence was visualised using BGR, I3, TX and A filter cubes, refer Table 
2-7.  
Using the I3 filter cube, fluorescence from 488nm (green) is visible allowing 
apoptotic nuclei to be seen and counted.  
Using the TX filter cube, fluorescence from 594nm (red) is visible allowing 
specific cell marker antibody staining to be seen and specific cell types to be counted. 
Using the BGR filter cube, fluorescence from both specific cell marker and apoptotic 
nucleus can be seen, as well as the blue fluorescence from the DAPI counterstain. BGR 
filter was used to count cells simultaneously stained by TUNEL and IHC (specific 
marker) techniques. 
Using the A filter cube, fluorescence from DAPI (blue) is visible allowing cell 
nuclei staining to be seen and total nucleus-containing cell present in the field to be 
counted.
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Table 2-6. 
Combined IHC and TUNEL Protocol 
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FLOW CYTOMETRY 
Cell suspensions were filtered through 70m filters and evenly distributed into 
flow tubes (Falcon) each containing 5l of human serum at the minimum concentration of 
1x10
5
 cells per tube in 100l of full medium. Tubes were kept on ice and analysed within 
1 hour. 
Control tubes were prepared for each experiment as follows: cells alone (no dye 
added); 5l of propitium iodide (PI) only added to cells (PI from Annexin V kit, BD); 5l 
of Annexin V conjugated with fluorescein isothiocyanate (FITC) (Ann) only added to 
cells. Test tubes had both 5l of PI and 5l of Ann added.  
Apoptosis in Jurkat cells induced with anti-Fas/DS was considered positive 
control in the experiments where the numbers of apoptotic cells were studied.  
Flow cytometric analysis was performed on Becton Dickinson (BD) Fluorescent 
Activated Cell sorter (FACS) AriaII. Data was analysed using FACS DIVA software 
version 6.1. 
Debris and cell doublets were gated out. Gates for living cells were set up and 
apoptotic cells were detected as PI
-
FITC+ subpopulation using Ann-FITC staining 
method. Apoptotic cell subpopulations were further analysed using fluorofore-conjugated 
antibodies raised against specific cell markers. Fluorescence detection of PI, PE, PerCp-
Cy5.5; PE-Cy7; APC; APC-H7 and V450 fluorophores was performed, refer Tables 2.8; 
2-9; 2-10. Crossover of fluorescence was compensated using FACS DIVA software 
version 6.1. A minimum of five thousand events per sample was recorded and analysed. 
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TABLE 2-7. Cubes for Immunofluorescence Detection 
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Table 2-8. 
Fluorescent Dye-Conjugated Reagents for Flow Cytometry 
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Table 2-9. 
Fluorescent Reagents for Flow Cytometry 
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Table 2-10. 
Fluorescent Reagent Panels for Flow Cytometry 
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Detection of cells undergoing apoptosis in cultured cells  
Jurkat cells were incubated with conditioned medium from LCH biopsies and cell 
suspensions were prepared at the end of the incubation. Numbers of apoptotic cells were 
detected using Ann-FITC and PI from BD Pharmingen FITC Annexin V Apoptosis 
Detection Kit II (Apoptosis detection kit) (BD, Australia) according to manufacturer 
instructions.  
Detection of cells undergoing apoptosis in single cell suspensions    
Fluorescent antibody panels, refer Tables 2-8; 2-9; 2-10, compatible with Ann-
FITC staining of cells in cell suspension were designed to detect cells undergoing 
apoptosis in single cell suspensions obtained from LCH and controls.  
Single cell suspensions were distributed between control and test tubes at the 
concentration of 10
5
/100l of full medium per tube. 5l of normal human serum was 
added to all tubes.  Antibody panels were added to test tubes and incubated on ice in the 
dark for 30 minutes. Control tubes remained on ice. At the end of the incubation cells in 
all tubes were washed with 4mls of PBS and centrifuged at 1200rpm for 10 minutes at 
4ºC. Supernatants were aspirated gently until approximately 100l was left in the tube 
and PI and Ann were added to control and test tubes. Cells were further incubated for 15 
minutes on ice. Binding buffer was prepared by diluting x10 binding buffer concentrate 
provided in Apoptosis detection kit with DW. 250l of binding buffer was added to each 
tube and flow cytometry analysis was performed within 1 hour after the addition of PI and 
Ann.  
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PROTEIN METHODS 
Tissues were defrosted on ice and washed with ice-cold PBS. Sufficient volume of 
lysis buffer 15 with protease inhibitors was added to cover sample in glass homogenizer 
(Sigma-Aldrich, Australia). Tissue was homogenised and incubated on ice for 30 minutes. 
At the end of the incubation the mix was transferred to a microcentrifuge tube and spun at 
14,000rpm for 30 minutes at 4C.  Lysate (SN) was removed, lipid layer and cellular 
debris was discarded. Protein concentration was determined using Bradford (Bradford, 
1976) assay. Lysates were aliquoted at 1000g/tube and stored at -80C.  
Protein concentration was determined by the method of Bradford (1976) using the 
BioRad protein assay dye concentrate and bovine serum albumin (BSA) (BioRad, USA) 
as a protein standard (Bradford, 1976). 
Human apoptosis antibody array   
The principle of human apoptosis antibody array is based on the specific 
recognition by antibodies linked to the membrane (provided in the kit) of the apoptotic 
proteins released into the solution during cell lysates preparation. To standardise data 
obtained in different experiments, the amount of protein is quantified and the same 
amount of total protein is incubated with membranes.  
For blocking, each array was placed into the well of 4-well multi-dish containing 
2mls of array buffer 1 and incubated for 1hour on the rocking platform (“Bioline platform 
rocker 8025”, Edwards Instruments, Australia). In a separate tube 1.25mls of array buffer 
1 and 250l of cell lysate were mixed. At the end of the blocking procedure array buffer 1 
was discarded and replaced by diluted cell lysate. Arrays were incubated overnight at 2- 
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8C on the rocking platform. Next day each array was removed and placed into individual 
plastic containers containing 20mls of x1 wash buffer. Arrays were washed for 10 
minutes three times on the rocking platform. For each array 15l of detection antibody 
cocktail was diluted to 1.5ml with x1 array buffer 2 in array buffer 3.  Arrays were placed 
into wells of a 4-well multi dish containing 1.5ml of diluted detection antibody cocktail 
and were incubated for 1 hour on the rocking platform. At the end of the incubation arrays 
were washed for 10 minutes three times on the rocking platform. Arrays were placed into 
1.5mls of the 1:2000 dilution of streptavidin-HRP in x1 array buffer 2 in array buffer 3  in 
the wells of the 4-well multi-dish and incubated for 30 minutes on the rocking platform. 
Arrays were washed for 10 minutes three times on the rocking platform. While the arrays 
were still in the washing buffer, chemiluminescent mix was prepared using Noves ECL 
Chemiluminescent Substrate Reagent Kit (WP20005, Invitrogen, Australia). 410l of 
substrate A from the kit was mixed with 410ml of substrate B. Each array was analysed 
separately. The array was taken out of the washing buffer and the excess of the liquid was 
allowed to drain (membranes were not allowed to over-dry at any stage). It was placed in 
a plastic container positioned in the centre of the platen in the Universal Hood II (BioRad, 
USA) which was set up for the chemiluninescent analysis. 820l of the chemiluminescent 
mix were pipetted on top of the membrane and the readings were taken after 10 minutes 
of exposure using Quantity One 1D analysis software (BioRad, USA). 
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Human cytokine array  
Principle of human cytokine array is based on the specific recognition by 
antibodies linked to the membrane (provided in the kit) to the proteins in conditioned 
medium obtained after the incubation of tissues in serum-free medium.  
For blocking each array was placed into the well of 4-well multi-dish containing 
2mls of array buffer 4 and incubated for 1 hour on the rocking platform (“Bioline 
platform rocker 8025”, Edwards Instruments, Australia). In a separate tube 0.5mls of 
array buffer 4 and 1ml of conditioned medium were combined. The volume was adjusted 
to 1.5ml with array buffer 5 if it was necessary. 15l of reconstituted cytokine array panel 
A detection antibody cocktail was added to each prepared sample and mixed. This tube 
was incubated at room temperature for one hour. At the end of the blocking procedure 
array buffer 4 was discarded and replaced by sample/antibody solution. Arrays were 
incubated overnight at 2-8C on the rocking platform. Next day each array was removed 
and placed into individual plastic containers containing 20mls of x1 wash buffer. Arrays 
were washed for 10 minutes three times on the rocking platform. Arrays were placed into 
2mls of the 1:2000 dilution of streptavidin-HRP in array buffer 5 in the wells of the 4-
well multi-dish and incubated for 30 minutes on the rocking platform. Arrays were 
washed for 10 minutes three times on the rocking platform. While the arrays were still in 
the washing buffer, chemiluminescent mix was prepared using Noves ECL 
Chemiluminescent Substrate Reagent Kit (WP20005, Invitrogen, Australia). 410l of 
substrate A from the kit was mixed with 410ml of substrate B. Each array was analysed 
separately. The array was taken out of the washing buffer and the excess of the liquid was 
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allowed to drain (membranes were not allowed to over-dry at any stage). It was placed in 
a plastic container positioned in the centre of the platen in the Universal Hood II (BioRad, 
USA) which was set up for the chemiluninescent analysi. 820l of the chemiluminescent 
mix were pipetted on top of the membrane and the readings were taken after 10 minutes 
of exposure using Quantity One 1D analysis software (BioRad, USA). 
MOLECULAR BIOLOGY METHODS 
Purification of total RNA, including miRNA, from frozen human 
tissues   
Total RNA was extracted from approximately 50mg of human tissues using 
miRNeasy kit (Qiagen, Australia). Manufacture’s instructions provided in the kit manual 
were followed (including DNAse treatment) with further described modifications. Prior to 
the final elution step 1l of DTT (20mM) (Beckton Dickinson, Australia) and 1l RNasin 
(40u/l) (Promega, Australia) were added to the bottom of the new collection tube and 
this tube was kept on ice. Final elution was done with 50l of DEPC treated warm water.   
The quality of RNA was assessed by agarose gel electrophoresis. RNA 
concentration was determined using QubIT RNA Quantification System (Invitrogen, 
Australia).  
RNA Agarose gel electrophoresis   
2l of purified RNA was loaded with appropriate volume of loading buffer into 
the wells of  2% agarose gel containing 0.1g/ml ethidium bromide stain. Gels were run 
in 1x TAE buffer prepared with DEPC treated water in a MultiSUB midi horizontal 
electrophoresis system (Westlab, Australia) using Elite 300 Plus power pack (Wealtec 
Corp., USA) at 110V for 30 minutes. The 0.24-9.5 kilobase pair RNA ladder (Invitrogen, 
Australia) was used as molecular weight marker.  
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Microarray analysis   
Quality and quantity of total RNAs from LCH and tonsillar tissues were re-
analysed using a bio-analyser before proceeding to the next steps. Remaining methods of 
labelling, hybridisation and analysis were done according to the Affymetrics chip 
technology as described in Chapter 7.  
cDNA synthesis   
RNA from LCH and tonsillar tissues was reverse transcribed to obtain ss-cDNA 
using SMART cDNA Library Construction Kit (Clontech Laboratories, Inc; BD 
Biosciences).  
For each sample the following reagents were combined in a sterile 0.5 ml 
microcentrifuge tube: 1-3 l of RNA sample (containing 1.5g of total RNA) in DEPC 
water; 1l SMART IV oligonucleotide; 1l CDS III/3’ PCR primer; total volume was 
adjusted to 5l with DEPC water. The contents of each tube was mixed and spun briefly. 
The tubes were incubated at 72C for 2 minutes and cooled on ice for 2 minutes. The 
tubes were spun and the following reaction mix was added to each tube to a final volume 
of 10l: 2l of x5 first-strand buffer; 1l of DTT (20mM); 1l of dNTP Mix (10mM); 
1l of PowerScript reverse transcriptase.  The contents of each tube were gently mixed, 
spun and incubated at 42C for 1hour. At the end of the incubation tubes were heated at 
70C for 10 minutes to terminate first-strand synthesis. They were transferred into -20C 
and used for further experiments within three months.  
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Reverse transcriptase Polymerase Chain Reaction (RT-PCR) 
PCR mix was prepared according to the following recipe: x l of ss cDNA 
(amount of cDNA was calculated individually for each sample); 2l x10 PCR buffer and 
0.4l of Advantage 2 Polymerase Mix (Clontech Laboratories, Inc); 0.4l of PCR 
Nucleotide mix (containing 10mM each dNTP, Roche); 0.5l of 10M forward primer; 
0.5l of 10M reverse primer and (16.2-x) l of DW. Total volume of reaction was 20l. 
Regime of PCR was: 1 minute at 95C followed by 30 cycles of [15sec at 95C; 10sec at 
60C; 15sec at 68C].  GeneAmp PCR System 2700 (Applied Biosystems) was used to 
carry out the thermal regime. Primers were from “Sigma-Aldrich”, refer Table 2-11.  
STATISTICAL ANALYSIS 
Statistical models chosen for data analysis were selected with the assistance of Dr. 
Chris Turville from the University of Ballarat (Ballarat, Australia). 
KITS  
ApopTag Plus Fluorescein in Situ Apoptosis Detection Kit. Cat.no.: S7111. 
“Millipore”, USA. 
Human Apoptosis Array Kit (Proteome Profiler Antibody Arrays). “R&D 
Systems”, USA supplied by “Bioscientific Pty., Ltd”, Australia.  
Human Cytokine Array Panel A Array Kit (“R&D Systems”, USA supplied by 
“Bioscientific Pty., Ltd”, Australia.  
BD Pharmingen FITC Annexin V Apoptosis Detection Kit II. Cat.no.: 51-6710AK 
(556570). “BD Biosciences”, USA.  
miRNeasy Mini Kit. “QIAGEN GmbH”, Germany. 
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TABLE 2-11. 
PCR Primers 
 
 
 
Oligo name 
 
 
MW 
 
Tm 
 
GC% 
 
Working 
concentration 
 
 
Fas fwd 696 
 
 
6998 
 
63.3 
 
43% 
 
10M 
 
Fas rev 837 
 
 
7053 
 
62.9 
 
39% 
 
10M 
 
HtrA2 fwd 
 
 
6446 
 
62.6 
 
52% 
 
10M 
 
HtrA2 rev 
 
 
6986 
 
63.7 
 
43% 
 
10M 
 
 
P27 fwd 
 
 
6124 
 
66.7 
 
55% 
 
10M 
 
P27 rev 
 
 
7001 
 
66.9 
 
48% 
 
10M 
 
XIAP fwd 
 
 
6399 
 
62.2 
 
48% 
 
10M 
 
XIAP rev 
 
 
6455 
 
66.3 
 
52% 
 
10M 
 
-actin fwd-
2661 
 
6352 
 
74.0 
 
66.7% 
 
10M 
 
-actin rev-
2974 
 
6447.1 
 
69.9 
 
61.9% 
 
10M 
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INTRODUCTION 
Langerhans Cell Histiocytosis (LCH) varies widely in its clinical manifestations, 
however the presence of high numbers of CD1a positive Langerhans cells (LCs) and their 
infiltration into normal tissues is common to all LCH lesions (Amir & Weintraub, 2008). 
Lesions may develop in any tissue, but bone, skin and lymph nodes are the most 
commonly affected, with more than 75% of patients having skeletal lesions (Geissmann et 
al., 2001). Typical LCH lesions are comprised of CD1a+ cells, histiocytes, monocytes, 
neutrophils, eosinophils, giant cells, plasma cells, lymphocytes and mast cells (Figure 1-
7). 
Apoptosis is a fundamental mechanism necessary for healthy tissue homeostasis. 
Healthy cell turnover depends on the balance between cell proliferation and cell death.  
An increase or decrease in apoptosis is observed in a variety of pathological conditions 
and may apply in the pathogenesis of LCH 
One type of LCH, namely – eosinophilic granuloma (EoG) of the bone - is known 
to have a high incidence of spontaneous regression. Hamada and co-authors (Hamada et 
al., 1995) suggested that such regression could be due to increased apoptosis in EoG 
lesions. Molecular mechanisms behind such regression and their relation to the apoptotic 
process have been little investigated. Weintraub and co-authors (Weintraub et al., 1998) 
detected p53 expression in LCH biopsies (n=10) and found that p53 was restricted to LCs, 
absent from adjacent cells and localised to the cell nuclei. No mutations of the p53 gene
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were found, nor was the abnormal expression of the p53 binding protein, mdm2. Another 
publication by Amir and Weintraub (Amir & Weintraub, 2008) examined the expression 
of TGF receptors I and II, p21, p16, Rb, MDM2, p53 and Bcl-2 in LCH and suggested 
that cell proliferation and suppression of apoptosis may be mechanisms of cell survival in 
the more aggressive forms of LCH (multisystem, “risk” bone involvement). Petersen and 
colleagues (Petersen et al., 2003) studied FAS/FAS-L expression in paediatric patients 
with LCH in order to determine whether the level of FAS/FAS-L could predict the 
outcome of the disease. The authors concluded that apoptosis mediated through 
FAS/FAS-L pathway may contribute to the spontaneous regression of lesions in single-
system disease. Petersen also suggested that a balance between autocrine death and 
survival of LCs may have been disturbed in patients with multisystem lesions.  
The aim of the study in this chapter was to analyse and compare levels of 
apoptosis in LCH and non-LCH inflammatory diseases (inflammatory controls): 
inflammatory bowel disease, sarcoidosis, tonsillitis and foreign body granuloma. Better 
understanding of apoptosis in LCH could provide a link between current fragmented 
knowledge of this phenomenon in LCH and point to the future studies necessary for the 
development of new therapeutic strategies. 
The study was conducted on paraffin-embedded tissues and single-cell 
suspensions prepared from fresh biopsies.   
In order to avoid false-positive results (Charriaut-Marlangue & Ben-Ari, 1995; 
Grasl-Kraipp et al., 1995) more than one method of apoptosis detection was used. IHC 
application of an Apostain antibody (anti-DNA antibody, single strand specific) and 
annexin V staining captured by flow cytometry allowed the detection of cells entering 
early apoptosis.  
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The apostain antibody specifically recognises deoxycytidine and requires ssDNA 
of at least 25-30 bases in length for binding. Changes in DNA-histone interactions 
occurring within the cell nucleus soon after the receipt of the apoptotic signal cause such 
ssDNA exposure (Kaufmann, 1989; Kuribayashi et al., 1996). The apostain antibody does 
not recognise necrotic cells, double-stranded DNA conformation or internucleosomal 
DNA fragmentation.  
In healthy cells, the phospholipids of the plasma membrane are distributed 
asymmetrically over the two leaflets of the bi-layer. While phosphatidylcholine and 
sphingomyelin are the predominant species of the outer membrane leaflet, 
phosphatidylserine (PS) is located exclusively in the inner membrane leaflet (Diaz & 
Schroit, 1996; Studzinski, 1999). In addition, the localization of PS to the inner 
membrane leaflet is maintained by association of PS with annexins, polyamines and 
membrane skeletal proteins such as fodrin (Fadok et al., 1992). Early in apoptosis, PS is 
externalised to the outer membrane (Vanags et al., 1996; Verhoven et al., 1995; Zwaal & 
Schroit, 1997). Koopman with colleagues (Koopman et al., 1994) were the first to 
describe detection of apoptotic cells in vitro using FITC-labelled annexin-V.  
Hapten-labelled annexin V can bind to externalised PS in the outer plasma 
membrane leaflet of apoptotic cells. It will not bind to normal cells because the molecule 
cannot trespass the phospholipid layer. In early apoptosis the integrity of the cell 
membrane remains intact in spite of the fact that PS is externalised on the cell surface. 
This allows the distinction of early apoptotic cells from both non-apoptotic cells and cells 
in the later stages of apoptosis (characterised by the breakages in the cell membrane). 
In necrotic cells however, the inner leaflet of the plasma membrane is available 
for binding, since the integrity of the plasma membrane is lost.  
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To discriminate between necrotic and apoptotic cells, propidium iodide (PI) DNA 
dye is routinely used in flow cytometry. Cells which do not bind annexin V and do not 
stain with PI are healthy, viable cells. Cells which bind annexin V, but do not stain with 
PI represent cells in an early apoptosis stage (intact membranes, but exposed PS). Cells 
which bind annexin V and stain with PI are the cells in the late stage of apoptosis or 
necrotic cells (their membrane integrity is lost and PI can bind DNA inside the cell). 
Therefore, on flow cytometry, apoptotic cells occupy PI-negative annexin V/FITC-
positive (PI-FITC+) quadrant as can be seen in Figure 3-2, A.   
Caspase-3 is one of the key executioners of apoptosis as it is either partially or 
totally responsible for the proteolytic cleavage of many key proteins. Upon the receipt of 
an apoptotic signal, inactive caspase-3 zymogen undergoes proteolytic processing into 
activated p17 and p12 fragments. Antibody against cleaved caspase 3 detects endogenous 
levels of the large fragment (17/19kDa) of activated caspase-3. This antibody does not 
recognise full length caspase-3 or other cleaved caspases. IHC using antibody against 
cleaved caspase-3 visualised cells in the active apoptotic stage.  
The late stage of apoptosis is characterised by the fragmentation of DNA. Such 
fragmentation produces single- and double-strand DNA breakages in 3’-OH position. 
Normal or proliferating nuclei have insignificant numbers of DNA 3’-OH ends. Using the 
TUNEL (Gavrieli et al., 1992) assay, the DNA strand breaks are detected by labelling the 
free 3’-OH termini with modified nucleotides. The TUNEL technique was used to detect 
late apoptosis. 
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METHODOLOGY RATIONALE 
Patients and samples 
Formalin-fixed paraffin-embedded (FFPE) tissues from LCH (n=6) and non-LCH 
patients (Inflammatory bowel disease (IBD) (n=10); sarcoidosis (n=6); tonsillitis (n=6) 
and foreign body granuloma (n=6)) were obtained from the Ballarat Cancer Research 
Centre (BCRC) tissue bank and St. John of God Health Care (SJOG HC) histology 
archives. 
Single cell suspensions from LCH (n=4) and tonsil (n=4) were prepared as 
described in Materials and Methods.  
Controls  
IHC controls  
Two slides cut from the same paraffin block and of the similar tissue morphology 
were selected for each tissue (test and control). Slides were treated as described in 
Chapter 2. For slides stained with anti-cleaved caspase-3 antibody (rabbit anti-human 
polyclonal) (Cell signalling, USA) rabbit immunoglobulin fraction (Dako Cytomation, 
Denmark) was used as background staining control, refer Tables 2-3, 2-4. In the 
experiments with apostain antibody (mouse monoclonal IgM) (Millipore, USA) normal 
mouse serum was used as the negative control (Dako Cytomation, Denmark).  
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TUNEL Controls 
Positive controol: search for permeabilisation agent. Heat antigen retrieval was 
combined with enzymatic treatment of the tissues to unmask antigens. Cytonin (Trevigen, 
USA); proteinase K (Trevigen or IHC Select, Millipore, USA) and triton X-100 
(Boehringer Mannheim, Germany) were tested as permeabilization agents. Treatment 
with 0.1% (v/v) of triton X-100 in PBS for 15 min at RT in a humid chamber was selected 
as optimal (Figure 3-1).  
Positive control: DNAse treatment. To fragment DNA in the cells on the slides, 
nuclease (Trevigen, USA) and DNAse1 (Roche, Australia) were tested as DNA 
fragmentation agents for TUNEL positive controls. Incubation of tissues with 5g/ml of  
DNAse 1 in PBS (v/v) for 45 min at 37C in the humid chamber proved to be sufficient 
for most of the DNA of the slide to be fragmented (Figure 3-1).  
Flow cytometry controls  
An analysis template was designed for every sample examined by flow cytometry. 
Cells alone, cells treated with PI only and cells treated with annexin V gates were used to 
set up the template (Figure 3-2, A).  
RESULTS 
Increased numbers of cells in early apoptosis found in LCH (EoG)  
Data presented in this chapter showed that early apoptosis is elevated in LCH 
compared to non-LCH inflammatory controls.  
Flow cytometry study: using flow cytometry software, cells in early apoptosis 
could be clearly distinguished from viable non-apoptotic and dead cells. Using this
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method early apoptosis was detected in all specimens single cell suspensions (LCH (n=4) 
and tonsil (n=4)). While cells in early apoptosis ranged from 8.6% to 37% (from viable 
cells) in inflamed tonsils, the percentage of cells in early apoptosis in LCH lesions ranged 
from 9.8% to 53.9%, as can be seen in Figure 3-2. If these apoptosis rates were averaged, 
32.3% of cells from LCH lesions and 19% of cells from inflamed tonsils were apoptotic. 
Mean of early apoptosis in LCH therefore was consistent with apostain experiments 
(mean of early apoptosis 33%). However it was accepted that low number of cases and 
the variations in the apoptotic rates preclude any statement being made to suggest that the 
percentage of early apoptosis is higher in LCH than in inflamed tonsil.  
Studies on formalin-fixed tissues: IHC application of Apostain antibody showed 
that numbers of apoptotic nuclei in LCH tissues were elevated (33.0+3.8%) compared to 
IBD (18.7% + 2.4%), sarcoidosis (12.2% + 3.3%), tonsillitis (3.6% + 1.4%) and foreign 
body granuloma (3.8% + 1.8%) as can be seen in Figures 3-3, 3-4. The post-hoc 
comparisons using the LSD test indicated that cell death in LCH detected by the Apostain 
antibody mean score was significantly different to the control tissue mean scores (p<10
-5
) 
in all cases.  
Increased numbers of cells in late apoptosis found in LCH (EoG)  
The levels of DNA fragmentation detected by the TUNEL assay were 
significantly higher in LCH (7.5+0.9%) compared to IBD (0.4+0.1%), sarcoidosis 
(0.3+0.1%), tonsillitis (2.5+0.4%) and foreign body granuloma (0.8%+0.3%) as can be 
seen in Figure 3-5).  Post-hoc comparisons using the LSD test indicated that cell death in 
LCH detected by the TUNEL assay mean score was significantly different to the control 
tissues mean scores (p<10
-5
) in all cases. 
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Apoptosis in LCH (EoG) follows caspase-3-independent pathway  
To confirm the TUNEL results IHC staining was performed on the same tissues 
using an antibody against cleaved caspase-3. Cleaved caspase-3 was only present in LCH 
in trace amounts, while there was a close correlation between TUNEL and cleaved 
caspase-3 staining in inflammatory controls as can be seen in Figure 3-5. The number of 
cells that stained with the cleaved caspase-3 antibody in LCH was minimal (0.1+0.1%). It 
was also low in IBD (0.1+0.0%) and sarcoidosis (0.2+0.1%). More caspase-3 –positive 
cells were detected in tonsillitis (2.3+0.5%) and foreign body granuloma (0.9+0.3%) as 
can be seen in Figure 3-5. Post-hoc comparisons using the LSD test indicated that cell 
death in LCH detected by the activated caspase-3 staining mean score was significantly 
different to the control tissue (tonsillitis and granuloma) mean scores (p<10
-5
).  
DISCUSSION  
Data presented in this chapter demonstrated elevated numbers of cells undergoing 
both early and late apoptosis in LCH when compared to inflammatory controls. Absence 
of activated caspase-3 in LCH lesions indicated that apoptosis in LCH (EoG) followed 
caspase-3 independent pathway.  
Of particular value is the use of the late apoptosis-related DNA fragmentation to 
cleaved caspase-3 ratio. It clearly demonstrated that by far the majority of cells in LCH 
undergo apoptosis without an accompanying rise in cleaved caspase-3.  
Published studies of apoptosis in LCH are restricted (Amir & Weintraub, 2008; 
Hamada et al., 1995; Petersen et al., 2003; Weintraub et al., 1998). Hamada and 
colleagues (Hamada et al., 1995) analysed FFPE tissues from LCH EoG patients (n=4). 
They used an enzyme-based single IHC technique to identify Langerhans cells and the 
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proliferative marker Ki-67. The enzyme based singular TUNEL technique was used to 
identify apoptosis-associated DNA fragmentation. “All positive cells of MIB-11 and 
TUNEL staining were considered to be histiocytic cells. The positive cells in each case 
were counted and the ratio of positive cells per 1000 Langerhans histiocytic cells was 
calculated…” In the patient whose tumour clinically showed spontaneous regression, the 
TUNEL staining index gave a higher score than the Ki-67 staining index. The authors 
therefore concluded that the main cause of the spontaneous regression of the lesions was 
apoptosis.  
Amir and Weintraub investigated the expression of apoptosis-related gene 
products (caspase-3, Bcl-2, NF-K(Amir & Weintraub, 2008) in LCH patients with 
localized disease (single system) to patients with multi-system disease and in patients 
with bone risk to patients without bone risk involvement. Enzyme-based single IHC 
technique was used to identify the antigens. The percentage of antigen-positive LCs 
against the total number of LCs was scored. The authors reported low caspase-3 presence 
in all affected tissues. However caspase-3 was found more frequently in LCs from 
patients with single-system disease. Results in this thesis complement and extend these 
findings.  
During PCD, a cell’s proteolytic system engages an array of molecules to 
precisely dismantle the cell. Pathways of this process in CI-PCD are not elucidated as yet. 
There is an accumulating body of data suggesting the role of cysteine proteases (calpains 
(Gao & Dou, 2000) cathepsins (Zuzarte-Luis et al., 2007);  and serine proteases like Omi 
                                                 
1
 MIB-1: antibody recognising Ki-67. 
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(Martins et al., 2004) and AP24 (Wright et al., 1994); or granzymes (Bots & Medema, 
2006; Lieberman & Fan, 2003) in the cascades that lead to the final stages of DNA 
fragmentation.  Torriglia and co-authors (Torriglia et al., 2008) refer to two 
endonucleases that have been related to non-caspase protease activation. These are 
granzyme A-activated DNase (GAAD) (Fan et al., 2003; Fan et al., 2005; Fan et al., 
2003) and L-DNase II (Torriglia et al., 1998). Recent reviews (Broker et al., 2005; 
Constantinou et al., 2009; Kroemer & Jaattela, 2005; Kroemer & Martin, 2005) have 
analysed evidence for the existence of caspase-independent PCD (CI-PCD). The 
mechanisms initiating CI-PCD are still not known. The endoplasmic reticulum acts as an 
important sensor of the cellular state (Travers et al., 2000) and as a carrier and/or storage 
compartment for Ca
2+
 ions (Matson, 2000; Paschen, 2001). Key molecules, such as Bcl-2 
protein family members (Adams & Cory, 1998; Kroemer, 1997; Zamzami et al., 1998) 
mitochondria with the pool of cell-death molecules in their inter-membrane space (Ferri 
& Kroemer, 2001) and lysosomes containing proteolytic enzymes released into the 
cytosol in response to death signals (Li et al., 2000) are all believed to play crucial roles 
in CI-PCD.  
In this study the analysis of apoptosis in LCH EoG was approached from 
adifferent perspective. The study was focused on the identification of the cells in different 
stages of apoptosis in LCH and non-LCH inflammatory diseases using a number of 
techniques.  
Early apoptosis was detected using methods of fluorecense-based IHC and flow 
cytometry. Significant amount of samples (at least five for each disease) from a range of 
inflammatory diseases (inflammatory bowel disease, sarcoidosis, tonsillitis and foreign 
body granuloma as well as LCH) were analysed by IHC. Clear differences were observed 
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in apoptosis rates between LCH and other diseases. The data were robust and statistically 
valid. Apoptosis detected using Apostain antibody was significantly higher in LCH than 
in all inflammatory controls (p<10
-5 
in all cases) suggesting that increased rates of early 
apoptosis in LCH was a reliable finding.  
As an addition, although not central to this research, apoptosis data (detected by 
staining with apostain antibody) for tonsillitis was statistically significant (p<10
-5
) when 
compared to LCH, sarcoidosis and IBD. Data for sarcoidosis were statistically significant 
(p<0.05) when compared to all diseases. Data for foreign body granuloma were 
statistically significant (p<0.05) when compared to LCH, sarcoidosis and IBD.  Data for 
IBD was statistically significant (p<10
-5
 in all cases). 
However it was realised that working with fixed tissues may have limitations, in 
particular, when the destruction of the protein confirmation could occur during the 
specimen preparation. In many cases this could lead to a less sensitive reflection of 
cellular events. Because of this relative insensitivity, examination of the early apoptosis 
using single cell suspensions derived from fresh biopsy material was undertaken. While 
the number of samples was limited, it was very clear that the sensitivity of the flow-
cytometric assay was much greater than that exhibited using fixed tissues. For example, in 
the tonsils SCS examined by flow cytometry the number of early apoptotic cells 
constituted between 8% and 37% of viable cells. The rate of early apoptotic cells in LCH 
SCS was in the range between 9.8% and 53.9%. In contrast, in formalin fixed tissues the 
mean of early apoptosis detected by apostain antibody was 3.6% for tonsillitis and 33% 
for LCH. The limitation on numbers is particularly apparent when carrying out research 
on rare diseases such as LCH. 
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Late apoptosis, detected using the TUNEL assay, was also elevated in LCH 
compared with non-LCH inflammatory controls. This data was supported by statistical 
analysis (p<10
-5
 in all cases).  
As another addition, although not central to this research, apoptosis data (detected 
by TUNEL assay) for tonsillitis were statistically significant (p<10
-5
) when compared to 
all diseases. Data for sarcoidosis were statistically significant (p<10
-5
) when compared to 
LCH and tonsillitis. Data for foreign body granuloma were statistically significant (p<10
-
5
) when compared to LCH and tonsillitis. Data for IBD were statistically significant when 
compared to LCH and tonsillitis.  
Numbers of cells displaying cleaved caspase-3 activity and apoptotic DNA 
fragmentation were similar in non-LCH inflammatory diseases. However, cleaved 
caspase-3 activity was absent in LCH tissues.  This finding indicated to caspase-3-
independent apoptotic pathway in LCH. Statistical analysis showed that the number of 
apoptotic cells in LCH tissues (as detected by staining with the antibodies against cleaved 
caspase 3) was statistically significant (p<10
-5
) in LCH when compared to tonsillitis and 
foreign body granuloma.  
As another addition, although not central to this research, apoptosis data (detected 
by staining with the antibody against cleaved caspase 3) for tonsillitis were statistically 
significant (p<10
-5
) when compared to all diseases. Data for sarcoidosis were statistically 
significant (p<0.05) when compared to tonsillitis and foreign body granuloma. Data for 
foreign body granuloma were statistically significant (p<0.05) when compared to all 
diseases. Data for IBD were statistically significant (p<10
-5
) when compared to tonsillitis 
and foreign body granuloma.  
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Taken together, the results of this chapter lead to the thought that apoptosis was a 
very significant event in the pathogenesis of LCH. The detailed analysis of the cell 
lineages undergoing apoptosis in LCH and inflammatory controls will constitute the aim 
of the study in the next chapter. 
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INTRODUCTION 
Discovery of increased numbers of apoptotic cells in LCH lesions reported in 
Chapter 3 lead to the investigation of cell lineages undergoing apoptosis in LCH and 
inflammatory controls. If specific elimination of certain cell types in LCH is different 
when compared to non-LCH inflammatory controls, different pathologic pathways could 
be activated. Detailed knowledge of such pathways could encourage new therapeutical 
approaches in the treatment of diseases. As a first step in understanding the complex 
mechanisms of biological control of cell death in LCH and non-LCH inflammatory 
diseases, it was important to elucidate and compare which cells were subjected to 
apoptotic death in these diseases. TNF 
IHC methods are routinely applied in LCH research to cell phenotypes (Bechan et 
al., 2006; Egeler et al., 2010; Geissmann et al., 2001; Laman et al., 2003) within the LCH 
lesion. Dual IHC staining is often used when either the proliferative state of particular 
cells is of interest (Senechal et al., 2007) or co-expression of specific receptors is under 
investigation (de Graaf et al., 1995; de Graaf et al., 1995; de Graaf et al., 1996; Egeler et 
al., 2010; Geissmann et al., 2002). In recent years, the role of apoptosis-related proteins in 
LCH lesions (Amir & Weintraub, 2008; Bank et al., 2002; Bank et al., 2003; Bank et al., 
2005; Petersen et al., 2003) was studied using single IHC staining. Petersen and co-
authors (Petersen et al., 2003) used single TUNEL and IHC techniques in an attempt to 
compare the amount of apoptosis-associated proteins (p53, FAS and FASL) and DNA 
fragmentation.  
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In this study, both fixed tissues preserved in paraffin (FFPE tissues) and cells 
purified from biopsies stored in liquid nitrogen were used to study apoptotic cell 
composition in LCH and controls.   
METHODOLOGY RATIONALE  
Sections of similar shape (see also chapter 2) were selected (where possible) for 
dual staining experiments to enable comparison of closely related areas on sequential 
slides. All data reported in this chapter were obtained using the dual staining procedure. 
Selection of reagents suitable for both IHC and TUNEL 
techniques  
To combine IHC and TUNEL techniques on one slide a combination of reagents 
suitable for both methods was devised. Of primary concern was the membrane 
permeabilisation step crucial for the TUNEL assay. This step had to be performed with 
minimal damage to the receptor – antibody targets. Therefore the permeabilisation ability 
of 3 agents was compared. The first was proteinase K  (Chemicon “IHC Select”, 5g/ml, 
15min at RT), the second was cytonin (ready to use, Trevigen, 50l/slide, 30min at RT) 
and the third was Triton X-100 (Boehringer Mannheim, v/v 0.1% in PBS, 15’ at RT) 
[data not shown]. Triton X-100 produced consistent results and was selected for further 
experiments.  
Antibody selection   
The antibodies against human CD1a; CD3; 3 different antibodies against CD4;  
CD8; Fox P3; CD14; 2 different antibodies against CD19; CD68; CD138; CD207 and  
MBP (eosinophils major basic protein) were tested. Only CD1a (Langerhans cell specific 
marker), CD3 (T-lymphocyte specific marker), CD19 (B-lymphocyte specific marker), 
CD68 (activated macrophage specific marker) and CD138 (plasmacyte and endothelial 
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cell specific marker) demonstrated strong selective binding with the target molecules. 
These antibodies were also able to withstand treatment with 0.1% Triton-X 100.   
RESULTS 
Study in FFPE tissues    
Application of the dual staining technique to FFPE tissues visualised 3 major 
categories of cells as well as apoptotic bodies: cells stained with antibodies against 
specific receptors only (IHC staining only); cells containing apoptotic nuclei only 
(TUNEL staining only) and cells stained by the antibodies against the specific receptor 
and containing apoptotic nuclei (or TUNEL-stained non-nucleic organelles) (combination 
of IHC and TUNEL staining).  
Single IHC staining 
Antibodies against CD1a, CD3, CD19, CD68 and CD138 demonstrated strong 
selective binding with the target molecules. These antibodies were also able to withstand 
the treatment with 0.1% Triton-X 100 as can be seen in Figures 4-1 and 4-2.  
Cell lineages: distribution in lesions 
Results summarised in Figure 4-3 and Appendix 8 show the distribution of cells 
within LCH and control lesions as detected by IHC staining only.  
LCH: for LCH, the majority of cells belonged to CD1a- and CD3-positive 
lineages (respectively, 10.2+2.3% and 12.3+2.3% from total cells). CD19- and CD68-
positive cells were present (5.5+1.9% and 6.1+1.2% respectively) and CD138-positive 
cells accounted for 2+0.4% of total cells. In descending order, T lymphocytes were the 
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most common, followed by Langerhans cells, activated macrophages, B lymphocytes and 
plasma cells.  
IBD: for IBD there were 2.4+1.8% of CD1a-positive cells; 18.2+10.3% of CD3-
positive cells; 10.9+1.7% of CD19-positive, 8.2+1.4% of CD138-positive and 12.2+5.3% 
of CD68-positive cells. In descending order, T lymphocytes were the most common, 
followed by activated macrophages, B lymphocytes, plasmacytes and Langerhans cells.  
Sarcoidosis: for sarcoidosis CD1a-positive cells were in low numbers: 3.8+0.9%. 
The majority of cells were CD3-positive: 23.4+3.1%. CD19-positive cells accounted for 
7.7+1.9% of total cells; CD138-positive cells – for 2.5+0.6%; and CD68-positive cells 
constituted 8.9+1.4% of total lesion cell population.  In descending order, T lymphocytes 
were the most common, followed by activated macrophages, B lymphocytes, Langerhans 
cells and plasmacytes.  
Tonsillitis: for tonsillitis 4+1.1% of total cells were CD1a-positive. CD3- and 
CD19-positive cells were present in higher numbers: 14.9+2.2% and 19.6+3.3% 
respectively.  CD138-positive cells were detected in lower quantities: 3.3+0.8%. CD68-
positive cells constituted 11.5+2.3% of total cells. In descending order, B lymphocytes 
were the most common, followed by T lymphocytes, activated macrophages, Langerhans 
cells and plasmacytes.  
Foreign Body Granuloma: for foreign body granuloma 7.5+1.7% of CD1a-
positive cells were detected; CD3-positive cells constituted 11.7+2% from total cells; 
CD19-positive cells accounted for 2+1.2% of cells; CD138- and CD68-positive cells were 
found in similar quantities: 6.9+2.3% and 9.2+1.8% respectively. In descending order, T 
lymphocytes were the most common, followed by activated macrophages, Langerhans 
cells, plasmacytes and B lymphocytes.  
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Cell lineages: comparison in diseases 
Results summarised in Figure 4-4 and Appendix 8 show the distribution of 
different cell lineages in LCH and control lesions as detected by IHC staining only. The 
results presented as a percentage of stained cells compared to the total number of the cells 
in the microscopic field + standard error (see Materials and Methods).  
CD1a-positive (Langerhans cells): CD1a-positive cells were present in higher 
numbers in LCH (10.2+2.3%) and foreign body granuloma (7.5+1.7%) compared to IBD 
(2.4+1.8%), sarcoidosis (3.8+0.9%) and tonsillitis (4+1.1%). In descending order, CD1a-
positive cells were the most common in LCH, followed by foreign body granuloma 
(FBG), tonsillitis, sarcoidosis and inflammatory bowel disease (IBD).  
CD3-positive (T lymphocytes): CD3-positive cells accounted for 12.0+2.3% in 
LCH; 18.2+10.3% in IBD; 23.4+3.1% in sarcoidosis; 14.9+2.2% in tonsillitis and 
11.7+2% in foreign body granuloma. In descending order, CD3-positive cells were the 
most common in sarcoidosis, followed by IBD, tonsillitis, LCH and FBG.  
CD19-positive (B lymphocytes): CD19-positive cells constituted 5.5+1.9% from 
total cells in LCH. In IBD, sarcoidosis, tonsillitis and foreign body granuloma CD19-
positive cells accounted for 10.87+1.7%; 7.7+1.9%, 19.6+3.3% and 2+1.2% from total 
cells respectively. In descending order, CD19-positive cells were the most common in 
tonsillitis, followed by IBD, sarcoidosis, LCH and FBG.  
CD68-positive (Activated macrophages): CD68-positive cells were found in 
similar numbers in LCH, sarcoidosis and foreign body granuloma (6.1+1.2%; 8.9+1.4% 
and 9.2+1.8% respectively); the numbers were slightly higher in IBD and tonsillitis 
(12.2+5.3% and 11.5+2.3% respectively). In descending order, CD68-positive cells were 
the most common in IBD, followed by tonsillitis, FBG, sarcoidosis and LCH.
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CD138-positive (Plasmacytes): CD138-positive cells were detected in LCH, 
sarcoidosis and tonsillitis in low quantities (2.01+0.4%; 2.5+0.6% and 3.3+0.8% 
respectively). They were found in slightly higher numbers in IBD and foreign body 
granuloma (8.2+1.4% and 6.9+2.3% respectively). In descending order, CD138-positive 
cells were the most common in IBD, followed by FBG, tonsillitis, sarcoidosis and LCH.  
Single TUNEL staining 
Results summarised in Figure 4-5 and Appendix 9 show apoptotic events in LCH 
were higher than in control tissues.  
Percentage of cells dying by apoptosis in LCH (3.1+0.4%) were about 3 times 
higher than in IBD (0.72+0.2%); sarcoidosis (1.28+0.1%); tonsillitis (1.2+0.1%); and 
foreign body granuloma (0.8+0.1%).  
Dual IHC and TUNEL staining 
Apoptotic cells: distribution in lesions 
Results summarised in Figure 4-6 and Appendix 10 show the distribution of 
apoptotic cells in LCH and control lesions as detected by the combination of IHC and 
TUNEL staining.   
For LCH the majority of cells undergoing apoptosis belonged to CD68-positive 
lineage (0.6% of total cells). Trace numbers of CD1a-, CD3-, and CD138-positive cells 
were undergoing apoptosis (0.07%; 0.01% and 0.01% respectively). Apoptosis was not 
detected among CD19-positive cells in LCH.   
For IBD apoptosis was not observed in CD1a- and CD19-positive cells. CD3- and 
CD68-positive cells were the dominant lineages undergoing apoptosis (0.09% and 0.21% 
respectively). A low number (0.04%) of CD138-positive cells also contained fragmented 
DNA.  
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Similar distribution of dual-stained cells was observed in sarcoidosis: CD68-
positive cells constituted 0.5% from total cells while CD1a-, CD3- and CD19-positive 
cells were not found to dye by apoptosis. CD138-positive cells were undergoing apoptosis 
in low numbers (0.04% from total cells).  
In tonsillitis, the majority of apoptotic cells belonged to CD68-positive lineage 
(0.5%). It is important to note that in tonsillar tissue, TUNEL-positive staining was 
located in cells’ cytoplasm compartments, leaving the nucleus intact as can be seen in 
Figure 4-8. This suggested that CD68-positive cells were actively phagocytising apoptotic 
bodies from their surroundings. CD3-, CD19- and CD138-positive cells were dying by 
apoptosis in minimal quantities (0.02%; 0.03% and 0.04% respectively). CD1a-positive 
cells in tonsillitis were not associated with fragmented DNA.   
For foreign body granulomas no apoptosis was detected among CD1a-, CD19- 
and CD138-positive cells. CD3-positive cells were dying by apoptosis in low numbers 
(0.02%). The majority of TUNEL-positive cells were CD68-positive (0.15%). 
Apoptotic cells: comparison in diseases 
Results summarised in Figure 4-7, A and Appendix 10 show the distribution of 
apoptotic cells of the same lineage in LCH and control lesions as detected by the 
combination of IHC and TUNEL staining.   
Apoptotic CD1a-positive cells were detected in LCH in trace amounts (0.07% 
from total cells). There were no apoptotic CD1a-positive cells in IBD, sarcoidosis, 
tonsillitis and foreign body granuloma lesions.  
Apoptotic CD3-positive cells were found in minimal numbers in LCH, tonsillitis 
and foreign body granuloma (0.01%, 0.02% and 0.02% respectively). They were not 
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TABLE 4-1. 
Fragmented DNA Distribution in Dually Stained Cells 
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detected in sarcoidosis. IBD had the highest number of apoptotic CD3-positive cells 
(0.09% from total cells).  
Apoptotic CD19-positive cells were not detected in LCH, IBD, sarcoidosis and 
foreign body granuloma. These were found in tonsillitis in very low numbers (0.03% 
from total cells).  
Apoptotic CD68-positive cells were found in higher numbers in all diseases. In 
LCH CD68-positive cells constituted 0.6% from total cells. In IBD, CD68-positive cells 
accounted for 0.21% from total cells. In sarcoidosis, tonsillitis and foreign body 
granuloma C68-positive cells accounted for 0.52%, 0.52% and 0.15% from total cells 
respectively. The amount of apoptotic CD68-positive cells among total CD68-positive 
cells is shown in Figure 4-7, B.  
Apoptotic CD138-positive cells were found in LCH (0.01%); IBD (0.04%); 
sarcoidosis (0.04%) and in tonsillitis (0.04%). Cells from this lineage were not dying by 
apoptosis in foreign body granuloma.  
Results summarised in Figure 4-9 and Table 4-1 show the localisation of 
fragmented DNA in LCH and control lesions as detected by the combination of IHC and 
TUNEL staining. 
LCH was the only disease where CD1a-positive cells were found to undergo 
apoptosis. Fragmented DNA in CD1a-positive cells in LCH was associated with both the 
nucleus (57% from dually-stained cells) and cytoplasm (43%). In LCH tissues stained 
with the antibody
1
 against CD3- and CD138-receptors fragmented DNA was found only 
in apoptotic bodies (100% in both cases).  In the tissues treated with the antibody against 
                                                 
1
 Throughout in this section: cells were dually stained with antibody (IHC) and TUNEL techniques.   
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CD68-receptor TUNEL staining was localised in nuclei of CD68-positive cells (50%) and 
in apoptotic bodies (50%). CD19-positive cells were not found among apoptotic cells in 
LCH.  
In IBD tissues stained with antibody against CD3-receptor most of fragmented 
DNA was found in CD3-positive cells’ nuclei (78%) and in apoptotic bodies (22%). In 
the tissues treated with the antibody against CD68-receptor TUNEL staining was 
associated with nuclei (59%) and apoptotic bodies (41%). In CD138-positive cells 
fragmented DNA was localised in nuclei (81%) and in lesser amounts in apoptotic bodies 
(19%). CD1a- and CD19-positive cells were not dying by apoptosis in IBD.  
In sarcoidosis fragmented DNA was found in association with the specific cell 
marker only in tissues treated with the antibodies against CD68- and CD138-receptors 
(respectively 40% and 100% of nuclei were apoptotic). The rest of the TUNEL staining in 
CD68-treated tissues was localised in apoptotic bodies (60%). CD1a-, CD3- and CD19-
positive cells did not contain fragmented DNA.  
There were no apoptotic cells among CD1a-positive cells in tonsillar tissues. 
Slides stained with the antibodies against CD3- and CD19-receptors showed DNA 
fragmentation association with CD3- and CD19-positive cells’ nuclei (100% in both 
cases). The majority of apoptotic CD68-positive cells contained fragmented DNA in 
cells’ cytoplasm organelles (78%). DNA fragmentation in the nuclei of CD68-positive 
cells accounted for 20% of dually-stained cells. The rest of TUNEL staining in CD68-
stained tissues was associated with apoptotic bodies (2%). In the tissues treated with the 
antibody against CD138-antigen fragmented DNA was found only in apoptotic bodies 
(100%). 
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Foreign body granuloma tissues stained with the antibody against CD3-receptor 
showed only apoptotic bodies-associated TUNEL staining (100%). In the tissues treated 
with the antibody against CD68 fragmented DNA was found in apoptotic bodies (54%), 
cell nuclei (33%) and in cytoplasm (13%). There were no CD/TUNEL-positive cells in 
the foreign body granuloma tissues treated with the antibodies against CD1a-, CD19- or 
CD138-receptors.  
Study in living cells   
Apoptotic cells distribution in LCH and tonsillar SCSs was examined using flow 
cytometry. LCH patient biopsies (n=3) and tonsillar tissues (n=4) were used to prepare 
SCSs. Two panels of antibodies (each antibody was conjugated with different fluorescent 
dye) were designed to detect CD1a-, CD3-, CD4-, CD8-, CD14-, CD19- and CD138-
positive cells, refer Tables 2-8, 2-9, 2-10. Annexin V kit (BD, Australia) was used to 
detect early apoptosis. PI dye was added to stain dead cells.  
In tonsillar tissue only trace numbers of CD1a-positive cells were apoptotic 
(0.1+0.0% here and further: from viable (PI-) cells) as can be seen in Figure 4-10, A. 
CD3-positive cells (4.5+1.2%) and CD19-positive cells (17+5.1%) accounted for the 
majority of cells in early apoptosis stage as can be seen in Figure 4-11 and Table 4-2. 
Small quantities of CD4-positive (0.1+0%); CD8-positive (0.1+0.1%); CD14-positive 
(0.2+0.1%) and CD138-positive (2.2+1.8%) cells were in early apoptosis stage.   
In LCH CD1a-positive cells (27.9+3.9%), CD4-positive cells (27.8+15.6%) and 
CD14-positive cells (17.9+10.9%) were dominating apoptotic cell population as can be 
seen in Figure 4-10,B and 4-11. Other cell types were undergoing apoptosis at lower 
rates: 4.8+0.8% in CD3-positive population; 0.6+0.4% in CD8-positive population and 
Chapter 4: Apoptotic Cell Composition in LCH 137 
 
 
2.2+0.5% in CD19-positive cells. CD138-positive cells were not dying by apoptosis in 
LCH.  
CD14 is the marker for monocyte/macrophages cell lineage; it could also be 
expressed in immature Langerhans cells and dendritic cells. To determine the phenotype 
of the apoptotic CD14-positive cells further analysis was performed. At the end of this 
analysis cell numbers of apoptotic CD1a-/CD14-; CD1a+/CD14-; CD1a+/CD14+ and 
CD1a-/CD14+ cells were determined.  
In tonsillitis CD1a-/CD14- accounted for the majority of apoptotic cells (99%) as 
can be seen in Figure 4-12. CD1a-/CD14+ cells were found among apoptotic cells at low 
concentration of 1%. Cells of CD1a+/CD14+ and CD1a+/CD14- phenotypes were not 
found among apoptotic cells.  
In LCH, however, CD1a-/CD14- cells accounted for only 19% of apoptotic cells. 
The majority of cells expressing PS on their membrane belonged to CD1a+/CD14- (12%) 
and CD1a+/CD14+ (60%) cell populations. Interestingly, 9% of CD1a-/CD14+ cells were 
found among early apoptotic cell population.  
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DISCUSSION 
To elucidate cell populations undergoing apoptosis in LCH and non-LCH 
inflammatory controls, dual staining with fluorescent IHC and TUNEL techniques was 
applied to slides prepared from FFPE tissues. To date, this approach has not been used in 
LCH-related research.  
Langerhans cells (CD1a-positive); T lymphocytes (CD3-positive); B lymphocytes 
(CD19-positive); activated macrophages (CD68-positive) and plasmacytes (CD138-
positive) were detected in the lesions. Localisation of fragmented DNA - a feature of late 
apoptosis – was determined using the TUNEL assay. Association of fragmented DNA 
with cell nuclei, cytoplasm or apoptotic bodies allowed numerical estimation of 
programmed cell death among cell lineages.   
While standard descriptions of specific inflammatory diseases can be found in 
texts (Kasper et al., 2008) and pathology atlases (Bloom & Fawcett, 1968; Di Fiore, 1967; 
Di Fiore, 1981; Leeson & Leeson, 1970), precise numerical assessment of cells and/or 
cell composition in many diseases is fragmented and sometimes published as indirect data 
(Rosok et al., 1997).  
The majority of publications on LCH follow this trend and provide descriptive 
rather than quantitative data (de Graaf et al., 1995; Egeler et al., 2010; Geissmann et al., 
2001; Laman et al., 2003; Schmitz & Favara, 1998).  
Favara and co-authors (Favara & members of the WHO committee on 
histiocytic/reticulum cell proliferations, 1997) reported that lymphocytes account for 
approximately 20% of the cells in LCH tissues. Geissmann and co-workers (Geissmann et 
al., 2001) reported that more than 75% of Langerhans cells (CD1a-positive cells) in LCH 
sections stained for Langerin. In the same publication the authors reported that up to 70% 
Chapter 4: Apoptotic Cell Composition in LCH 143 
 
 
Chapter 4. Apoptotic Cell Composition in LCH 144 
 
of cells had a CD1a/CD14 co-expression. This data was consistent with the results of the 
flow cytometry experiments described in this chapter where 60% of CD1a+/CD14+ cells 
were found in LCH cell suspensions.  
IHC work presented in this chapter refined the classical descriptions of LCH and 
non-LCH inflammatory diseases histopathology. 
Single IHC staining experiments showed that the number of CD1a-positive cells 
(Langerhans cells) was the highest in LCH. CD3-positive cells (T lymphocytes) were 
found in the highest numbers in inflammatory bowel disease and sarcoidosis. CD19-
positive cells (B lymphocytes) were found in the highest concentrations in tonsillitis. 
CD68-positive cells were present at similar numbers in all diseases. CD138-positive cells 
(plasmacytes) were found in higher numbers in IBD and foreign body granuloma.  
TUNEL assay application confirmed the findings from the previous chapter and 
demonstrated that apoptosis was higher in LCH compared to non-LCH inflammatory 
diseases.  
The attempts to identify the cell type undergoing apoptosis resulted in data that 
was only robust when related to cells staining with antibody against CD68. Very few cells 
stained with four other antibodies (anti-CD1a, -CD3, -CD19 and –CD138) were 
apoptotic. Among the examined diseases (LCH, inflammatory bowel disease, sarcoidosis, 
tonsillitis and foreign body granuloma) the apoptotic CD68-positive cells were found in 
the largest numbers in LCH and sarcoidosis. Often positive TUNEL staining was not 
associated with CD staining at all, indicating that CD receptors could not be identified by 
the antibodies used in the study on the surface or in the cytoplasm of apoptotic cell or that 
fragmented DNA was located in apoptotic bodies.  
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The highest numbers of cells undergoing apoptosis in all diseases were found to 
be CD68-positive (activated macrophages). In LCH apoptotic CD68-positive cells 
accounted for 0.6% of cells (from total cells); in IBD – for 0.2%; in sarcoidosis – for 
0.5% and in IBD – for 0.15%. In these diseases fragmented DNA was associated with cell 
nucleus. In tonsillitis 0.5% of total cells were CD68-positive cells undergoing apoptosis. 
Interestingly, in tonsillitis fragmented DNA in CD68-positive apoptotic cells was found 
in both nucleus (approximately 40% from apoptotic cells) and cytoplasmic organelles 
(approximately 59% from apoptotic cells), as can be seen in Figure 4-7, A and B.  
Flow cytometry in living cells again demonstrated high sensitivity of this method 
over the methods applicable to fixed tissues. For example, flow cytometric single CD1a-
positive staining of LCH (EoG) SCS accounted for at least 50% of cells in LCH (data not 
shown). IHC application to fixed LCH (EoG) tissues showed that on average 10.2% of 
cells in the lesion belonged to CD1a-positive lineage (Appendix 8).  
Flow cytometry allowed comparison of how cells in the early stage of apoptosis 
were distributed in LCH and tonsillar single cell suspensions. The highest number of 
apoptotic cells in LCH was associated with CD1a-positive lineage (Langerhans cells), 
followed by CD4-positive cells (T lymphocytes) and CD14-positive cells (macrophages). 
In tonsillar tissue apoptotic cells were predominantly of CD19-positive lineage (B 
lymphocyte) with some CD3-positive (T lymphocyte) and CD138-positive (plasmacyte) 
cells undergoing apoptosis as well.  
Further analysis of flow cytometry data showed that 60% of apoptotic cells in 
LCH co-expressed CD1a and CD14 receptors as can be seen in Figure 4-12. However, 
9% of CD14-positive cells were CD1a-negative/CD14-positive. In control tonsillar single 
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cell suspensions there were no CD1a-positive/CD14-positive cells discovered and CD1a-
negative/CD14-positive cells constituted only 1% of viable cells.  
Taken together, the results of this chapter demonstrated that in LCH early 
apoptotic morphology was shown by Langerhans cells, macrophages and T lymphocytes. 
The late apoptosis in LCH was higher when compared to non-LCH inflammatory 
diseases. Apoptotic DNA fragmentation in five major cell types characteristically present 
in LCH and non-LCH inflammatory lesions were tested and CD68-positive cells were 
found to be the most noticeably subjected to the late apoptosis in all diseases under 
investigation. Clearly these cells came in contact with the apoptotic stimuli. However, the 
origin of such apoptotic stimuli in LCH is currently unknown. The next chapter will 
investigate if the apoptosis could be induced by the factors present/secreted into the extra-
cellular environment by the cells from LCH (EoG) lesion. 
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Chapter 5. Detection of Apoptotic Proteins in LCH 
Using a Human Apoptosis Antibody Array 
INTRODUCTION 
The molecular pathways leading to cell death by apoptosis have been the subject 
of extensive research in last decade (Aggarwal, 2003; Aguda & Algar, 2003; Daniel, 
2000; Rossi & Gaidano, 2003; Tabas & Ron, 2011). Death receptors, mitochondria and 
caspases are considered major participants in the apoptotic signal transduction within the 
cell.  
Increased levels of apoptosis in LCH demonstrated in previous chapters of this 
thesis instigated further research into the apoptotic protein profile of LCH.  
During PCD, a cell’s proteolytic system engages an array of molecules to 
precisely dismantle the cell. Pathways of this process in LCH are not elucidated as yet. 
Some apoptosis-related proteins have been shown to be present in LCH in the past (Amir 
& Weintraub, 2008; Bank et al., 2002; Bank et al., 2003; Petersen et al., 2003; Weintraub 
et al., 1998). Apoptotic regulation in LCH could be similar to that seen in non-LCH 
inflammatory, neurological and autoimmune diseases as well as cancer and a better 
understanding of apoptotic mechanisms in LCH could provide additional clues in the 
therapeutic strategies targeting these diseases. In recent years the role of apoptosis-related 
molecules such as TRAIL; TNF; (Wajant et al., 2005); Omi/Htr2 (Verhagen et al., 2002); 
caspase-8 (Teitz et al., 2000); Bax, Bak and Bid (Walensky et al., 2004) and many others 
(Debatin & Fulda, 2006) in oncogenesis and chemotherapy have been studied extensively. 
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“Anticancer drugs are increasingly being designed to target specific molecules, many of 
which are involved in apoptosis”. (Debatin & Fulda, 2006). 
In this chapter, cell lysates obtained from LCH and non-LCH biopsies were tested 
for the presence of 35 apoptosis-related proteins - components in standard apoptotic 
pathways. This study should broaden the existing knowledge about the apoptosis process 
in LCH and help to better understand apoptotic pathways activated in LCH.   
The study was based on the use of a human apoptosis antibody array involving the 
specific recognition by antibodies linked to the membrane (provided in the kit) of the 
apoptotic proteins in the solution obtained during cell lysate preparation.  
METHODOLOGY RATIONALE 
Human apoptosis arrays (supplied as a kit) were used to capture and estimate the 
concentration of 35 apoptosis-related proteins in lysates prepared from LCH (n=4) and 
tonsil (n=4) tissue biopsies. The known role of each of these proteins in apoptosis is 
summarised in Appendix 6.  
Captured and control antibodies against 35 apoptotic proteins are commercially 
spotted in duplicate on nitrocellulose membranes which were supplied in the “Human 
Apoptosis Antibody Array Kit” (R&D Systems, USA). Cellular extracts from the tissues 
under investigation were diluted and incubated with the membranes. The membranes 
were washed to remove unbound proteins and were incubated with a cocktail of 
commercial biotinylated detection antibodies (supplied in the kit). Streptavidin-HRP and 
chemiluminescent detection agents were than applied to the membranes and a signal was 
produced at each capture spot corresponding to the amount of bound protein. Membranes 
were exposed to chemiluminescent agent for 10 minutes and the images acquired using 
Chapter 5. Human Apoptosis Antibody Array in LCH 149 
BioRad Universal Hood II and Quantity One 1D software as can be seen in Figures 5-1, 
5-2 and 5-3. The density of the chemiluescent signal (seen as a black spot in the white 
membrane background) was proportional to the amount of the protein bound by the 
antibodies linked to the membrane (the bigger and darker the spot, the more protein was 
captured by the antibody).  
The density at cursor displayed the signal intensity of the pixel on the image. It 
also showed the average intensity for a 3 x 3 pixel box
1
.   
RESULTS 
Positive controls were 3 duplicates of captured antibody against an unspecified 
protein
2
 commercially designed for the internal confirmation of the method. The data 
obtained for specified proteins from LCH and tonsil cell lysates was averaged and means 
for LCH and tonsillar cell lysates were compared to each other or to the baseline (0 
density reading). 
Apoptotic proteins elevated in LCH: signposts of a pathway  
The profile of apoptosis-related proteins detected in LCH cell lysates can be seen 
in Figure 5-4. Protein concentrations elevated over the baseline were Bax (939.6+277.5), 
pro-caspase-3 (6760.8+473.7); catalase (1942.3+109.3); cytochrome c (1487.7+516.9), 
Fas/TNFRSF6 (1390.1+322.9), SMAC/DIABLO (2077+500.6). 
                                                 
1
 Box was the area around the tip of the cursor. 
2 The details of the control spots in the kit are proprietary information. The positive controls are 
spotted with “biotinylated irrelevant proteins” that are expected to show strong positive signal if the detection 
system (including SA-HRP and chemiluminescent reagent) works correctly and if the assay is performed at 
optimum condition. The negative control are precise “spotted buffers”, that are not expected to light up but 
close to the background of the array. 
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Apoptotic proteins down-regulated or absent in LCH compared to 
tonsil tissue  
Relative concentrations of apoptosis-related proteins were compared in LCH and 
tonsil cell lysates and can be seen in Figure 5-5 and Table 5-1. The most noticeable 
difference in protein expression in LCH and tonsil tissues was observed for Bax 
(939.6+277.5 compared to 6036+1482.3 in tonsil); Bcl-2 (400.5+59.4 compared to 
5450.1+1977.6); pro-caspase 3 (6760.8+473.7 compared to 20308.3+3016); catalase 
(1942.3+109.3 compared to 9659.1+1445); clusterin (427.2+139.2 compared to 
6103.7+1284.1); cytochrome c (1487.7+516.9 compared to 11343.1+3465.7); 
Fas/TNFRSF6 (1390.1+322.9 compared to 11741.8+1912.7); HSP60 (677.1+148 
compared to 6671.8+2707.6); HTRA/Omi (517.9+122.7 compared to 8476.7+2892.3); 
p27/Kip1 (318.2+61.3 compared to 7545.6+1688.8); SMAC/DIABLO (2077+500.6 
compared to 12088+2913.7); and XIAP (345.5+87 compared to 7171.4+3056.7).   
DISCUSSION 
Following the discovery of elevated numbers of apoptotic cells in LCH compared 
to non-LCH inflammatory controls described in Chapters 3 and 4 of this thesis, it was of 
particular interest to investigate which apoptosis-related molecules were up- or down-
regulated in LCH and in control tissues.  
Results described in this chapter complement existing knowledge about the range 
of apoptosis-related proteins in LCH lesions. The data were obtained using a different 
method from the more usual IHC method. The human apoptosis antibody array was used 
for the simultaneous detection of 35 apoptosis-related proteins in cell lysates from biopsy 
tissues.
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Data presented in this chapter shows an activation of some, but certainly 
not all components of classical extrinsic apoptotic pathway. Some evidence presented in 
Figure 5-4 supported the extrinsic nature of apoptotic signal in LCH (increased 
concentration of Fas/TNFRSF6). Other evidence in Figure 5-4 indicated that the signal 
could initiate intrinsic pathway (elevated concentration of BAX protein). There is some 
evidence of the activation of cytochrome C, HSP60, HSP70, SMAC/DIABLO. All these 
proteins are the members of the network commonly activated in both extrinsic and 
intrinsic pathways (Beere, 2004).  
Fas/TNFRSF6 is an early component in the classical extrinsic apoptotic cascade. 
The activation of the Fas/TNFRSF6 receptor is followed by the engagement of death-
inducing signalling complex containing Fas-associated death domain (FADD), caspase-8 
and caspase-10. This complex assists proteolytic auto-processing of caspases. Processed 
caspases trigger downstream caspase cascade leading to apoptosis.  In this study the 
amount of Fas/TNFRSF6 protein was found to be elevated in both LCH and tonsil lysates 
but increase of FADD was not observed in either disease. This might need further 
investigation in the separate study.  
Pro-apoptotic Bax-protein participates in MMP which is followed by the release 
of the proteins like cytochrome c and SMAC/DIABLO from the mitochondria IMS into 
the cytosol where they engage in subsequent apoptotic cascades. Bcl-2 and Bcl-X on the 
contrary, prevent MMP permeabilisation. Concentration of Bax, Bcl-2 and Bcl-X in LCH 
were lower compared to tonsillar tissues, but in this group of three proteins, the 
concentration of Bax was the highest. This could explain the increased amount of 
cytochrome c and SMAC/DIABLO detected in LCH. 
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Data presented in Figure 5-5 shows that HtrA2/Omi, p27/Kip1 and XIAP 
proteins were detected in LCH cell lysates in trace quantities which was noticeably 
different from the concentrations of these proteins detected in tonsil cell lysates. In 
healthy circumstances HtrA2/Omi serine protease resides in mitochondria IMS where it 
binds inhibitors of caspases XIAP and SMAC/DIABLO (Hegde et al., 2002; Martins et 
al., 2002). Upon receipt of the apoptotic signal, HtrA2/Omi unleashes caspase activity by 
proteolytically removing their natural inhibitors (Srinivasula et al., 2003; Vande Walle et 
al., 2008; Yang et al., 2003). The model proposed by Vance Walle and co-authors (Vande 
Walle et al., 2008) suggests biphasic process where IAP proteins are sequestered at the 
first step (Martins et al., 2002; Suzuki et al., 2001; van Loo et al., 2002; Verhagen et al., 
2002) and degraded at the second (Srinivasula et al., 2003; Yang et al., 2003). In LCH, 
however, HtrA2/Omi was not detected and theoretically the concentration of IAP proteins 
should be elevated (they should be locked in complexes with SMAC/DIABLO). However 
this was not observed. The noticeable difference in protein concentration between LCH 
and tonsil cell lysates was seen for XIAP protein (up-regulated in tonsil tissue, absent in 
LCH). Some models (Martins et al., 2002) described that experimental addition of 
HtrA2/Omi siRNA in vitro (Martins et al., 2002) eliminated the expression of HtrA2/Omi 
and rendered cells significantly more resistant to the induction of apoptosis. 
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The role of SMAC/DIABLO is to eliminate the inhibition of caspases by cIAP 
proteins and to promote proteolytic activation of pro-caspase-3 and enzymatic activity of 
caspase-3. Data from Chapter 3 (and from previous reports (Amir & Weintraub, 2008) 
proves that cleaved caspase-3 is very rarely detected in LCH cells. This raises the 
question about the quality of the SMAC/DIABLO substrate - pro-caspase-3 - and its 
proteolytic processing mechanisms in LCH.  
Data presented in Figure 5-5 shows that HtrA2/Omi, p27/Kip1 and XIAP proteins 
were detected in LCH cell lysates in trace quantities which was noticeably different from 
the concentrations of these proteins detected in tonsil cell lysates. In healthy 
circumstances HtrA2/Omi serine protease resides in mitochondria IMS where it binds 
inhibitors of caspases XIAP and SMAC/DIABLO (Hegde et al., 2002; Martins et al., 
2002). Upon receipt of the apoptotic signal, HtrA2/Omi unleashes caspase activity by 
proteolytically removing their natural inhibitors (Srinivasula et al., 2003; Vande Walle et 
al., 2008; Yang et al., 2003).  The model proposed by Vance Walle and co-authors 
(Vande Walle et al., 2008) suggests biphasic process where IAP proteins are sequestered 
at the first step (Martins et al., 2002; Suzuki et al., 2001; van Loo et al., 2002; Verhagen 
et al., 2002) and degraded at the second (Srinivasula et al., 2003; Yang et al., 2003). In 
LCH, however, HtrA2/Omi was not detected and theoretically the concentration of IAP 
proteins should be elevated (they should be locked in complexes with SMAC/DIABLO). 
However this was not observed. The noticeable difference in protein concentration 
between LCH and tonsil cell lysates was seen for XIAP protein (up-regulated in tonsil 
tissue, absent in LCH). Some models (Martins et al., 2002) described that experimental 
addition of HtrA2/Omi siRNA in vitro (Martins et al., 2002) eliminated the expression of 
HtrA2/Omi and rendered cells significantly more resistant to the induction of apoptosis. 
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This model however did not coincide with the findings in this thesis (Chapters 3 and 4) as 
increased levels of apoptosis were observed in LCH in the absence of HtrA2/Omi. The 
elimination of cleaved caspase-3 activity, even in the absence of IAP proteins, - in 
particular XIAP - was also observed. HtrA2/Omi and XIAP gene expression analysis 
could assist in better understanding of apoptotic mechanism(s) in LCH.  
Another molecule whose concentration was strikingly lower in LCH compared to 
tonsil cell lysates was cyclin-dependent kinase (CDK) inhibitor p27/Kip1. This protein 
prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes thus causing cell 
cycle arrest at G1 phase. It is often referred to as “cell cycle inhibitor” because its major 
function is to stop or slow down the cell division. In general, extracellular growth factors 
which prevent cell growth cause an increase in p27/Kip1 levels inside a cell (Toyoshima 
& Hunter, 1994). The mutation of the p27Kip1 gene may lead to uncontrolled cellular 
proliferation (Fero et al., 1996; Kiyokawa et al., 1996; Nakayama et al., Cell). Loss of 
p27/Kip1 expression has been observed in metastatic canine mammary carcinomas 
(Klopfleisch et al., 2009; Klopfleisch et al., 2010; Klopfleisch et al., 2010). Decreased 
TGF-beta signalling has been suggested to cause loss of p27 expression in this tumour 
type (Klopfleisch et al., 2009). Expression levels of p27/Kip1 gene, as well as the factors 
regulating this expression, are yet to be investigated in LCH.   
Taken together, the results presented in this chapter complemented existing 
knowledge and described human apoptosis proteins in cell lysates from LCH. It was 
demonstrated that concentrations of apoptosis proteins in LCH were lower compared to 
tonsil tissue and particularly that HtrA2/Omi, XIAP and p27/Kip1 molecules were absent 
in LCH samples. Based on these results it is tempting to speculate that the apoptotic 
pathway/s in LCH is/are of extrinsic origin and that apoptosis in LCH follows a caspase-
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independent route, possibly incorporating mitochondrial membrane permeabilisation. 
However, the cross-talk between extrinsic and intrinsic pathways in LCH cannot be 
excluded and needs further investigation.  
RT-PCR and microarray analysis of genes corresponding to apoptotic proteins 
down-regulated in LCH will be addressed in Chapter 7 of this thesis.  
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Chapter 6. Studies of LCH Conditioned Media-
Induced Apoptosis 
INTRODUCTION 
Cytokines, as hormones that mediate communication between cells of the immune 
and hemapoietic systems (Bechan et al., 2006; Kishimoto et al., 1994), and chemokines, 
as small molecules that play a central role in inflammatory responses (Annels et al., 2003; 
Bechan et al., 2006; Fleming et al., 2003), were described in LCH (Anderson et al., 2004; 
de Graaf et al., 1996; Egeler et al., 1999; Kannourakis & Abbas, 1994). Several groups 
studied an involvement of cytokines in the tissue damage and bone resorption similar to 
those observed in LCH lesions (Arenzana-Seisdedos et al., 1986; Bockman & Repo, 
1981; Da Costa et al., 2005; Gowen et al., 1983). Others have investigated the role of 
cytokines contributing to: LC development from various precursors (Caux et al., 1999; 
Geissmann et al., 1998; Ito et al., 1999; Larregina et al., 2001; Riedl et al., 1997; Strobl et 
al., 1996), cell migration (Caux et al., 1992; Kaplan et al., 1992),  as well as proliferation 
and differentiation of LCH cell progenitors (Egeler et al., 1999). Ludewig and co-authors 
(Ludewig et al., 1995), investigated the role of TNF as the inhibitor of spontaneous 
apoptosis in mature LCs. However, to date there are no reports exploring whether 
cytokines present in the LCH lesions contribute to the development of apoptosis in LCH. 
Better understanding of the role of cytokines involved in the regulation of apoptosis in 
LCH could open novel therapeutical frontiers.  
The study presented in this chapter complements the existing knowledge and 
demonstrates that molecules produced by cells from LCH biopsies stimulate apoptosis in 
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cultured cells. Cytokine analysis of medium conditioned by LCH biopsies provides the 
preliminary indication of which cytokines can be involved in such stimulation.  
The methods of cell culture, annexin V–based detection of early apoptosis in 
cultured cells and membrane-based detection of cytokines in the conditioned medium 
were employed in the studies described in this chapter.  
METHODOLOGY RATIONALE  
Conditioned media (CM) used in the experiments was obtained as described in 
Chapter 2 of this thesis. In brief, fresh biopsies were placed into the FBS-free medium 
and incubated for seven days (168 hours). At the end of the incubation the liquid was 
collected and stored frozen at -80C, refer Table 6-1. Normal medium (IMDM 
complemented with 10% FBS) was used as the negative control. Synovial fluid from a 
rheumatoid arthritis (RhA) patient (n=1) and media conditioned by the cells from reactive 
lymph nodes (rLNs) (n=2) were used as non-LCH inflammatory controls. All conditioned 
media was thawed out and diluted on the day of the experiment.   
Apoptosis in controls   
PBMCs, tonsillar SCSs and Jurkat cells (JCs) were seeded in IMDM 
complemented with 10% FBS in 96 well plates at a concentration of 2x104 cells per well 
and incubated for 48 hours at 37C in the atmosphere of 5% CO2. Using flow cytometry, 
apoptosis was measured at three hour intervals for the first 24 hours followed by 
measurements at 36 and 48 hours. PBMCs died by apoptosis within the first 24 hours as 
can be seen in Figure 6-1, A. They also demonstrated high natural exposure of 
phosphatidyl serine (data not shown) and were not selected for further experiments.
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Tonsil SCSs shown in Figure 6-1, B also died within the  first 24 hours. At 36 hours of 
incubation they showed signs of bacterial contamination (consistent with diagnosis for 
tonsillar resection) and were not selected for further experiments.  
Under normal circumstances JCs have a  very low stable rate of apoptosis which 
was confirmed using flow cytometry measurements. JCs were seeded at a concentration 
of 2x104 JCs/100l of full medium and incubated for 48 hours. With the exception of the 
24 hours post seeding, apoptosis in JCs was lower than 10%, as can be seen in Figure 6-1, 
C. At 24 hours post seeding the rate of apoptosis in JCs rose to approximately 20-25% 
(mean score 20.62+0.5% (from viable cells)). JCs incubated for longer than 24 hours (48 
hours post seeding) showed steady survival and continuing low rates of apoptosis not 
exceeding 10%, as can be seen in Figure 6-1, C. Steady rates of apoptosis in JCs provided 
a reliable negative control for further experiments.  
Apoptosis induction: selection of a positive control 
Several agents were selected in an attempt to induce JCs to undergo apoptosis, 
these included:  
 dexamethasone (0.5mM) 
the combination of dexamethasone (0.5mM) and DMSO (at 1.5% v/v) 
 24 hours FBS deprivation 
 anti-Fas activating antibody, clone CH-11 (100ng/ml) 
 anti-Fas activating antibody, clone CH-11 (100ng/ml) in combination with dextran 
(Manero et al., 2004)  
 
The combination of anti-Fas antibody clone CH-11 and DS induced an apoptotic 
rate of up to 82% at 24 hours in JCs. Anti-Fas antibody clone CH-11 alone induced up to 
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69% of JCs to undergo apoptosis at 24 hours. All other agents resulted in the induction of 
an apoptosis rate of less than 65% in JCs at 24 hours.  
The combination of anti-Fas antibody CH-11 and DS was chosen as a positive 
control agent (Figures 6-2; 6-3; 6-4).  
Conditioned media serial dilutions protocol  
JCs were maintained in log-phase of growth for several passages prior to being 
used for this experiment. Cells were seeded at a concentration of 2x104cells/100l in 
media containing 5, 10, 25, 50 and 100% of conditioned medium and incubated for 1, 3, 
6, 24, 48 and 72 hours, refer to the protocol in the appendix 5 and Table 6-1. At the end 
time-point of incubation PI dye and Annexin V conjugated with FITC were added to the 
cells. Viable, apoptotic and necrotic cells were counted using flow cytometry. Controls on 
each plate were:  
 control 1 (cells alone)     
 control 2 (cells alone + PI)    
 control 3 (cells alone +AnnV)    
 control 4 (cells alone +PI+Ann)  
 control 5 (cells +CH11/DS)  
CM from LCH patients (n=6), RhA patient synovial fluid (n=1) and CM obtained 
from rLNs (n=2) were tested against non-induced cells grown in full medium and results 
are presented in Figure 6-5. The full protocol of the experiment can be found in Appendix 
4. 
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TABLE 6-1 
Medium for Conditioned Media Study 
 
 
CM 
 
Disease 
 
 
Storage  
CM1 Conditioned medium 1, LCH Long term storage  
CM2 Conditioned medium 2, LCH Long term storage  
CM6 Conditioned medium 6, LCH Long term storage 
CM7 Conditioned medium 7, LCH Long term storage 
CM8 Conditioned medium 8, LCH Long term storage 
CM9 Conditioned medium 9, LCH Short term storage 
rLN Reactive lymph node Long term storage 
RhA Rheumatoid Arthrytis synovial 
fluid 
Long term storage 
NM Normal Medium 
(IMDM+10%FBS) 
NA 
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Several agents were selected in an attempt to induce apoptosis in Jurkat cells. Anti-Fas 
antibody clone CH-11 (100ng/ml) alone induced up to 69% of JCs to undergo apoptosis 
at 24 hours. The combination of anti-Fas antibody clone CH-11 (100ng/ml) and dextran 
sulphate (100 g/ml) induced an apoptotic rate of up to 82% at 24 hours incubation in 
JCs. Induction of apoptosis with all other agents resulted in a rate of apoptosis induction 
of less than 65% in JCs at 24 hours. In non-stimulated JCs the rate of apoptosis did not 
exceed 25% (red line) at 24 hours. 
Chapter 6. Studies of LCH Conditioned Media-Induced Apoptosis 169 
 
Chapter 6. Studies of LCH Conditioned Media-Induced Apoptosis 170 
 
Chapter 6. Studies of LCH Conditioned Media-Induced Apoptosis 171 
 
 
 
Chapter 6. Studies of LCH Conditioned Media-Induced Apoptosis 172 
 
Chapter 6. Studies of LCH Conditioned Media-Induced Apoptosis 173 
 
Chapter 6. Studies of LCH Conditioned Media-Induced Apoptosis 174 
 
Chapter 6. Studies of LCH Conditioned Media-Induced Apoptosis 175 
 
Chapter 6. Studies of LCH Conditioned Media-Induced Apoptosis 176 
 
Chapter 6. Studies of LCH Conditioned Media-Induced Apoptosis 177 
 
Chapter 6. Studies of LCH Conditioned Media-Induced Apoptosis 178 
 
Human cytokine array  
Human cytokine array (supplied as a kit) was used to capture and estimate the 
amount of 36 cytokines in LCH and non-LCH CM. Human cytokine array coordinates are 
shown in Figure 6-6.   
CM were pre-incubated with a cocktail of biotinylated antibodies and the mixture 
was added onto the cytokine array membrane. Any cytokine/detection antibody complex 
present in the solution was bound by its cognate immobilised capture antibody on the 
membrane. Following a wash in washing buffer (supplied in the kit) to remove unbound 
material, Streptavidin-HRP and chemiluminescent detection reagents were added 
subsequently. Data was collected as signal intensity of the pixel on the image. Density at 
cursor for 3x3 pixel box was measured after 10 min exposure using BioRad Universal 
Hood II and Quantity One ID software as can be seen in Figure 6-7.   
The density of the chemiluminescent signal was proportional to the amount of the 
protein bound by the membrane. Only those LCH CM (n=2) that stimulated apoptosis in 
JCs were tested in Human cytokine array. Negative control was serum-free IMDM.  
RESULTS 
LCH conditioned media induced apoptosis in Jurkat cells at 24 
hours 
On average 20% of non-induced JCs (20.6+0.5% (from viable cells)) were 
apoptotic at 24 hours time point as can be seen in Figure 6-5. At the same time point 
CH11/DS induced into apoptosis on average 75% of JCs (73.4+3.4%) as can be seen in 
Figures 6-4, 6-5. The rate of early apoptosis induced in JCs at 24 hours by LCH CM at a  
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50%; and rLN CM 12.2+3.9% compared to LCH CM 29.9+7.2% at 100%, as can be seen 
in Figure 6-5. The rate of early apoptosis induced in JCs by LCH CM at 50% 
(30.4+6.9%) and 100% (29.9+7.2%) was approximately 10% higher than in non-
stimulated JCs (additional negative control) where average rate of apoptosis was 
20.6+0.5%, as can be seen in Figures 6-3; 6-4; 6-5.  
Induction of early apoptosis by individual LCH CM from two patients at 25%, 
50% and 100% approached the levels of positive control (CH11/DS) and was twice the 
level of negative control (data not shown). Although this induction (in approximately 40-
55% apoptotic cells) did not reach very high levels of artificially induced apoptosis 
achieved by the combination of anti-Fas clone CH11 antibody and dextran sulphate 
(approximately 75% apoptotic cells), it was therefore decided to investigate cytokine 
levels in these most active LCH CMs.  
RhA synovial fluid killed JCs at 24 hours 
RhA synovial fluid (n=1) at the concentrations approaching and exceeding 25% 
killed most of the JCs within the first 6 hours of incubation (data not shown). Early 
apoptosis was not induced in JCs at 24 hours by RhA synovial fluid at a concentration of 
5% and 10%.  
LCH conditioned media cytokine profiles  
Densities of the signal on each membrane were categorised in four groups 
compared to positive control: low; intermediate, high and very high, as can be seen in 
Figures 6-8, 6-9. sICAM-1, ILra, IL-8, MIF and Serpin E1 were commonly at high levels, 
as can be seen in Figures 6-10, 6-11. Knowing that the sample use was limited, it can be 
reasonably concluded that there was a remarkable number of cytokines that were at or 
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near baseline levels (not present) in LCH CM. However, there were five cytokines 
(sICAM-1; ILra; IL-8; MIF; Serpin E1) whose involvement in LCH may be worthy of 
further investigation.  
DISCUSSION 
In this Chapter, Jurkat Cells (JC) were used as target cells for apoptotic soluble 
factors obtained from LCH lesional conditioned media.   
JCs were selected for the development of the apoptosis induction model. 
Approximately 20% of Jurkat Cells in the non-stimulated culture were undergoing 
apoptosis, however when induced with anti-Fas antibody clone (CH11) and dextran 
sulphate (DS) this number increased to approximately 75 percent. Dead and viable cell 
numbers after induction of apoptosis were proportional and reproducible, and could be 
measured after prolonged periods of incubation. Apoptosis induction at 24 hours was 
selected as the optimal time point. Single cells from tonsillar tissue and from peripheral 
blood were dying quickly and could not provide reliable data after 6 hours of incubation.  
Attempts have been made in the past to establish in vitro cell culture of LCH cells 
(Geissmann et al., 2001; Nezelof & Basset, 1998), as well as a xenograft models in 
immune-deficient mice  et al., 2004), but have not been successful (Egeler et al., 2010). 
There is a paucity of published data on cytokine profiles in medium conditioned by LCH 
cells.  
Using JCs a specific combination of anti-Fas antibody and dextran sulphate 
produced apoptosis in 75 percent of Jurkat Cells. This model may therefore detect Fas-
related apoptotic proteins, but other mechanisms may also play a role.  
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Media conditioned by LCH cells, induced apoptosis in Jurkat Cells only when the 
concentration of CM exceeded 25 percent. However, variation in the activity of CM 
samples was apparent from different LCH patients (some active, some inactive). Such 
variation could be partially explained by the stage of the disease at the time of biopsy, 
with some lesions representing early lesions and some later in the course of the disease.  
Media conditioned by cells from reactive lymph nodes (rLN) biopsies did not 
induce higher than control levels of apoptosis in Jurkat Cells and was  independent of 
concentration.  
RhA synovial fluid at a concentration approaching or exceeding 25 percent, 
induced cell death within the first six hours of incubation. However, in a strict sense it 
was not a CM, but a biological fluid. RhA synovial fluid contains a range of cytokines 
such as TNF (Saxne et al., 1988), T lymphocyte related cytokines (IL-2; IL-4; IL-13; 
IL-17); stromal cell and macrophage related cytokines (EGF; bFGF; IL-1; IL-15) (Raza et 
al., 2005) which could explain its toxic properties. At a concentration lower than 10 
percent RhA synovial fluid did not induce apoptosis in Jurkat Cells at 24 hours.  
Cytokine assay showed that concentrations of sICAM-1; IL-1ra; IL-8; MIF and 
Serpin were commonly elevated in CM from two LCH patients, also refer Appendix 7.  
 A complex sequence of cytokine regulation at the site of inflammation (Utgaard 
et al., 1998) results in the surge of chemokine production (or release from storage) by the 
homing cells. IL-8 is one of the inflammatory cytokines released during the inflammatory 
process. Traditionally IL-8 is known as neutrophil attractant and activating factor (Schall 
et al., 1993). It is also reported to attract T lymphocytes in vitro and in vivo (Larsen et al., 
1989).  
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sICAM-1 (Yang et al., 2005) belongs to the group of cytokines (sICAM) 
stimulating T lymphocyte migration from the bloodstream into the tissue. Cell adhesion 
mediated by these molecules  is critical for interaction between T cells and antigen-
presenting cells. Increased concentration of sICAM-1 is also consistent with the onset of 
inflammation in LCH lesions.  
Elevated concentrations of IL-1ra (Dinarello, 1994) and Serpin 1E (Binder et al., 
2002) indicated that normal epidermal surveillance and clot resorption could be inhibited 
in LCH (EoG).  
Elevated amounts of MIF (macrophage migration inhibitory factor) (Dumitru et 
al., 2011; Kim-Saijo et al., 2008) were detected in LCH CM using cytokine assays,  is 
consistent with the ongoing process of inflammation in LCH lesions. An increased 
concentration of MIF in LCH lesions could be responsible for the inhibition of 
macrophages’ movement out of the inflammatory site thus causing their death by 
apoptosis, which was indeed observed in IHC experiments presented in Chapter 4 of this 
thesis.  
Analysis of the results from Chapters 3 and 4 of this thesis shows increased 
apoptosis in LCH lesions. The results from the current chapter show the induction of 
apoptosis in Jurkat Cells by two LCH CM. At the same time increased concentrations of 
sICAM-1, IL-1ra, IL-8, MIF and Serpin were detected in these conditioned media.  
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Chapter 7. Validation of Apoptotic Genes 
Expression in LCH Using RT-PCR and 
Microarray Analysis 
INTRODUCTION 
Polymerase Chain Reaction (PCR) which was originally described by Mullis in 
1983 (Stetler et al., 1982), is now widely used as a measure of gene expression. The 
exponential gene amplification via reverse-transcriptase (RT-PCR) provides a highly 
sensitive technique by which a very low copy number of RNA molecules can be detected.  
Another novel technology, allowing simultaneous analysis of the expression levels 
of large numbers of genes is use of microarray analysis (Lockhart et al., 1996; Lockhart & 
Barlow, 2001).  
In the past, several authors reported no abnormalities in LCH DNA following the 
analysis of DNA content (da Costa  et al., 2009; McLelland et al., 1989; Ornvold et al., 
1990; Rabkin et al., 1988). McClain and co-authors (McClain et al., 2005) compared 
cytokine expression profiles of microdissected LCs from normal and LCH tissues to that 
of whole tissue cytokine expression using a custom-designed array platform. Authors 
found that the gene expression profiles of LCs from normal skin or diseased tissue were 
similar.  
Based on the results contained in Chapter 5, the expression of apoptosis-related 
genes Fas, HtrA2/Omi, p27 and XIAP were analysed at the mRNA level using RT-PCR 
methodology and microarray analysis. These genes were selected because of the 
significant difference in the concentration of corresponding proteins in LCH and tonsil 
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cell lysates, as detected by the Human Apoptosis Antibody Array. A better understanding 
of factors involved in the regulation of apoptotic genes regulation and protein expression 
could open new directions in LCH research.  
METHODOLOGY RATIONALE 
RT-PCR  
PCR procedure is based on the repeated cycles of heating and cooling which  
provide the conditions for DNA melting and enzymatic replication. Specific primers 
which are the components of the reaction mix, provide selective amplification of genes 
under investigation.  
Optimisation  
RT-PCR was performed in two steps: ss-cDNA synthesis was followed by PCR 
amplification. Primers were designed for human -actin; Fas; HtrA2/Omi; p27 and XIAP 
sequences, refer Table 2-11. PCR conditions were optimised for each primer pair. The 
amount of template for each reaction was optimised using -actin as internal control.  
Quantitation of PCR products 
Quantitation of PCR products in agarose gel electrophoresis images was 
performed using Quantity One 1D analysis software (BioRad, USA). Volume rectangles 
were drawn around the bands and total signal intensity inside these boxes was measured. 
Adjusted volume for each band represented the intensity in the box minus background 
volume, refer Table 7-1. The mean and standard errors were calculated based on volume 
measurements. 
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Table 7-1. 
Measurements for RT-PCR Products 
 
 
Name 
 
 
Intensity, mm2 
Fas LCH 1 175998 
Fas LCH 2 109143 
Fas LCH 3 162336 
Fas Tonsil 1 84109 
Fas Tonsil 2 177782 
Fas Tonsil 3 46133 
p27 LCH 1 96322 
p27 LCH 2 54947 
p27 LCH 3 46843 
p27 Tonsil 1 87938 
p27 Tonsil 2 63741 
p27 Tonsil 3 48562 
HtrA2 LCH1 39603 
HtrA2 LCH 2 61714 
HtrA2 LCH 3 41254 
HtrA2 Tonsil 1 81548 
HtrA2 Tonsil 2 53917 
HtrA2 Tonsil 3 47709 
XIAP LCH 1 121041 
XIAP LCH 2 116667 
XIAP LCH 3 28922 
XIAP Tonsil 1 166206 
XIAP Tonsil 2 53808 
XIAP Tonsil 3 39881 
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Microarray 
In standard microarrays, the probes are synthesised and then attached to a solid 
surface by a covalent bond to a chemical matrix (via epoxy-silane, amino-silane, lysine, 
polyacrylamide or others). The solid surface can be a glass or silicon chip, in which case 
they are colloquially known as an Affy chip when an Affymetrix chip is used.  
RNA extracted from LCH and tonsillar tissues was quality checked using RNA 
gel electrophoresis and bio-analyser as described in Materials and Methods. Quality RNA 
from LCH (n=3) and tonsillar (n=3) tissues was sent to Adelaide Microarray Centre for 
the analysis by Affymetrix array technology (Affymetrix Human Genechip Gene 1.0 ST 
Array).  
Gene microarray analysis of total RNA extracted from three LCH and three 
tonsillar tissues was commercially performed by Adelaide Microarray Centre. Expression 
of apoptotic protein-corresponding genes was addressed in preliminary analysis of 
microarray data.  
RESULTS 
RT-PCR data analysis 
RT-PCR amplification profiles for Fas, HtrA2/Omi, p27 and XIAP genes are 
shown in Figures 7-1, 7-2.   
RT-PCR products mean for Fas constituted 149159.4+20392.98 counts for LCH 
(n=3) and 102675+39121 counts for tonsil (n=3). The mean for p27 was 66037+15322 
counts for LCH and 66747+11465 counts for tonsil. The mean for HtrA2 products was  
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Figure 7-3. Validation of Protein Expression by RT-PCR.  
 
The expression levels of Fas, p27, HtrA2 and XIAP PCR products as indicated by 
RT-PCR (A)  did not explain the reduced levels of the corresponding proteins in 
LCH and tonsillar tissue cell lysates as shown by Human Apoptosis Antibody 
Array (B) reported in Chapter 5. 
A.  
B.  
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Figure 7-4. Microarray Analysis Compared Apoptotic Genes in LCH and Tonsillar Tissues  
 
Total RNA from LCH (n=3) and tonsillar (n=3) tissues was commercially analysed using Affymetrix chip technology 
. 
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47524+7111 counts for LCH and 61058+10400 counts for tonsil. The mean for XIAP 
RT-PCR product was 88876+30003 counts for LCH and 86632+39989 counts for tonsil, 
as can be seen in Figure 7-3, A.  
Gene Microarray Analysis 
Although an enormous volume of data was generated from a single microarray 
chip providing the expression profile of 45,000 genes, the study in this Chapter was 
restricted to the group of apoptotic genes based on the results of Chapter 5. Microarray 
data (showing gene expression profiles in LCH and tonsil tissues) was compared with 
Human Apoptosis Antibody Array data (showing protein concentrations in LCH and 
tonsil tissues) in order to observe the correlation between gene expression and protein 
concentration in LCH and tonsil cell lysates.  
Microarray analysis found that expression of Fas, HtrA2, p27 and XIAP genes 
was down-regulated in LCH compared to those detected in tonsillar tissue by -1.46, -1.10, 
-1.34 and -1.05 fold respectively, as can be seen in Figure 7-4, refer Tables 7-2, 7-3. 
Protein products of these genes were present in LCH in noticeably lower amounts than in 
tonsillar tissue as shown by Human Apoptosis Antibody Array, as can be seen in Figure 
5-5. Bax, Bcl-X, cytochrome C and Hsp70 gene expressions were up-regulated in LCH 
compared to tonsil by 1.6, 1.09, 1.44 and 1.78 fold respectively, as can be seen in Figure 
7-4. However, the Human Apoptosis Antibody Array analysis found protein products of 
these genes to be down-regulated in LCH compared to tonsillar tissue, as can be seen in 
Figure 5-5. Interestingly, p53 gene expression detected by microarray analysis was the 
most down-regulated (-10.75 fold) in LCH (Figure 7-4), while concentrations of p53 
found in LCH and tonsillar tissues by the Human Apoptosis Antibody array were similar,
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Table 7-2 
Microarray Analysis Results for Apoptotic Proteins 
Protein 
 
Gene Symbol Fold change 
Bad BAD -1.07 
Bax BAX 1.60 
Bcl-2 BCL2 -1.96 
Bcl-X BCL2L1 1.09 
Pro-caspase 3 CASP3 -1.13 
Catalase CAT -1.28 
cIAP-1 BIRC2 -1.12 
cIAP-2 BIRC3 -3.12 
Claspin CLSPN 1.35 
Clusterin CLU -2.13 
Cytochrome C CYCS 1.44 
TRAIL R1/DR4 TNFRSF10A -2.50 
TRAIL R2/DR5 TNFRSF10B 1.71 
FADD FADD -1.04 
Fas/TNFRSF6 FAS -1.46 
HIF-1a HIF1A -1.09 
HO-1/HMOX1 HMOX1 1.95 
HO-2/HMOX2 HMOX2 -1.03 
HSP27 HSPB1 -2.03 
Hsp60 NA NA 
Hsp70 HSP70 1.78 
HTRA2/Omi HTRA2 -1.10 
Livin BIRC7 -1.01 
PON2 PON2 1.56 
p21/CIP1 CDKN1A 1.98 
p27/Kip1 CDKN1B -1.34 
p53 TP53 -10.75 
Rad17 RAD17 -2.02 
SMAC/DIABLO DIABLO -1.02 
Survivin BIRC5 1.08 
TNFR1 TNFRSF1A 1.50 
XIAP XIAP -1.05 
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as can be seen in Figure 5-5. This phenomenon needs a further investigation in a separate 
study.  
DISCUSSION 
In the past, studies examined karyotypes (da Costa et al., 2009) and DNA content 
(McLelland et al., 1989; Ornvold et al., 1990; Rabkin et al., 1988) in LCH. “In a large 
multi-institute study using a range of techniques, including conventional cytogenetics, 
array-based comparative genomic hybridization and single nucleotide polymorphism 
analysis on CD1a+-sorted cell populations, no abnormalities could be  substantiated. This 
largely ruled out gross chromosomal abnormalities to be causative for the disease and 
suggested a restricted oligoclonal stimulation rather than an unlimited neoplastic 
proliferation” (Egeler et al., 2010). Brown (Brown, 2002) proposed pathogenetic 
sequence for the chromosomal breakage and chromosome 7 abnormality in LCH. Many 
investigators concentrated their research on the proliferation of cells within LCH lesions 
(Amir & Weintraub, 2008; Bank et al., 2003; Hamada et al., 1995; Schouten et al., 2002; 
Senechal et al., 2007) and found that between 3% and 25% of lesional cells may express 
the proliferation marker Ki-67 (Egeler et al., 2010). 
However, molecular biology studies targeting apoptotic gene expression in LCH 
are limited. Weintraub and colleagues (Weintraub et al., 1998) analysed the integrity of 
the p53 gene using the PCR-based SSCP technique. Exons 4 to 11 of the coding region of 
the p53 gene were screened and no mutations were found. Da Costa and colleagues (Da 
Costa et al., 2009)  came to the similar conclusion after sequencing exons 5 to 8 of p53 
gene which showed no alterations in seven cases.  
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Results described in Chapter 5 of this thesis demonstrated the down-regulation of 
a number of apoptotic proteins in LCH compared to tonsillar tissues. To further 
investigate this phenomenon RT-PCR technique and microarray analysis were employed 
to compare apoptotic genes expression in LCH and tonsillar tissues. Analysis of proteins 
extracted from LCH and tonsil cell lysates showed the most noticeable difference in 
concentrations of Fas, p27, HtrA2 and XIAP. However, RT-PCR did not confirm the 
Human Apoptosis Antibody Array findings as similar concentrations of corresponding 
genes were detected in LCH and tonsillar tissues.  
Microarray analysis, on the contrary, confirmed the Human Apoptosis Antibody 
Array data and showed the down-regulation of Fas, p27, HtrA2 and XIAP genes 
expression in LCH compared to tonsil.  
While contradictory at first sight, these results could be explained by the semi-
quantitative nature of RT-PCR technique. Microarray analysis provides a more accurate 
assessment. Further experimental work and more sophisticated analysis of microarray 
data could clarify the role of apoptotic genes and their products in the development of 
LCH. Work performed in the course of this thesis provided a basis for such investigations 
to proceed.  
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Chapter 8. General Discussion 
INTRODUCTION 
Programmed cell death, or apoptosis, is one form of the biological process 
responsible for the homeostatic balance between cell proliferation and cell death in 
multicellular organisms. In humans, imbalance of apoptosis can lead to increased cell 
proliferation (which is observed in cancers) or increased cell elimination (observed in 
neurological and immune disorders).  Better understanding of the molecular events that 
regulate apoptosis and medical adaptations of cellular mechanisms involved in apoptotic 
cascades, could provide novel opportunities for a more rational approach to develop 
molecular tools for clinical diagnosis and therapy.   
Langerhans Cell Histiocytosis (LCH) is a group of rare disorders of an unknown 
aetiology. The clinical picture of LCH varies from single-site disease to multi-system 
involvement. More than 75 percent of LCH patients have skeletal lesions. The single-site 
form of LCH located in bone (also called eosinophilic granuloma) is known to have a 
high incidence of spontaneous regression and high levels of apoptosis. It was this 
observation that instigated the current research into apoptosis in LCH lesions.  
Comparison of apoptosis in LCH and non-LCH inflammatory lesions reported in 
this thesis, demonstrated significant differences in apoptotic cells numbers, the type of 
cells undergoing apoptosis and apoptotic gene expression profile between LCH and non-
LCH inflammatory controls. The more that is known about the spontaneous regression of 
lesions in LCH and the role of apoptosis in this process, the closer we may get to the 
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development of molecular tools for clinical-based therapies in LCH, cancer and related 
disorders.  
KEY FINDINGS AND FUTURE DIRECTIONS 
In the course of this study, quantitative comparison of apoptosis in LCH and non-
LCH inflammatory controls was performed on fixed tissues and living cells. Apoptotic 
cells are characterised by a range of biochemical and morphological changes which can 
be detected using a variety of techniques. In the work presented in this thesis, LCH 
lesions were compared to non-LCH inflammatory disorders such as tonsillitis, 
inflammatory bowel disease, sarcoidosis and foreign body granulomas. Such comparison 
has not been reported to date.  
DNA conformational change is an early event in a cell’s reaction to an apoptotic 
stimulus. The results presented in Chapter 3, demonstrated that cells in all tissues under 
investigation had high rates of early apoptosis response (as detected using the Apostain 
antibody) and that LCH had the highest percentage of early apoptotic cells among the 
studied diseases. The detection of early apoptosis in LCH lesions using Apostain antibody 
or annexin V-based flow cytometry analysis has not been reported to date.  
In the past Amir and Weintraub (Amir & Weintraub, 2008)used cleaved caspase-3 
staining to compare apoptosis in different types of LCH (risk bone involvement and non-
risk bone involvement) and found low numbers of cleaved caspase-3-positive cells.  
However, the study did not use TUNEL staining and did not compare apoptosis onset in 
LCH and non-LCH diseases but rather within different types of LCH.  Based on cleaved 
caspase-3 staining results the authors concluded that apoptosis was inhibited in more 
aggressive manifestation of LCH.  
Chapter 8. General Discussion 198 
Results of this thesis provide different interpretation of similar results. According 
to data described in Chapter 3, in non-LCH inflammatory diseases, the number of cleaved 
caspase-3 positive cells was of the same order as cells undergoing apoptotic DNA 
fragmentation (as detected by TUNEL assay). In LCH lesions, however, the amount of 
cells in late apoptosis far exceeded cells exhibiting cleaved caspase-3 activity. This 
indicated that in LCH, apoptosis was associated with a caspase-3 independent pathway.  
Hamada and colleagues (Hamada et al., 1995) used the TUNEL technique for the 
detection of DNA fragmentation and proliferation marker Ki-67 staining for the detection 
of proliferative activity of cells within the same LCH lesions. However, the study was 
focused on the correlation between cell proliferation and cell death within the same LCH 
lesion and did not compare the onset of apoptosis in LCH and non-LCH inflammatory 
diseases.  
By the time cells reached the late stages of apoptosis, characterised by DNA 
fragmentation (detected by TUNEL assay), the percentage of apoptotic cells dropped to 
low numbers. However in LCH the numbers of cells in late apoptosis (even though lower 
than at early stages) remained elevated when compared to non-LCH inflammatory control 
tissues, and on average accounted for 7.5+ 0.9%1 of cells in the total cell population.  
The finding of increased apoptosis in LCH compared to non-LCH inflammatory 
controls, raised the question as to the type of cell lineages undergoing apoptosis in these 
disorders. The cellular composition of LCH lesions has been described in detail by 
several authors (de Graaf et al., 1995; Egeler et al., 2010; Favara & members of the WHO 
committee on histiocytic/reticulum cell proliferations, 1997; Geissmann et al., 2001; 
                                                                 
1
 The number of cells undergoing apoptosis in LCH tissues detected by the fluorescent 
TUNEL assay was at times as high as 15-20% (data not shown).  
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Kannourakis & Abbas, 1994; Laman et al., 2003; Schmitz & Favara, 1998). Hamada and 
colleagues (Hamada et al., 1995) used enzymatic TUNEL staining and considered 
TUNEL-positive cells to be of histiocytic lineage. However, to date there are no 
published data on dual staining of LCH lesional cells undergoing apoptosis.   
Dual staining (IHC technique immediately followed by TUNEL assay) was 
applied to FFPE tissues. Findings from dual staining experiments could be divided into 
three groups:  
1. detection of cell lineages (cells stained using CD antibodies only);  
2. apoptotic cell nuclei and apoptotic bodies (cells stained using TUNEL only);  
3. cell lineages undergoing apoptosis or phagocytising apoptotic bodies (cells 
stained by the combination of CD antibody and TUNEL).  
Data presented in Chapter 4 of this thesis, demonstrated the distribution of cells in 
LCH lesions relative to non-LCH inflammatory controls. As expected, the number of 
CD1a-postive Langerhans cells in LCH lesions was the highest; numbers of CD3-positive 
T lymphocytes were higher in inflammatory bowel disease and sarcoidosis; numbers of 
CD19-positive B lymphocytes were the highest in tonsillitis; numbers of CD68-positive 
activated macrophages were similar in all diseases, though slightly lower in LCH; 
numbers of CD138-positive plasmacytes were low in all diseases, though the highest 
numbers were observed in inflammatory bowel disease. Low numbers of CD3-; CD19- 
and CD68-positive cells in LCH compared to all other inflammatory controls, suggested 
that these cells may be suppressed in LCH lesions.  
The majority of cells found to be double stained by IHC and TUNEL techniques 
belonged to the CD68-positive lineage in all diseases. LCH had the highest number of 
CD68-positive cells containing fragmented DNA in nuclei (0.6% of total cells). 
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Sarcoidosis showed slightly lower numbers of CD68-positive cells containing fragmented 
DNA in nuclei (0.5% from total cells). CD68-positive cells from inflammatory bowel 
disease and foreign body granuloma contained lower quantities of fragmented DNA in 
their nuclei (0.2% and 0.15% from total cells respectively). Interestingly, CD68-positive 
cells from tonsillitis contained fragmented DNA in both cytoplasm (59% of apoptotic 
cells) and nuclei (40% of apoptotic cells), indicating that active phagocytosis was taking 
place in acute tonsillitis.  
A method of dual staining of living cells in single cell suspensions was developed 
for flow cytometry application. Using this method, early apoptotic cells could be 
distinguished from intact viable cells and from dead or necrotic cells.  
Flow cytometry analysis of LCH and tonsillar tissues single cell suspensions 
showed that early apoptotic cells in LCH belonged to Langerhans cells (CD1a-positive), 
T lymphocytes (CD4-positive) and monocytes (CD14-positive) lineages (27.9%; 27.8% 
and 17.9% from viable cells respectively). In tonsillar tissues the majority of cells in early 
apoptotic stage were T lymphocytes (CD3-positive) and B lymphocytes (CD19-positive) 
(4.5% and 17% from viable cells respectively).  High concentration of B lymphocytes in 
tonsillar single cell suspension was consistent with the physiological function of tonsils. 
Increased numbers of early apoptotic Langerhans cells, T lymphocytes and monocytes in 
LCH, indicated that these cell were the first to respond to apoptotic stimuli.  
Further analysis of apoptotic CD14-positive cells in LCH showed that 9% were 
CD1a-/CD14+ cells of monocyte-macrophage lineage (compared to 1% in tonsillar 
tissue).  
Flow cytometry analysis demonstrated that mature Langerhans cells 
(CD1a+/CD14-) in LCH accounted for approximately 12% (from viable cells). In 
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tonsillar single cell suspension CD1a+ cells were not detected among apoptotic cells 
(probably due to low numbers).  
In LCH, approximately 60% of immature Langerhans cells with CD1a+/CD14+ 
phenotype were in early apoptosis. This was in contrast to tonsillar single cell suspension 
where no CD1a+/CD14+ cells were found among apoptotic cells.  
Taken together the results from Chapters 3 and 4 demonstrated that the number of 
cells subjected to early and late apoptosis in LCH were higher than in non-LCH 
inflammatory controls. Flow cytometry studies showed that CD1a-positive Langerhans 
cells, CD4-positive T lymphocytes and CD14-positive monocytes accounted for the 
majority of early apoptotic cells in LCH.  Absence of cleaved caspase-3 staining in LCH 
tissues implied a caspase-independent mechanism of apoptosis in LCH.  
To examine which apoptotic proteins might be involved in the apoptotic signal 
transduction in LCH and tonsillar tissues, the Human Apoptosis Antibody Array assay 
was employed. This method allowed the detection of 35 major apoptotic proteins in 
lysates prepared from LCH and tonsillar tissues. To date no such analysis had been 
reported in LCH.  Previously Weintraub and colleagues (Amir & Weintraub, 2008; 
Weintraub et al., 1998) studied the role of apoptosis-related proteins Bcl-2, p53 and 
cleaved caspase-3 in LCH lesions. Petersen and co-authors (Petersen et al., 2003) 
published the study on Fas/FasL pathway of apoptosis in LCH lesions. Further studies 
from the same group (Bank et al., 2005), investigated the expression of three proteins 
engaged in the classical Fas signalling cascade (FADD, FLICE and FLIP) in LCH lesions, 
and came to the conclusion that Fas signalling pathway may be involved in the 
pathogenesis of LCH.  Weintraub and colleagues (Weintraub et al., 1998) and Bank and 
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colleagues (Bank et al., 2002), showed that p53 and mdm2 molecules were present in 
LCH lesions but found no mutations in related genes.  
In this thesis, the screening of protein lysates for the presence of 35 apoptotic 
proteins was compared for LCH and tonsillar tissues. Results demonstrated that the 
concentration of all 35 apoptotic proteins was lower in LCH compared to tonsillitis.  
The Human Apoptosis Antibody Array confirmed that cleaved caspase-3 
production was down-regulated in LCH compared to tonsillar tissue. The amount of 
cleaved caspase-3 zymogen – pro-caspase-3 was also found to be lower in LCH than in 
tonsillar tissue protein lysates. Together with cleaved caspase-3, the striking down-
regulation in LCH was observed for Fas-, HtrA2/Omi, p27/Kip and XIAP proteins. 
Further studies are needed to investigate the role of these molecules in apoptosis 
development in LCH and the reason they are so dramatically down-regulated.  
Apoptotic protein profiles for LCH indicated that compared to inflammatory 
controls, increased amounts of Fas, Bax, SMAC/DIABLO, and cytochrome C were 
present in LCH tissues.  
Such profile suggests that the extrinsic pathway of apoptosis is activated in LCH, 
and may involve mitochondrial membrane permeabilisation at some point of signal 
processing by the LCH cells. Future research is warranted to further investigate apoptotic 
signal transduction in LCH.  
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RT-PCR and mircroarray analysis were used to validate the data obtained from the 
Human Apoptosis Antibody Array Assays. RT-PCR provided semi-quantitative 
assessment of selected (Fas, p27, HtrA2 and XIAP) genes expression in LCH and 
tonsillar tissues, and showed that these genes were expressed at approximately the same 
concentrations in both types of tissues. Microarray analysis, however, confirmed that the 
gene expression of these proteins was down-regulated in LCH compared to tonsillar 
tissue. Of particular interest was the 10-fold down-regulation of the p53 gene expression 
in LCH compared to tonsil controls.  
The ability of LCH lesions to induce apoptotic signals was tested in experiments 
utilizing media conditioned by LCH cells. LCH CM at a concentration exceeding 25 
percent induced apoptosis in up to 50 percent of target Jurkat cells within first 24 hrs of 
co-incubation. These results indicate that LCH lesional cells produce soluble factors) that 
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may induce apoptosis of target cells (such as Jurkat Cells). The effect of LCH CM 
appeared to be dose-dependent and not toxic to the target Jurkat cells in contrast to 
synovial fluid from rheumatoid arthritis patients, which induces toxic cell death.  
The conditioned media which induced apoptosis in targer cells was subsequently 
tested by the Human Cytokine Array Assay. Some variations in results were observed 
which could be due to many factors, including age, gender, stage of the disease and 
medical interference at the time of or prior to biopsy.  Interestingly, Serpin E1, a protein 
responsible for the inhibition of blood clot breakdown, was elevated in LCH CM. 
Concentration of IL-1ra, a protein responsible for the inhibition of IL-1a and IL-1b (these 
were indeed inhibited) was elevated in LCH CM. IL-1a and IL-1b belong to the IL-1 
group (Arend, 2003) and are responsible for maintaining skin barrier, wound healing and 
immune response regulation.  
Another cytokine elevated in LCH CM was IL-8. IL-8 is released by macrophages 
after interaction with an antigen (Utgaard et al., 1998).  IL-8 is the chemoattractant of the 
neutrophils to the site of inflammation (Cohen & Burns, 2002). Previously Kannourakis 
and colleagues (Kannourakis & Abbas, 1994) reported elevated concentration of IL-8 in 
sera from patients with active LCH and in media conditioned by mononuclear cells 
obtained from eosinophillic granuloma. Authors suggested that the pattern of constitutive 
cytokine production by mononuclear cells from LCH lesions implicated the 
proinflammatory cytokines, including IL-8, in the pathogenesis of LCH. Results in this 
thesis were obtained using the media conditioned by the mixture of cells from LCH EoG 
lession. Even though the method of cytokine detection (the Human Cytokine Array 
Assay) was different from immunoassay techniques used by Kannourakis and colleagues 
in the past, the results of this thesis confirmed previous observations and showed that the 
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concentration of IL-8 was elevated in media conditioned by LCH lesional cells.  Future 
research in the role of IL-8 in LCH is needed.  
MIF – macrophage migration inhibitory factor was found in LCH CM in increased 
concentrations. It is tempting to hypothesise that elevated quantities of MIF could play a 
role in the inhibited migration of macrophages from (or around) the LCH lesion thus 
contributing to the increased apoptosis of these cells in LCH lesions.    
Further studies will be needed to investigate the complex production of cytokines 
in LCH.   
FINAL SUMMATION 
Increased apoptosis detected by TUNEL assay in LCH lesions compared to non-
LCH inflammatory disorders, was confirmed by these studies. Low numbers of cleaved 
caspase-3-positive LCH lesional cells, argues for a caspase-independent pathway of 
apoptosis in LCH. Increased levels of early apoptotic responses in CD1a-negative/CD14-
positive cells, increased CD68-positive cells undergoing late apoptosis, as well as higher 
levels of non-cleared apoptotic bodies in LCH FFPE tissues, indicates a possible 
malfunction of the clearance mechanism in LCH lesions. Increased apoptosis among 
CD14-positive and CD68-positive cells could be due to the elevated concentration of 
macrophage migration inhibitory factor (MIF) detected by the Human Cytokine Array in 
media conditioned by LCH lesional cells. We hypothesise that increased concentrations 
of MIF may prevent CD68-positive cells from migration from LCH lesion thus causing 
their death by apoptosis. Apoptotic death of CD68-positive phagocytic cells could in turn 
be the reason for the accumulation of apoptotic bodies in LCH detected in IHC 
experiments.  
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Based on the results of IHC, Human Apoptosis Antibody Arrays and microarray 
analysis reported in this thesis, apoptosis in LCH lesions does not follow classical 
caspase-3 dependent pathways, and does not involve the activation of classical apoptotic 
proteins. We therefore conclude that apoptosis in LCH follows a novel, caspase-3 
independent, pathway. 
Data presented in this thesis, as well as experimental methodology established in 
the course of this work, could provide a solid foundation for the future research. 
Mechanism(s) of protein downregulation and the significance of caspase-independent 
pathways in LCH are of particular interest.  
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Appendix 1:  Conferences Attendance and 
Participation 
2008 University of Ballarat Annual Research Conference: 
 
Oral Presentation: “Apoptosis (cell death) detection in Langerhans 
Cell Histiocytosis”  
 
2010   University of Ballarat Annual Research Conference: 
Oral Presentation: “Apoptosis (cell death) in Langerhans Cell 
Histiocytosis Follows Caspase-Independent Pathway” 
 
2011  University of Ballarat Annual Research Conference: 
  Attended 
 
2009 ISEH 39th Annual Scientific Meeting, Melbourne, Australia 
  Attended
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Appendix 2: Copies of Ethics Approvals 
Attached are the copies of ethics approvals for the project “Use of Human Tissues 
for the Study of Langerhans Cell Histiocytosis (LCH)”.  
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Appendix 3: Buffers 
Antigen retrieval solution, 10mM Tris 1mM EDTA 0.05% Tween 20, pH=9: 
Trisma Base    1.21g 
EDTA(Na2)    0.37g 
Make up to 1000ml with DW, adjusting to pH=9.0 
Add Tween-20:            0.5ml 
Store at:             4°C.  
 
Antigen retrieval solution, formamide 50% 
Formamide stock solution   100ml 
Distilled water    100ml 
 
Buffer A: 
10ml of 1mg/ml DNAse 1 were added to 10ml IMDM/10% FBS. 
 
Blocking buffer for IHC: 
Add 200 (400) l of serum to 1800 (3600) l of milk buffer. Type of serum was 
determined by the species in which 2° antibodies were raised. 
 
Dispase II 
Dispase II was used undiluted. Store at -20°C. 
 
DNAse1 stock solution for IHC: 1mg/ml 
Prepare 1:1 w/v solution of DNAse 1 (powder) in NaCl/Glycerol buffer. Aliquot into 
200l batches. Store at -20°C. 
 
Diethylpyrocarbonate (DEPC) water 
Add 1.5ml of 100% DEPC to 1000ml of DW, mix, place at 37C for at least 1hr. 
Autoclave.  
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Ethidium bromide 0.1g/ml 
Add 1l of 10g/ml stock solution to 100ml of 2% agarose gel at 70C. 
 
EDTA 0.5M (pH=8.0) 
EDTA     18.6g 
Add 100ml of DW, adjusting pH=8.0.  
Store at RT. 
 
X10 Hank’s Balanced Salt Solution (HBSS): 
KCl     3.73g 
KH2PO4    5.44g 
NaCl     80.65g 
NaHCO3    3.36g 
Na2HPO4    7.95g 
Make up to 1000ml with DW 
Store at RT. 
 
X1 Hank’s Balanced Salt Solution (HBSS): 
900ml of DW were added to 100ml of HBSS (x10). Store at RT. 
Iscove’s Modified Dulbecco’s Medium (IMDM) supplemented with 10% 
FBS 
50ml of FBS were added into 500ml IMDM. 
Milk buffer: 
Prepare 5% milk solution by dissolving 0.2g of skinny dry milk in 0.2% Tween-20. 
Paraformaldehyde 4% 
900ml of PBS were added to 100ml 40% paraformaldehyde. Store at RT. 
X10 Phosphate Buffered Saline (PBS): 
25 tablets were dissolved in 500ml of DW adjusting pH=7.4 
 
x1 Phosphate Buffered Saline (PBS):  
PBS x10 stock diluted 1:10 with DW 
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Phosphate Buffered Saline with 0.05% Tween 20 (PBST):  
Add 1ml of Tween 20 (100%) to 2000ml of PBS x1 
 
Red Blood Cell Lysis buffer (RBC lysis buffer): NH4Cl (155mM), KHCO3 
(10mM), EDTA (0.1M):  
NH4Cl     4.15g 
KHCO3    0.5g 
Make up to 450ml with DW 
EDTA (0.5M)    100l 
Adjust to pH to 7.4 
Sodium Chloride (NaCl)/Glycerol buffer: 
Glycerol (100%)   3.1ml 
NaCl 2M     463l  
H2O     2.6ml 
Prepare immediately before use, do not store. 
 
X10 Tris Buffered Saline (TBS): 
Tris Base              30g 
NaCl               80g 
KCl                2g________________ 
Make up to 1000ml with DW, adjust pH to 7.4. Store at RT. 
 
X1 Tris Buffered Saline (TBS):  
Diluted 1:10 with DW from x10 stock 
TBS complemented with 0.05% Tween 20:  
Add 1ml of Tween 20 (100%) to 2000ml of TBS x1 
 
Trypsin 0.25% 
49.5ml of PBS were added to 0.5ml of 25% trypsin. Solution was aliquoted into 4ml 
batches. Store at -20°C.  
 
Tween-20 0.2%: 
Add 160l of 5% Tween-20 to 3840l PBS 
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Tween-20 5%:  
Add 0.5ml of 100% Tween-20 to 9.5ml of DW 
X20 Tris (0.8M) acetate (TAE) buffer: 
Tris base     96.8g 
Glacial acetic acid   22.84ml 
EDTA 0.5M (pH=8.0)  40ml 
 
X1 Tris-acetate 0.04M  EDTA 0.001M (TAE) buffer: 
Add 950ml of DEPC water to 50ml of x20 TAE 
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Appendix 4: Methods in Apoptosis Research 
Apoptotic 
changes in: 
Source of 
material 
Method of 
detection 
Reference 
phology Fixed tissues 
Frozen tissues 
Living cells 
Light and electron 
microscope assessment 
of cell/nuclear 
appearance 
Studzinski,  1999 
Immunohistochemistry 
 
TUNEL (detects all DNA 
breakages) 
Gavrieli, 1992 
ISEL (detects 
3’overhangs only) 
Wijsman, 1993 
 
Cytoskeleton and 
nucleoskeleton 
Fixed tissues 
Living cells 
 
Methods based on 
annexin V affinity 
towards 
Phosphatidylserine (PS) 
Koopman, 1994 
DNA Living cells 
Living tissues 
 
DNA laddering shown by 
electrophoresis 
Walker, 1997 
Filter elution assay  
Mitochondrial to 
nuclear DNA ratio 
Living cells 
Living tissues 
 
Hybridization, 
Southern blot analysis 
Tepper, 1992 
Gene Expression Living cells 
Living tissues 
 
Molecular biology 
methods; 
Microarray assay 
 
Metabolism  
(mitochondrial 
transmembrane  
potential; reactive 
oxygen species; 
Living cells Flow cytometry; 
Enzymatic methods; 
Spectrophotometric 
analysis 
Salvioli, 1997; 
Griffith, 1980; 
Rice, 1986; 
Aebi, 1984 
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gluthatione levels; 
catalase) 
 
Bcl-2 family proteins  Living cells 
Living tissues 
Artificial membranes 
 
 
Immunoblot; 
flow cytometry; 
immunofluorescence; 
Norhtern blot of Bcl-2 
mRNA; 
 
RT-PCR; 
 
immunohistochemistry; 
 
production of 
recombinant Bcl-2 family 
proteins in bacteria; 
 
measuring of pore 
formation; 
 
cytotoxic and 
cytoprotective functions 
tests 
Krajewski, 1996; 
Schendel, 1997;  
Xie, 1998;  
Matsuyama, 1998; 
Ink, 1997 
Proteolysis Living cells 
Living tissues 
Fixed tissues 
 
Immunoblotting; 
Caspase activity assay 
(using fluorogenic 
substrates) 
 
Detection of active 
caspases by affinity 
labelling 
Immunohistochemistry 
Talanian, 1997; 
Thornberry, 1995;  
Kaufmann, 1989 
Cytotoxicity Living cells Chromium (51Cr) 
release assay; 
Iododeoxyuridine 
(125IUdR)release assay; 
[3H]Thymidine-labelled 
DNA retention by living 
cells assay; 
Fas-based cytotoxicity in 
the absence of perforin-
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granzyme contribution 
(perforin-granzyme 
defective cells used); 
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Appendix 5: Induction of apoptosis in Jurkat Cells by LCH and non-LCH 
conditioned media 
          
 
Time course:  
 
Plate 1:  0hrs 
 
Plate 2:  3hrs 
 
Plate 3:  6hrs 
 
Plate 4:  24hrs 
 
Plate 5:  48hrs 
 
Plate 6:  72hrs 
 
 
 
Appendix 5. 279 
 
 
 
 
Controls 
Control 1:  Cells alone -PI-Ann    1 well 
Control 2:  Cells alone +PI    3 wells 
Control 3: Cells alone +Ann   3 wells 
Control 4:  Cells alone +PI+Ann   3 wells 
Control 5: Cells alone +CH11/DS+PI+Ann   3 wells  
 
CM from LCH biopsies available from BCRC tumour bank was divided in 3 groups, each was tested on different day under standardised conditions. JCs 
were seeded in the wells of 96 well plates at the concentration of 2x104
group contained negative (non-treated cells in full medium diluted to 5, 10, 25, 50 and 100% with serum free medium) and positive (cells in full medium 
containing anti-Fas antibody complemented with dextran sulphate) controls. The optimal time of apoptosis ind uction was tested and selected as 24 hrs (data not 
shown).   
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Procedure  
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Appendix 5. 282 
 
 
Appendix 5. 283 
 
 
Anti-Fas antibody clone CH11 (CH11)   Prepare 2000ml of CH11/DS solution in full medium 
Stock:   500g/ml    CH11: 1/5000 = 1/50/100:  
Working:  100ng/ml    1/50 1l (stock) + 49l full medium 
Dilution: 1/5000      
 
Dextran Sulphate (DS) 
Stock:   100mg/ml    DS: 1/1000 = 1/10/100 
Working: 100g/ml    1/10 2l(stock) + 18l full medium 
Dilution: 1/1000 
 
       CH11/DS in full medium: 
       20l CH11 (1/50) + 20l DS (1/10) + 1960l full medium 
  
          
      
       Filter-sterilise (0.22m) 
          
        
Appendix 5. 284 
 
 
Appendix 5. 285 
 
Prepare Serial Dilutions of CM Following the Chart:  
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Appendix 5. 287 
 
 
Appendix 5. 288 
 
 
Appendix 5. 289 
 
 
Appendix 5. 290 
 
 
Appendix 5. 291 
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 Collect cells through 70m filter (filter-cap or filter) into the flow tube 
 Add 4mls of sterile PBS into each tube, resuspend cells 
 Spin for 5 min at 1500 rpm 
 Aspirate PBS leaving approximately 100l of liquid at the bottom (do not aspirate cell pellet) 
 Add 5l of PI and 5l of Annexin V per tube where necessary 
 Vortex tubes to suspend the cells into the solution 
 Incubate in the dark for 15 min  
 While incubating prepare x1 binding buffer from x10 concentrate using sterile DW 
 At the end of the incubation add 250l of x1 binding buffer per tube 
 Perform flow cytometry 
 
 
 
Appendix 6 293 
Appendix 6. Apoptotic Proteins Tested in the Human Apoptosis Antibody Array 
 
Protein 
 
 
Family 
 
Pro- or Anti-
apoptotic 
 
Location in the Cell 
 
Pathway  
 
Bad  
(the Bcl-2-associated death 
promoter)(Bae, 2001; Adachi, 
2002) 
 
 
 
Bcl-2 family of proteins 
BH3-only subfamily 
 
Pro-apoptotic: tasked with 
sensing a broad range of 
apoptotic stimuli and 
transmitting this signal to 
other Bcl-2 proteins to 
initiate PCD (Leibowitz, 
2010). Upon activation, 
Bad is able to form a 
heterodimer with anti-
apoptotic proteins and 
prevent them from 
stopping apoptosis 
(Kelekar, 1997). 
 
 
 
Cytosolic organelles 
resembling mitochondria 
(Kitada, 1998) 
 
Intrinsic (Leibowitz, 2010) 
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Appendix 6. Continued 
 
Bcl-2  
(B-cell lymphoma 2) 
(Hockenbery et al., 1990)  
 
 
 
 
Bcl-2 family of proteins 
 
Anti-apoptotic: Bcl-2 
inhibits caspase activity 
either by preventing the 
release of cytochrome c 
from the mitochondria 
and/or by binding to the 
apoptosis-activating factor  
APAF-1) (Adams & Cory, 
2007; Leibowitz & Yu, 
2010) 
 
 
On mitochondrion, nucleus 
and endoplasmic reticulum 
membranes 
 
 
Intrinsic (Leibowitz & Yu, 
2010) 
 
Bcl-XL (Bogner et al., 2010; 
Soriano & Scorrano, 2010)  
 
 
 
Bcl-2 family of proteins 
 
Anti-apoptotic: prevents 
the release of cytochrome 
C from the mitochondrial 
inter-membrane space 
into the cytosol 
 
 
In the cytosol in association 
with the mitochondria 
membranes 
 
Intrinsic  (Leibowitz & Yu, 
2010) 
 
Pro-caspase 3 (Stennicke et 
al., 1998) 
 
 
Caspase-3 zymogen 
(precursor) 
 
 
Not active 
 
Cytosol 
 
Not active  
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Catalase (Loew, 1900; Sumner 
et al., 1937; Sumner & Gralen, 
1938; Schroeder  et al., 1969; 
Murthy et al., 1981) 
 
 
NA 
 
Pro-apoptotic: suppresses 
HSP70 and HSP27 thus 
up-regulates intrinsic 
apoptotic pathway 
(Sancho et al., 2003). 
Responsible for H2O2 
catabolism (Alberts et al., 
2002) 
 
 
Peroxisomes 
 
 
Intrinsic  
 
cIAP-1, cIAP-2  
(Inhibitor of apoptosis) (Liston 
et al., 1996; Rothe et al., 1996) 
 
Inhibitor of apoptosis 
family of proteins 
 
Anti-apoptotic: inhibits 
caspases-3, -7 and -9 
activity as well as 
proteolytic processing of 
pro-caspase-3 (Roy et al., 
1997) 
 
Nucleus (Samuel et al., 2005) 
 
Extrinsic: associated with 
TNFR2 signalling complex.  
Multi-functional molecules. 
Involved in cell cycle 
regulation and signal 
transduction as well as 
apoptosis (Liston et al., 
2003; Salvesen, 2002) 
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Livin (Vucic et al., 2000; 
Ashhab et al., 2001)  
 
 
Inhibitor of apoptosis 
family of proteins 
 
 
Anti-apoptotic: full-length 
Livin Pro-apoptotic: 
truncated Livin (Wang et 
al., 2008; Abd-Elrahman 
et al., 2009) 
 
Nucleus, diffusely in 
cytoplasm (Kasof et al., 2001) 
 
Under investigation 
 
 
 
 
 
XIAP 
(X-linked inhibitor of apoptosis 
protein) (Liston et al., 1996)  
 
 
Inhibitor of apoptosis 
family of proteins 
 
 
Anti-apoptotic: directly 
binds and inhibits 
caspase-3, -7 and -9, 
blocks cell death induced 
by TNFa, Fas, UV light 
and genotoxic agents  
(Duckett et al., 1998)  
 
Cytoplasm (Samuel et al., 
2005) 
 
Intrinsic: downstream of 
Bcl-X and Cytochrome C 
(Duckett et al., 1998) 
 
Ubiquitin/proteasome 
pathway (Ni et al., 2005; 
Kaur et al., 2005) 
 
Survivin  (Sah et al., 2006) 
 
Inhibitor of apoptosis 
family of proteins 
 
Anti-apoptotic: directly 
binds and inhibits 
caspase-3, -7 and -9 
(Tamm et al., 1998) may 
play role in enhancing 
XIAP stability (Dohi et al., 
2004) 
Cell cycle regulation 
(Caldas, 2005) 
Nucleus (Caldas et al., 2005)  
Not found in terminally 
differentiated cells (Sah et al., 
2006) 
 
 
Not well understood 
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Claspin (Kumagai et al., 
2000) 
 
 
Mediator protein 
required for Chk1 
kinase activation 
 
 
Anti-apoptotic (Matsuura 
et al., 2008; Myers et al., 
2009; Chini et al., 2006) 
 
 
Nucleus 
 
ATR-Chk1 pathway 
(replication checkpoint 
control), remains to be fully 
understood 
 
 
Clusterin (Blaschuk et al., 
1983) 
 
 
Chaperone 
 
Under investigation (Rizzi 
et al., 2010) 
 
 
ER, nucleus  (Rizzi et al., 
2010) 
 
Not well understood 
 
Cytochrome C 
 
 
 
Cytochrome C family 
of proteins 
 
 
Pro-apoptotic: mediator in 
caspase activation  
 
Mitochondrion inner 
membrane and inter-
membrane space 
 
Extrinsic and intrinsic 
 
TRAIL-R1/DR4); 
TRAIL-R2/DR5;  
Fas/Apo-1/TNFRSF6 
 
TNF receptor 
superfamily 
 
Pro-apoptotic (Sancho-
Martinez et al., 2009) 
 
Cell surface membrane 
 
Extrinsic pathways 
 
FADD (Eberstadt et al., 1998) 
(Fas-Associated protein with 
Death Domain) 
 
 
NA Pro-apoptotic: adaptor 
molecule, mediates 
apoptotic signals 
transduction from receptor 
to intracellular molecules 
Cytosol Extrinsic pathways 
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HIF-1Greijer et al., 2004; 
Blancher et al., 1998; 
Semenza et al.,  1998)
(Hypoxia Inducible Factor) 
 
 
NA 
 
Pro-apoptotic: initiates 
apoptosis by inducing 
high concentrations of 
pro-apoptotic proteins 
(Greijer et al., 2004) 
 
 
 
Cytoplasm and nucleus 
(Wiesener et al., 1998) 
 
Hypoxia response pathway 
 
HO-1/HMOX1/HSP32 
(Heme oxygenase-1) 
HO-2/HMOX2 
(Heme oxygenase-2) 
 
 
Hem oxygenase family 
 
Anti-apoptotic (Morse et 
al., 2009) 
 
 
ER; nucleus; plasma 
membrane (lipid 
rafts);mitochondria (Lin et al., 
2007; Sacca et al., 2007; Kim 
et al., 2004; Feron et al., 
1996; Converso et al., 2006) 
 
 
Extrinsic and intrinsic 
stress-induced pathways 
(Morse et al., 2009) 
 
HSP27 
(Heat Shock 27kDa Protein) 
 
 
 
 
 
 
 
Small Heat shock 
proteins family 
 
Anti-apoptotic: prevents 
damage to the cell from 
high heat. (Beere, 2004; 
Lanneau, 2008) 
 
Chaperone activity 
 
 
 
Cytosol, ER, nucleus (Sarto, 
2000; Vargas-Roig, 1997; Rui, 
2003) 
 
Extrinsic and intrinsic 
pathways (Beere, 2004) 
JNK, NF-B, AKT 
cascades (Beere, 2004) 
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HSP60 (Gupta et al., 1995) 
(Heat Shock 60kDa Protein) 
 
 
Heat Shock Proteins 
60kDa family 
 
Anti-apoptotic: prevents damage 
to the cell from high heat.  
 
Maintains conformational 
integrity of the cell’s proteins in 
response to the environmental 
changes.  
Transports and maintains 
mitochondrial proteins. 
Participates in transmission and 
replication of mitochondrial DNA. 
 
 
Mitochondrial 
chaperonin: 
transportation and 
refolding of proteins 
from cytoplasm into the 
mitochondrial matrix 
(Itoh et al., 2002) 
 
 
Heat shock signal 
pathways (Calabrese et al., 
2007) 
Stress-induced pathways 
(Rossi et al., 2002) 
 
 
HSP70 (Ritossa et al., 1962; 
Ritossa et al., 1996) 
(Heat Shock 70kDa Protein) 
 
Heat Shock Proteins 
70kDa family 
Anti-apoptotic: blocks the 
recruitment of procaspase-9 to 
the apoptosome; interacts with 
ER stress sensor protein 
protecting from ER stress-
induced apoptosis (Beere et al.,  
2000; Gupta et al., 2010) 
HSP70 temporarily binds  
to partially-denaturated proteins, 
preventing them from 
aggregating and allowing them to 
re-fold.  
Cytosol, mitochondria, 
nucleus (Arya et al., 
2007) 
 
Ubiquitination and 
proteolysis pathways 
(Luders et al., 2000) 
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HTRA2/Omi 
(High-temperature 
requirement) A2 member 
 
 
 
HtrA family of serine 
proteases 
 
Pro-apoptotic: proteolytically 
removes caspase-3,-7 and -9 
inhibitors (Yang et al., 2003; 
Srinivasula et al., 2003; Martins 
et al., 2002; Hegdeet al., 2002) 
 
 
Mitochondria inter-
membrane space 
(Vande Walle et al., 
2008; Hegde et al., 
2002; Martins et al., 
2002) 
 
Extrinsic and intrinsic 
caspase-dependent and -
independent mechanisms 
of apoptosis (Vande Walle 
et al., 2008) 
 
 
 
PON2 
(Paraoxonase-2) 
 
 
Paraoxonase family of 
enzymes 
 
Anti-apoptotic: protects the cell 
from oxidative stress-induced 
apoptosis preventing 
mitochondria superoxide 
production and diminishing ROS 
(Horke et al., 2008; Altenhofer et 
al., 2010; Devarajan et al., 2010) 
 
Perinuclear region, ER 
and mitochondria 
(Horke et al., 2007; Ng 
et al.,  2001; Rothem e 
al., 2007) 
 
Unfolded protein response 
(UPR) pathway; 
JNK pathway (downsteam 
from UPR pathway); 
Intrinsic pathway 
 
P21/CIP1/CDNKIA (Harper et 
al., 1993; el-Diery et al., 1993) 
(Cyclin-dependent kinase 
inhibitor A) 
 
G1-checkpoing cyclin-
dependent kinases 
inhibitors  
 
Pro-apoptotic: reduces or 
eliminates proliferation by 
inhibiting cyclin-CDK complexes 
(Xiong et al., 1993)  
 
Nucleus, cytoplasm 
(Slingerland et al., 
2000; Blain, 2002) 
 
Multifaceted protein, 
potentially with several 
important roles in cell cycle 
regulation. Involved in P53-
dependent and -
independent pathways 
(Coller, 2000; Abukhdeir, 
2009) 
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P27/KIP1 (Koff, 1993; Polyak, 
1994) 
(Cyclin-dependent kinase 
inhibitor B) 
 
 
G1-checkpoing cyclin-
dependent kinases 
inhibitors  
 
Pro-apoptotic: inhibits cyclin-
CDK complexes from 
phosphorylating histone H1. 
Overexpression of p27 prevents 
CDK activation and entry into the 
S phase of the cell cycle (Polyak, 
1994; Toyoshima, 1994) 
 
 
Nucleus, cytoplasm 
(Slingerland, 2000; 
Blain et al., 2002) 
 
Multifaceted protein, 
potentially with several 
important roles in cell cycle 
regulation. Involved in P53-
dependent and -
independent pathways 
(Coller et al., 2000; 
Abukhdeir et al., 2009) 
 
 
 
SMAC/DIABLO (Du et al., 
2000) 
(Second mitochondria-derived 
activator of caspases) 
 
 
 
 
NA 
 
Pro-apoptotic: eliminates 
inhibition by IAP. Promotes 
proteolytic activation of 
procaspase-3 and enzymatic 
activity of caspase-3 (Chai et al., 
2000)  
 
 
 
 
 
 
Resides in 
mitochondria, works in 
cytosol (Du et al., 
2000) 
 
Intrinsic 
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p53 (Levine et al., 1997; 
Vogelstein et al., 2000) 
Phospho-p53(S15) 
 
 
 
p53 phosphorylated at 
Ser15 
 
 
In apoptosis: Transcription-
independent p53 functions have 
been reported to mediate 
apoptosis under some 
experimental conditions 
(Caelleset al., 1994; Haupt et al., 
1997; Ahn et al., 2009) 
P53 can bind directly to 
mitochondrial proteins and 
induce apoptosis in a 
transcription-independent 
manner (Mihara et al., 2003) 
P53 functions primarily as a 
transcription factor that regulates 
multiple genes involved in 
regulation of cell growth and 
homeostasis.  
Phosphorylation at Ser15 
enhances the interaction of p53 
with transcriptional co- 
Activators (Sakaguchi et al., 
1998; Lambert et al., 1998; 
Dumaz,1999) 
 
Nucleus, cytoplasm 
(Slingerland et al., 
2000; Blain et al., 
2002) 
 
P53 pathways 
 
Apoptotic activity of p53 is 
the most complex and least 
understood of its functions 
(Thompson et al., 2004) 
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Phospho-p53(S46) 
 
 
 
p53 phosphorylated at 
Ser46 
 
 
Same as for Phospho-p53(S15) 
 
 
 
 
Nucleus, cytoplasm 
(Slingerland et al., 
2000; Blain et al., 
2002) 
 
P53 pathways 
 
 
Phospho-p53(S392) 
 
 
 
p53 phosphorylated at 
Ser392 
 
 
Same as for Phospho-p53(S15) 
 
 
 
Nucleus, cytoplasm 
(Slingerland et al., 
2000; Blain et al., 
2002) 
 
P53 pathways 
 
 
Phospho-Rad17(S635) 
(Parker et al., 1998) 
(hRad17 protein 
phosphorylated at Ser635) 
 
 
Rad family of proteins 
 
Pro-apoptotic: participates in cell 
cycle blockade after DNA 
damage induced by genotoxic 
stress (Rauen et al., 2000; 
Lindsey-Boltz et al., 2001) 
 
 
Nucleus (Lin et al., 
2007) 
 
Checkpoint signalling 
cascades in geno-toxic 
stress 
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Appendix 7. Cytokines Secreted by LCH 
 
Cytokine 
 
 
Molecule 
 
Function 
CD5a RWRW (Monk et al., 2007) 
(Complement Component 5a)  
 
 
Protein  C5a causes the release of histamine from mast cells 
 
 leukocyte chemoattractant, causes the accumulation of WBCs, especially 
neutrophils, at sites of complement activation 
 
 activates WBCs by increasing avidity for WBCs integrins and upregulating the 
Lipoxygenase pathway for arachidonic acid metabolism 
 
 C5a is a powerful inflammatory mediator, and seems to be a key factor in the 
development of pathology of many inflammatory diseases involving the 
complement system 
 
 C5a modulates balance between activating versus inhibitory IgG Fc receptors 
on leukocytes, thereby enhancing autoimmune response. 
 
G-CSF (Hamilton et al., 2004) 
(CSF , CSF-3). (Granulocyte 
colony-stimulating factor) 
Glycoprotein  Secreted by macrophages, T lymphocytes, mast cells, endothelial cells and 
ibroblasts.Granulocyte/macrophage colony-stimulating factor that act in hematopoiesis 
by controlling the production, differentiation and function of granulocytes.  
 Appendix 7 305 
 
 
Appendix 7. Continued 
 
GM-CSF (Hamilton et al., 2004)  
(CSF, CSF-2) 
(Granulocyte macrophages 
colony-stimulating factor) 
 
 
Protein 
 
Controls the production, differentiation, and function of granulocytes and 
macrophages 
 
GRO(Haskill et al., 1990)
CXCL1). Chemokine (C-X-C 
motif) ligand 1 
 
Protein 
 
CXCL1 is expressed by macrophages, neutrophils and epithelial cells.  
Neutrophil chemoattractant.  
 
 
sICAM-1 (Abraham et al., 1984; 
Yang et al., 2005)  
(CD54) 
(Inter-Cell Adhesion Molecule-1) 
 
 
Protein 
 
Continuously present in low concentrations in the membranes of leukocytes and 
endothelial cells.  
It binds to two integrins on leukocytes, LFA-1 and Mac-1. Cell adhesion mediated by 
these molecules is critical for leukocyte adhesion to endothelial cells and interaction 
between T cells and antigen-presenting cells.  
When activated, leukocytes bind to endothelial cells via ICAM-1/LFA-1 and then 
transmigrate into tissues. 
More recently, ICAM-1 has been characterized as a site for the cellular entry of 
human rhinovirus.  
IL-1ra (Dinarello et al., 1994) 
(Interleukin-1 receptor antagonist) 
 
Protein Inhibits the activities of IL-1a and IL-1b 
Modulates a variety of interleukin 1 related immune and inflammatory responses. 
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Appendix 7. Continued 
 
IL-6 (Smolen et al., 2006) 
(Interleukin-6) 
 
 
 
Protein 
 
Secreted by T lymphocytes, macrophages, ostaoblasts (to stimulate osteoclast 
formation) and smooth muscle cells in tunica media of many blood vessels.  
Anti-inflammatory cytokine: inhibits TNF-alpha and IL-1, activates IL-1ra and IL-10. 
 
IL-8 (Utgaard et al., 1998) 
(Interleukin-8) 
 
Protein 
 
The primary cells to first encounter the antigen are the macrophages who 
phagocytose the particle. Upon processing, they release chemokines to signal other 
immune cells to come in to the site of inflammation. IL-8 is one such chemokine. It 
serves as a chemical signal that attracts neutrophils at the site of inflammation, and 
therefore is also known as neutrophil chemotactic factor. 
 
IL-16 (Cruikshank et al., 2000)  
(LCF) 
(Interleukin-16) 
 
Protein 
 
Recruits and activates cells expressing the CD4 molecule, including monocytes, 
eosinophils and dendritic cells  
 
 
MCP-1 (Carr et al., 1994; Xu et 
al., 1996) (CCL-2) 
(Monocyte chemotactic protein-1) 
 
Protein 
 
Recruits monocytes, memory T lymphocytes and dendritic cells to sites of tissue 
injury, infection and inflammation 
MIF (Dumitru et al., 2011; Kim-
Saijo et al., 2008) (GIF, DER6) 
(Macrophage migration inhibitory 
factor) 
Protein Pro-inflammatory cytokine. Involved in the innate immune response to bacterial 
pathogens. The expression of MIF at sites of inflammation suggests a role as 
mediator in regulating the function of macrophages in host defence. 
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Appendix 7. Continued 
 
MIP-1a (Maurer et al., 2004; 
Sherry et al., 1988)  
(CCL3) 
(Macrophage inhibitory protein) 
 
 
Protein 
 
Produced by many cells, particularly by activated macrophages, dendritic cells and lymphocytes.  
Activates granulocytes. Induces the synthesis and release of other pro-inflammatory cytokines such 
as interleukin 1 (IL-1), IL-6 and TNF-α from fibroblasts and macrophages. 
 
 
Serpin E1 (Binder et al., 2002)  
(PAI-1) 
(Serine protease inhibitor) 
 
 
 
 
Protein 
 
Inhibits physiological breakdown of blood clots. 
Inhibits matrix metalloproteinases. 
Plays a significant role the progression to fibrosis: lower Serp in E1 – more rapid degradation of 
fibrin.  
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Appendix 8. Cell Composition in LCH and 
Control Lesions 
 
Disease 
 
CD1a+ 
 
CD3+ 
 
CD19+ 
 
CD68+ 
 
CD138+ 
  
Single Stained Cells (% From Total Cells) 
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M
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n
  
S
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LCH 
 
10.2 
 
2.3 
 
12 
 
2.3 
 
5.5 
 
1.9 
 
6.1 
 
1.2 
 
2 
 
0.4 
 
IBD 
 
2.4 
 
1.8 
 
18.2 
 
10 
 
10.9 
 
1.7 
 
12.2 
 
5.3 
 
8.2 
 
1.4 
 
Sarcoidosis 
 
3.8 
 
0.9 
 
23.4 
 
3.1 
 
7.7 
 
1.9 
 
8.9 
 
1.4 
 
2.5 
 
0.6 
 
Tonsillitis 
 
4 
 
1.1 
 
14.9 
 
2.2 
 
19.6 
 
3.3 
 
11.5 
 
2.3 
 
3.3 
 
0.8 
 
Foreign Body 
Granuloma 
 
 
7.5 
 
1.7 
 
11.7 
 
2 
 
2 
 
1.2 
 
9.2 
 
1.8 
 
6.9 
 
2.3 
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Appendix 9. DNA Fragmentation Detected 
by Singular and Dual Staining Techniques 
Disease 
Singular TUNEL 
staining 
Dual staining TUNEL & 
IHC 
  TUNEL-Positive Cells (% From Total Cells) 
  
M
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n
  
S
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r 
 
M
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S
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LCH 7.5 0.9 3.1 0.4 
IBD 0.4 0.1 0.7 0.2 
Sarcoidosis 0.3 0.1 1.3 0.1 
Tonsillitis 2.5 0.4 1.2 0.1 
FBG 0.8 0.3 0.8 0.1 
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Appendix 10. Apoptotic Cell Composition in LCH and Control Lesions 
 
